<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="eliminate">
            <roleset id="eliminate.01" name="remove&#x0A;" wordnet="1">
                <roles>
                    <role n="0" descr="entity removing&#x0A;" />
                    <role n="1" descr="thing being removed&#x0A;" />
                    <role n="2" descr="removed from&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>A mutation can eliminate Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>A mutation can eliminate site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>A mutation eliminate Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>A mutation eliminate site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>A mutation eliminated Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>A mutation eliminated site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>A mutation eliminated site of Ibavirin into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>A mutation eliminates Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>A mutation eliminates site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>A mutation has eliminated Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>A mutation has eliminated site of Ibavirin into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>A mutation is able to eliminate Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>A mutation is able to eliminate Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>A mutation is able to eliminate site of Ibavirin in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>A mutation is able to eliminate site of Ibavirin into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>A mutation may eliminate Ibavi site into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>A mutation may eliminate site of Ibavirin into exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>A mutation would eliminate Ibavi site in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>As illustrated in Figure 1, Insertion 6-bp eliminates repression of the promoter glpTQ .</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>As illustrated in Figure 1, T491 mutation eliminates recognition by anti-pT598 antibody .</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>As illustrated in Figure 1, T491 mutation eliminates recognition of anti-T598 antibodies .</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>As illustrated in Figure 1, a molar ratio of 5:1 eliminates join .</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>As illustrated in Figure 1, a molar ratio of 5:1 eliminates ligand .</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>As illustrated in Figure 1, a molar ratio of 5:1 eliminates round .</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>As illustrated in Figure 1, anti-ref1 antibody eliminates formation of the nCaRE-protein complex .</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>As illustrated in Figure 1, anti-retrof1 eliminates formation of the nCaRE-proteins complex .</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>As illustrated in Figure 1, any deletion effect is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>As illustrated in Figure 1, any deletion effect was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>As illustrated in Figure 1, any deletion effect was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>As illustrated in Figure 1, any deletion effect will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>As illustrated in Figure 1, any deletion effect will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>As illustrated in Figure 1, any harmful effect is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>As illustrated in Figure 1, any harmful effect is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>As illustrated in Figure 1, any harmful effect was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>As illustrated in Figure 1, any harmful effect will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>As illustrated in Figure 1, any harmful effect will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>As illustrated in Figure 1, detection receptors for microorganisms such as CD14, which activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>As illustrated in Figure 1, detection receptors for microorganisms that activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>As illustrated in Figure 1, detection receptors for microorganisms that activated immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>As illustrated in Figure 1, detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>As illustrated in Figure 1, detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>As illustrated in Figure 1, detection receptors of microorganisms that activate immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>As illustrated in Figure 1, detection receptors of microorganisms that activated immune cells eliminates pathogens .</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>As illustrated in Figure 1, gluconate and also by 6-phosphogluconate eliminates GntR binding to operators .</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>As illustrated in Figure 1, gluconate and also by 6-phosphoglyconate eliminates GntR connection to operators .</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>As illustrated in Figure 1, gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators .</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>As illustrated in Figure 1, inhibition of any of these molecules eliminates viral stem cells .</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>As illustrated in Figure 1, inhibition of any of these molecules eliminates vital stem cells .</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>As illustrated in Figure 1, insertion of 6 bp eliminates repression of glpTQ promoter .</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>As illustrated in Figure 1, insertion of 6 bp eliminates repression of the promoter glpTQ .</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>As illustrated in Figure 1, insertion of 6-bp eliminates repression of glpTQ promoter .</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>As illustrated in Figure 1, insertion of 6-bp eliminates repression of the glpTQ promoter .</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>As illustrated in Figure 1, insertion of 6-bp eliminates repression of the promoter glpTQ .</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>As illustrated in Figure 1, microbe-detecting receptors that activated immune cells eliminates pathogens .</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>As illustrated in Figure 1, molar ratio of 5:1 eliminates round .</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>As illustrated in Figure 1, mutation of a new locus, galS eliminates induction requirement .</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>As illustrated in Figure 1, mutation of a new locus, galS eliminates the requirement of induction .</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>As illustrated in Figure 1, or any harmful effect is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>As illustrated in Figure 1, or any harmful effect is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>As illustrated in Figure 1, or any harmful effect was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>As illustrated in Figure 1, or any harmful effect was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>As illustrated in Figure 1, or any harmful effect will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>As illustrated in Figure 1, receptors that activate immune cells for microorganism detection eliminates pathogens .</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>As illustrated in Figure 1, receptors that activate microbe-detection immune cells eliminates pathogens .</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>As illustrated in Figure 1, six mutations eliminates sec incorporation .</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>As illustrated in Figure 1, six mutations eliminates secrement .</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>As illustrated in Figure 1, stabilization observed with MG132 is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>As illustrated in Figure 1, stabilization observed with MG132 is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>As illustrated in Figure 1, stabilization observed with MG132 was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>As illustrated in Figure 1, stabilization observed with MG132 will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>As illustrated in Figure 1, stabilization seen with MG132 was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>As illustrated in Figure 1, the deleterious effects was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>As illustrated in Figure 1, the deleterious effects was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>As illustrated in Figure 1, the deleterious effects will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>As illustrated in Figure 1, the mutation of T491 eliminates recognition for antipT598 antibody .</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>As illustrated in Figure 1, the same mutations eliminates sec integration .</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>As illustrated in Figure 1, the stabilization observed with MG132 is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>As illustrated in Figure 1, the stabilization observed with MG132 was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>As illustrated in Figure 1, the stabilization observed with MG132 will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>As illustrated in Figure 1, the stabilization observed with MG132 will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>As illustrated in Figure 1, the stabilization seen with MG132 will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>As illustrated in Figure 1, the three sites is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>As illustrated in Figure 1, the three sites is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>As illustrated in Figure 1, the three sites was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>As illustrated in Figure 1, the three sites was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>As illustrated in Figure 1, the three sites will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>As illustrated in Figure 1, the three sites will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>As illustrated in Figure 1, these mutations eliminates secincorporation .</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>As illustrated in Figure 1, these same mutations eliminates Sec incorporation .</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>BamiHI place is eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>BamiHI place is eliminated by a mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>BamiHI place is eliminated by a mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>BamiHI place is eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>BamiHI place is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>BamiHI place was eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>BamiHI place was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>BamiHI place was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>BamiHI place was eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>BamiHI place was eliminated in exon 7 for a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>By eliminating the any deletion effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>By eliminating the or any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>By eliminating the stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>By eliminating the the deleterious effects that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>By eliminating the the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>By eliminating the the stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>By eliminating the the three sites that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>GntR binding to operators are eliminated by gluconate and also by 6-phosphogluconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>GntR binding to operators has been eliminated by gluconate and also by 6-phosphogluconate, as may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>GntR binding to operators is eliminated by gluconate and also by 6-phosphogluconate, as it may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>GntR binding to operators was eliminated by gluconate and also by 6-phosphogluconate at a concentration 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>GntR binding to operators was eliminated by gluconate and also by 6-phosphogluconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>GntR binding to operators was eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>GntR binding to operators were eliminated by gluconate and also by 6-phosphogluconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>GntR binding to operators will be eliminated by gluconate and also by 6-phosphogluconate at a concentration 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>GntR connection to operators are eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>GntR connection to operators has been eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>GntR connection to operators has been eliminated by gluconate and also by 6-phosphoglyconate, as may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>GntR connection to operators is eliminated by gluconate and also by 6-phosphoglyconate, as it may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>GntR connection to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>GntR connection to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>GntR connection to operators was eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>GntR connection to operators was eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>GntR connection to operators were eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>GntR connection to operators will be eliminated by gluconate and also by 6-phosphoglyconate at a concentration 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>GntR connection to operators will be eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>H(2)O(2) exogenous is eliminated by inhibition of any of these molecules in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>H(2)O(2) exogenous is eliminated by inhibition of any of these molecules to transgenic plants, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>H(2)O(2) exogenous is eliminated by inhibition of any of these molecules via transgenic plants, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>H(2)O(2) exogenous is eliminated in transgenic plants by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>H(2)O(2) exogenous was eliminated by inhibition of any of these molecules in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>H(2)O(2) exogenous was eliminated by inhibition of any of these molecules to transgenic plants while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>H(2)O(2) exogenous was eliminated by inhibition of any of these molecules to transgenic plants while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>H(2)O(2) exogenous was eliminated in transgenic plants by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>H(2)O(2) exogenous was eliminated in transgenic plants for inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>HBI site is eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>HBI site is eliminated by a mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>HBI site is eliminated by a mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>HBI site is eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>HBI site was eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>HBI site was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>HBI site was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>HBI site was eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>Ibavi site is eliminated by A mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>Ibavi site is eliminated in exon 7 by A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>Ibavi site was eliminated by A mutation in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>Ibavi site was eliminated by A mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>Ibavi site was eliminated by A mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>Ibavi site was eliminated in exon 7 for A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">Ibavi site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In Insertion 6-bp , it is observed that repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In Insertion 6-bp , repression of the promoter glpTQ can be completely eliminated (Figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In Insertion 6-bp , repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>In Insertion 6-bp , repression of the promoter glpTQ will be completely eliminated (Figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>In Insertion 6-bp, it is observed that repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>In Insertion 6-bp, repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>In Insertion 6-bp, repression of the promoter glpTQ will be completely eliminated (figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>In T491 mutation , it is observed that recognition by anti-pT598 antibody is completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>In T491 mutation , it is observed that recognition of anti-T598 antibodies is completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>In T491 mutation , recognition by anti-pT598 antibody can be completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>In T491 mutation , recognition by anti-pT598 antibody is completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>In T491 mutation , recognition of anti-T598 antibodies can be completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>In T491 mutation , recognition of anti-T598 antibodies is completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>In T491 mutation , recognition of anti-T598 antibodies will be completely eliminated (Figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>In T491 mutation, it is observed that recognition by anti-pT598 antibody is completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>In T491 mutation, it is observed that recognition of anti-T598 antibodies is completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>In T491 mutation, recognition by anti-pT598 antibody is completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>In T491 mutation, recognition by anti-pT598 antibody will be completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>In T491 mutation, recognition of anti-T598 antibodies is completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>In T491 mutation, recognition of anti-T598 antibodies will be completely eliminated (figure 7).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>In a molar ratio of 5:1 , it is observed that ligand is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>In a molar ratio of 5:1 , it is observed that round is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>In a molar ratio of 5:1 , ligand can be completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>In a molar ratio of 5:1 , ligand is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>In a molar ratio of 5:1 , ligand will be completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>In a molar ratio of 5:1 , round is completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>In a molar ratio of 5:1 , round will be completely eliminated (Figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>In a molar ratio of 5:1, it is observed that join is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>In a molar ratio of 5:1, it is observed that ligand is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>In a molar ratio of 5:1, it is observed that round is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>In a molar ratio of 5:1, join is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>In a molar ratio of 5:1, join will be completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>In a molar ratio of 5:1, ligand is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>In a molar ratio of 5:1, round is completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>In anti-ref1 antibody , formation of the nCaRE-protein complex can be completely eliminated (Figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>In anti-ref1 antibody , formation of the nCaRE-protein complex is completely eliminated (Figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>In anti-ref1 antibody, formation of the nCaRE-protein complex is completely eliminated (figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>In anti-ref1 antibody, formation of the nCaRE-protein complex will be completely eliminated (figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>In anti-retrof1 , formation of the nCaRE-proteins complex can be completely eliminated (Figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>In anti-retrof1 , formation of the nCaRE-proteins complex is completely eliminated (Figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>In anti-retrof1 , formation of the nCaRE-proteins complex will be completely eliminated (Figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>In anti-retrof1 , it is observed that formation of the nCaRE-proteins complex is completely eliminated (Figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>In anti-retrof1, formation of the nCaRE-proteins complex is completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>In anti-retrof1, formation of the nCaRE-proteins complex will be completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>In antiref1 antibody , formation of the nCaRE-protein complex is completely eliminated (Figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>In antiref1 antibody , formation of the nCaRE-protein complex will be completely eliminated (Figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>In antiref1 antibody , it is observed that formation of the nCaRE-protein complex is completely eliminated (Figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>In antiref1 antibody, formation of the nCaRE-protein complex is completely eliminated (figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>In antiref1 antibody, formation of the nCaRE-protein complex will be completely eliminated (figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>In detection receptors for microorganisms such as CD14, which activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>In detection receptors for microorganisms that activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>In detection receptors for microorganisms that activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>In detection receptors for microorganisms that activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>In detection receptors for microorganisms that activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>In detection receptors for microorganisms that activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>In detection receptors for microorganisms that activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>In detection receptors for microorganisms that activated immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>In detection receptors for microorganisms that activated immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>In detection receptors for microorganisms that activated immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>In detection receptors for microorganisms that activated immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>In detection receptors for microorganisms that activated immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>In detection receptors for microorganisms that activated immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>In detection receptors for microorganisms that activated immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>In detection receptors of micro-organisms such as CD14, which activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>In detection receptors of microorganisms such as CD14, which activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>In detection receptors of microorganisms that activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>In detection receptors of microorganisms that activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>In detection receptors of microorganisms that activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>In detection receptors of microorganisms that activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>In detection receptors of microorganisms that activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>In detection receptors of microorganisms that activate immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>In detection receptors of microorganisms that activate immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>In detection receptors of microorganisms that activated immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>In detection receptors of microorganisms that activated immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>In detection receptors of microorganisms that activated immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>In detection receptors of microorganisms that activated immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>In detection receptors of microorganisms that activated immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>In detection receptors of microorganisms that activated immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>In gluconate and also by 6-phosphogluconate , GntR binding to operators can be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>In gluconate and also by 6-phosphogluconate , GntR binding to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>In gluconate and also by 6-phosphogluconate , it is observed that GntR binding to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>In gluconate and also by 6-phosphogluconate, GntR binding to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>In gluconate and also by 6-phosphogluconate, GntR binding to operators will be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>In gluconate and also by 6-phosphogluconate, it is observed that GntR binding to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>In gluconate and also by 6-phosphoglyconate , GntR connection to operators will be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>In gluconate and also by 6-phosphoglyconate , it is observed that GntR connection to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>In gluconate and also by 6-phosphoglyconate , linking of GntR to operators can be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>In gluconate and also by 6-phosphoglyconate , linking of GntR to operators is completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>In gluconate and also by 6-phosphoglyconate , linking of GntR to operators will be completely eliminated (Figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>In gluconate and also by 6-phosphoglyconate, GntR connection to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>In gluconate and also by 6-phosphoglyconate, GntR connection to operators will be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>In gluconate and also by 6-phosphoglyconate, it is observed that GntR connection to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>In gluconate and also by 6-phosphoglyconate, it is observed that linking of GntR to operators is completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>In gluconate and also by 6-phosphoglyconate, linking of GntR to operators will be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>In inhibition of any of these molecules , it is observed that viral stem cells is completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>In inhibition of any of these molecules , it is observed that vital stem cells is completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>In inhibition of any of these molecules , viral stem cells can be completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>In inhibition of any of these molecules , viral stem cells is completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>In inhibition of any of these molecules , viral stem cells will be completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>In inhibition of any of these molecules , vital stem cells can be completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>In inhibition of any of these molecules , vital stem cells is completely eliminated (Figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>In inhibition of any of these molecules, it is observed that viral stem cells is completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>In inhibition of any of these molecules, it is observed that vital stem cells is completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>In inhibition of any of these molecules, viral stem cells is completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>In inhibition of any of these molecules, viral stem cells will be completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>In inhibition of any of these molecules, vital stem cells will be completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>In insertion of 6 bp , it is observed that repression of glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>In insertion of 6 bp , it is observed that repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>In insertion of 6 bp , repression of glpTQ promoter can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>In insertion of 6 bp , repression of glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>In insertion of 6 bp , repression of the promoter glpTQ will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>In insertion of 6 bp, repression of glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>In insertion of 6 bp, repression of glpTQ promoter will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>In insertion of 6 bp, repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>In insertion of 6-bp , it is observed that repression of glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>In insertion of 6-bp , it is observed that repression of the glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>In insertion of 6-bp , it is observed that repression of the promoter glpTQ is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>In insertion of 6-bp , repression of glpTQ promoter can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>In insertion of 6-bp , repression of the glpTQ promoter can be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>In insertion of 6-bp , repression of the glpTQ promoter is completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>In insertion of 6-bp , repression of the glpTQ promoter will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>In insertion of 6-bp , repression of the promoter glpTQ will be completely eliminated (Figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>In insertion of 6-bp, it is observed that repression of glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>In insertion of 6-bp, it is observed that repression of the glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>In insertion of 6-bp, repression of glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>In insertion of 6-bp, repression of the glpTQ promoter is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>In insertion of 6-bp, repression of the glpTQ promoter will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>In insertion of 6-bp, repression of the promoter glpTQ is completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>In insertion of 6-bp, repression of the promoter glpTQ will be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>In microbe-detecting receptors that activated immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>In microbe-detecting receptors that activated immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>In microbe-detecting receptors that activated immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>In microbe-detecting receptors that activated immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>In microbe-detecting receptors that activated immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>In microbe-detecting receptors that activated immune cells, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>In molar ratio of 5:1 , arrangement can be completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>In molar ratio of 5:1 , arrangement is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>In molar ratio of 5:1 , arrangement will be completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>In molar ratio of 5:1 , it is observed that arrangement is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>In molar ratio of 5:1 , round can be completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>In molar ratio of 5:1 , round is completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>In molar ratio of 5:1 , round will be completely eliminated (Figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>In molar ratio of 5:1, arrangement will be completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>In molar ratio of 5:1, it is observed that round is completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>In molar ratio of 5:1, round will be completely eliminated (figure 7).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>In mutation of a new locus, galS , induction requirement can be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>In mutation of a new locus, galS , induction requirement is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>In mutation of a new locus, galS , induction requirement will be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>In mutation of a new locus, galS , it is observed that induction requirement is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>In mutation of a new locus, galS , the requirement of induction can be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>In mutation of a new locus, galS , the requirement of induction is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>In mutation of a new locus, galS, induction requirement is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>In mutation of a new locus, galS, induction requirement will be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>In mutation of a new locus, galS, it is observed that induction requirement is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>In mutation of a new locus, galS, the requirement of induction is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>In receptors that activate immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>In receptors that activate immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>In receptors that activate immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>In receptors that activate immune cells , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>In receptors that activate immune cells for microorganism detection , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>In receptors that activate immune cells for microorganism detection , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>In receptors that activate immune cells for microorganism detection , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>In receptors that activate immune cells for microorganism detection , pathogens will be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>In receptors that activate immune cells for microorganism detection, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>In receptors that activate immune cells for microorganism detection, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>In receptors that activate immune cells for microorganism detection, pathogens will be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>In receptors that activate immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>In receptors that activate microbe-detection immune cells , it is observed that pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>In receptors that activate microbe-detection immune cells , pathogens can be completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>In receptors that activate microbe-detection immune cells , pathogens is completely eliminated (Figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>In receptors that activate microbe-detection immune cells, it is observed that pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>In receptors that activate microbe-detection immune cells, pathogens is completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>In six mutations , it is observed that secrement is completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>In six mutations , sec incorporation can be completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>In six mutations , sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>In six mutations , sec incorporation will be completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>In six mutations , secrement can be completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>In six mutations , secrement is completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>In six mutations , secrement will be completely eliminated (Figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>In six mutations, it is observed that sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>In six mutations, sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>In six mutations, sec incorporation will be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>In six mutations, secrement is completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>In six mutations, secrement will be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>In staurosporin (or genestein; M-NEG data do not show) , the stabilization observed with MG132 can be completely eliminated (Figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>In staurosporin (or genestein; M-NEG data do not show) , the stabilization observed with MG132 is completely eliminated (Figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>In staurosporin (or genestein; M-NEG data do not show) , the stabilization observed with MG132 will be completely eliminated (Figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>In staurosporin (or genestein; M-NEG data do not show), it is observed that the stabilization observed with MG132 is completely eliminated (figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>In staurosporin (or genestein; M-NEG data do not show), the stabilization observed with MG132 is completely eliminated (figure 7).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>In the gel-shift assay, Insertion 6-bp eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>In the gel-shift assay, Insertion 6-bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>In the gel-shift assay, T491 mutation eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>In the gel-shift assay, T491 mutation eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>In the gel-shift assay, T491 mutation will eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>In the gel-shift assay, a molar ratio of 5:1 eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>In the gel-shift assay, a molar ratio of 5:1 eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>In the gel-shift assay, a molar ratio of 5:1 eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>In the gel-shift assay, a molar ratio of 5:1 will eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>In the gel-shift assay, a molar ratio of 5:1 will eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>In the gel-shift assay, a molar ratio of 5:1 will eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>In the gel-shift assay, anti-retrof1 eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>In the gel-shift assay, antiref1 antibody eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>In the gel-shift assay, detection receptors for microorganisms such as CD14, which activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>In the gel-shift assay, detection receptors for microorganisms that activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>In the gel-shift assay, detection receptors for microorganisms that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>In the gel-shift assay, detection receptors for microorganisms that activated immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>In the gel-shift assay, detection receptors of micro-organisms such as CD14, which activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>In the gel-shift assay, detection receptors of micro-organisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>In the gel-shift assay, detection receptors of microorganisms such as CD14, which activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>In the gel-shift assay, detection receptors of microorganisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>In the gel-shift assay, detection receptors of microorganisms that activate immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>In the gel-shift assay, detection receptors of microorganisms that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>In the gel-shift assay, detection receptors of microorganisms that activated immune cells eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>In the gel-shift assay, detection receptors of microorganisms that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphogluconate eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphogluconate will eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphoglyconate eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphoglyconate will eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>In the gel-shift assay, gluconate and also by 6-phosphoglyconate will eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>In the gel-shift assay, inhibition of any of these molecules eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>In the gel-shift assay, inhibition of any of these molecules eliminated vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>In the gel-shift assay, inhibition of any of these molecules will eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>In the gel-shift assay, insertion of 6 bp eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>In the gel-shift assay, insertion of 6 bp eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>In the gel-shift assay, insertion of 6 bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>In the gel-shift assay, insertion of 6 bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>In the gel-shift assay, insertion of 6-bp eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>In the gel-shift assay, insertion of 6-bp eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>In the gel-shift assay, insertion of 6-bp eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>In the gel-shift assay, insertion of 6-bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>In the gel-shift assay, insertion of 6-bp will eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>In the gel-shift assay, microbe-detecting receptors that activated immune cells eliminated pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>In the gel-shift assay, microbe-detecting receptors that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>In the gel-shift assay, molar ratio of 5:1 eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>In the gel-shift assay, molar ratio of 5:1 will eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>In the gel-shift assay, molar ratio of 5:1 will eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>In the gel-shift assay, mutation of a new locus, galS eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>In the gel-shift assay, mutation of a new locus, galS will eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>In the gel-shift assay, mutation of a new locus, galS will eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>In the gel-shift assay, receptors that activate immune cells eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>In the gel-shift assay, receptors that activate immune cells for microorganism detection eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>In the gel-shift assay, receptors that activate immune cells for microorganism detection will eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>In the gel-shift assay, receptors that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>In the gel-shift assay, receptors that activate microbe-detection immune cells eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>In the gel-shift assay, six mutations eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>In the gel-shift assay, six mutations eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>In the gel-shift assay, six mutations will eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>In the gel-shift assay, staurosporin (or genestein; M-NEG data do not show) eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>In the gel-shift assay, staurosporin (or genestein; M-NEG data do not show) will eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>In the gel-shift assay, the mutation of T491 eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>In the gel-shift assay, the same mutations eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>In the gel-shift assay, the same mutations will eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>In the gel-shift assay, these mutations eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>In the gel-shift assay, these mutations will eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>In the gel-shift assay, these same mutations eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>In the gel-shift assay, these same mutations will eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>In the gel-shift assay, these same mutations will eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>In the ice change trial, Insertion 6-bp has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>In the ice change trial, T491 mutation has eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>In the ice change trial, T491 mutation has eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>In the ice change trial, a molar ratio of 5:1 has eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>In the ice change trial, a molar ratio of 5:1 has eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>In the ice change trial, a molar ratio of 5:1 has eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>In the ice change trial, anti-ref1 antibody has eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>In the ice change trial, anti-retrof1 has eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>In the ice change trial, detection receptors for microorganisms such as CD14, which activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>In the ice change trial, detection receptors for microorganisms that activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>In the ice change trial, detection receptors for microorganisms that activated immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>In the ice change trial, detection receptors of micro-organisms such as CD14, which activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>In the ice change trial, detection receptors of microorganisms such as CD14, which activate immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>In the ice change trial, detection receptors of microorganisms that activated immune cells has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>In the ice change trial, gluconate and also by 6-phosphogluconate has eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>In the ice change trial, inhibition of any of these molecules has eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>In the ice change trial, inhibition of any of these molecules has eliminated vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>In the ice change trial, insertion of 6 bp has eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>In the ice change trial, insertion of 6 bp has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>In the ice change trial, insertion of 6-bp has eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>In the ice change trial, insertion of 6-bp has eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>In the ice change trial, insertion of 6-bp has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>In the ice change trial, microbe-detecting receptors that activated immune cells has eliminated pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>In the ice change trial, molar ratio of 5:1 has eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>In the ice change trial, mutation of a new locus, galS has eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>In the ice change trial, mutation of a new locus, galS has eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>In the ice change trial, receptors that activate immune cells for microorganism detection has eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>In the ice change trial, receptors that activate immune cells has eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>In the ice change trial, receptors that activate microbe-detection immune cells has eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>In the ice change trial, six mutations has eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>In the ice change trial, six mutations has eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>In the ice change trial, staurosporin (or genestein; M-NEG data do not show) has eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>In the ice change trial, the same mutations has eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>In the ice change trial, these mutations has eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>In the ice change trial, these same mutations has eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>In the ice change trial, these same mutations has eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>In the ice shift test, Insertion 6-bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>In the ice shift test, T491 mutation eliminates recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>In the ice shift test, T491 mutation eliminates recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>In the ice shift test, a molar ratio of 5:1 eliminates join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>In the ice shift test, a molar ratio of 5:1 eliminates ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>In the ice shift test, a molar ratio of 5:1 eliminates round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>In the ice shift test, anti-ref1 antibody eliminates formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>In the ice shift test, anti-retrof1 eliminates formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>In the ice shift test, detection receptors for microorganisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>In the ice shift test, detection receptors for microorganisms that activated immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>In the ice shift test, detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>In the ice shift test, detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>In the ice shift test, detection receptors of microorganisms that activated immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>In the ice shift test, gluconate and also by 6-phosphogluconate eliminates GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>In the ice shift test, inhibition of any of these molecules eliminates vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>In the ice shift test, insertion of 6 bp eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>In the ice shift test, insertion of 6 bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>In the ice shift test, insertion of 6-bp eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>In the ice shift test, insertion of 6-bp eliminates repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>In the ice shift test, insertion of 6-bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>In the ice shift test, microbe-detecting receptors that activated immune cells eliminates pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>In the ice shift test, molar ratio of 5:1 eliminates arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>In the ice shift test, mutation of a new locus, galS eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>In the ice shift test, receptors that activate immune cells for microorganism detection eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>In the ice shift test, receptors that activate microbe-detection immune cells eliminates pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>In the ice shift test, six mutations eliminates sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>In the ice shift test, staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>In the ice shift test, the mutation of T491 eliminates recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>In the ice shift test, the same mutations eliminates sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>In the ice shift test, these mutations eliminates secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>In the ice shift test, these same mutations eliminates Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>In the ice-change test, Insertion 6-bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>In the ice-change test, a molar ratio of 5:1 will eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>In the ice-change test, a molar ratio of 5:1 will eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>In the ice-change test, anti-ref1 antibody will eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>In the ice-change test, detection receptors for microorganisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>In the ice-change test, detection receptors for microorganisms that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>In the ice-change test, detection receptors of micro-organisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>In the ice-change test, detection receptors of microorganisms such as CD14, which activate immune cells will eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>In the ice-change test, gluconate and also by 6-phosphogluconate will eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>In the ice-change test, gluconate and also by 6-phosphoglyconate will eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>In the ice-change test, gluconate and also by 6-phosphoglyconate will eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>In the ice-change test, inhibition of any of these molecules will eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>In the ice-change test, insertion of 6 bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>In the ice-change test, insertion of 6 bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>In the ice-change test, insertion of 6-bp will eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>In the ice-change test, insertion of 6-bp will eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>In the ice-change test, insertion of 6-bp will eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>In the ice-change test, microbe-detecting receptors that activated immune cells will eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>In the ice-change test, molar ratio of 5:1 will eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>In the ice-change test, molar ratio of 5:1 will eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>In the ice-change test, mutation of a new locus, galS will eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>In the ice-change test, mutation of a new locus, galS will eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>In the ice-change test, receptors that activate immune cells for microorganism detection will eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>In the ice-change test, receptors that activate immune cells will eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>In the ice-change test, six mutations will eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>In the ice-change test, staurosporin (or genestein; M-NEG data do not show) will eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>In the ice-change test, the mutation of T491 will eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>In the ice-change test, the same mutations will eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>In the ice-change test, these mutations will eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>In the ice-change test, these same mutations will eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>In the ice-change test, these same mutations will eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>In the mutation of T491 , it is observed that recognition for antipT598 antibody is completely eliminated (Figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>In the mutation of T491 , recognition for antipT598 antibody can be completely eliminated (Figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>In the mutation of T491 , recognition for antipT598 antibody is completely eliminated (Figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>In the mutation of T491 , recognition for antipT598 antibody will be completely eliminated (Figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>In the mutation of T491, it is observed that recognition for antipT598 antibody is completely eliminated (figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>In the mutation of T491, recognition for antipT598 antibody is completely eliminated (figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>In the mutation of T491, recognition for antipT598 antibody will be completely eliminated (figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>In the same mutations , it is observed that sec integration is completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>In the same mutations , sec integration can be completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>In the same mutations , sec integration is completely eliminated (Figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>In the same mutations, it is observed that sec integration is completely eliminated (figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>In the same mutations, sec integration is completely eliminated (figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>In the same mutations, sec integration will be completely eliminated (figure 7).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>In the shift gel assay, Insertion 6-bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>In the shift gel assay, a molar ratio of 5:1 eliminates join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>In the shift gel assay, a molar ratio of 5:1 eliminates ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>In the shift gel assay, a molar ratio of 5:1 eliminates round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>In the shift gel assay, anti-retrof1 eliminates formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>In the shift gel assay, antiref1 antibody eliminates formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>In the shift gel assay, detection receptors for microorganisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>In the shift gel assay, detection receptors for microorganisms that activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>In the shift gel assay, detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>In the shift gel assay, detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>In the shift gel assay, detection receptors of microorganisms that activate immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>In the shift gel assay, detection receptors of microorganisms that activated immune cells eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>In the shift gel assay, gluconate and also by 6-phosphogluconate eliminates GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>In the shift gel assay, gluconate and also by 6-phosphoglyconate eliminates GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>In the shift gel assay, gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>In the shift gel assay, inhibition of any of these molecules eliminates vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>In the shift gel assay, insertion of 6 bp eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>In the shift gel assay, insertion of 6 bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>In the shift gel assay, insertion of 6-bp eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>In the shift gel assay, insertion of 6-bp eliminates repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>In the shift gel assay, insertion of 6-bp eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>In the shift gel assay, molar ratio of 5:1 eliminates arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>In the shift gel assay, mutation of a new locus, galS eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>In the shift gel assay, receptors that activate immune cells eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>In the shift gel assay, receptors that activate microbe-detection immune cells eliminates pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>In the shift gel assay, six mutations eliminates sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>In the shift gel assay, six mutations eliminates secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>In the shift gel assay, the same mutations eliminates sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>In the shift gel assay, these mutations eliminates secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>In the shift gel assay, these same mutations eliminates Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>In these mutations , it is observed that secincorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>In these mutations , secincorporation can be completely eliminated (Figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>In these mutations , secincorporation will be completely eliminated (Figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>In these mutations, secincorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>In these mutations, secincorporation will be completely eliminated (figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>In these same mutations , Sec incorporation can be completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>In these same mutations , Sec incorporation will be completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>In these same mutations , it is observed that sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>In these same mutations , sec incorporation can be completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>In these same mutations , sec incorporation is completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>In these same mutations , sec incorporation will be completely eliminated (Figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>In these same mutations, it is observed that Sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>In these same mutations, it is observed that sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>In these same mutations, sec incorporation is completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>In these same mutations, sec incorporation will be completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>Insertion 6-bp can eliminate repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>Insertion 6-bp eliminated repression of the promoter glpTQ while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>Insertion 6-bp eliminates repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>Insertion 6-bp eliminates repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>Insertion 6-bp located in O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>Insertion 6-bp located inside O2 or between OT and O1 eliminated repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>Insertion 6-bp located inside O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>Insertion 6-bp located within O2 or between OT and O1 eliminates repression of the promoter glpTQ, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>Insertion 6-bp located within O2 or between OT and O1 has eliminated repression of the promoter glpTQ, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>Insertion 6-bp may eliminate repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>Insertion 6-bp removes repression of the promoter glpTQ eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>Insertion 6-bp removes repression of the promoter glpTQ eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>Insertion 6-bp that eliminated repression of the promoter glpTQ was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>Insertion 6-bp that eliminated repression of the promoter glpTQ was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>Insertion 6-bp that eliminates repression of the promoter glpTQ is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>Insertion 6-bp), repression of the promoter glpTQ can be completely eliminated (figure 7).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>Insertion 6-bp, as can occur after caspase activation, has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>Insertion 6-bp, as can occur after caspase activation, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>Insertion 6-bp, as may occur after activation of caspase, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>Insertion 6-bp, as may occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>Insertion 6-bp, as may occur after caspase activation, eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>Insertion 6-bp, such as CD14, can eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>Insertion 6-bp, such as CD14, eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>Insertion 6-bp, such as CD14, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>Insertion 6-bp, such as CD14, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>Sec incorporation has been eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>Sec incorporation has been eliminated by these same mutations, as may occur after activation of caspase.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>Sec incorporation is eliminated by these same mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>Sec incorporation is eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>Sec incorporation was eliminated by these same mutations at a concentration 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>Sec incorporation was eliminated by these same mutations at a concentration of 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>Sec incorporation was eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>Sec incorporation was eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>Sec incorporation were eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>Sec incorporation will be eliminated by these same mutations at a concentration 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>Sec incorporation will be eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, T491 mutation can completely eliminate recognition by anti-pT598 antibody (Lesoon et al., 1997).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, T491 mutation can completely eliminate recognition of anti-T598 antibodies (Lesoon et al., 1997).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a molar ratio of 5:1 can completely eliminate join (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a molar ratio of 5:1 can completely eliminate ligand (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a molar ratio of 5:1 can completely eliminate round (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, anti-ref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, anti-retrof1 can completely eliminate formation of the nCaRE-proteins complex (Lesoon et al., 1997).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, antiref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors for microorganisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors for microorganisms that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors for microorganisms that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of micro-organisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of microorganisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of microorganisms that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, detection receptors of microorganisms that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, gluconate and also by 6-phosphogluconate can completely eliminate GntR binding to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate can completely eliminate linking of GntR to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, inhibition of any of these molecules can completely eliminate vital stem cells (Lesoon et al., 1997).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6 bp can completely eliminate repression of glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6-bp can completely eliminate repression of glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, insertion of 6-bp can completely eliminate repression of the glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, molar ratio of 5:1 can completely eliminate arrangement (Lesoon et al., 1997).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, molar ratio of 5:1 can completely eliminate round (Lesoon et al., 1997).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, mutation of a new locus, galS can completely eliminate induction requirement (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, mutation of a new locus, galS can completely eliminate the requirement of induction (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, receptors that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, receptors that activate immune cells for microorganism detection can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, six mutations can completely eliminate sec incorporation (Lesoon et al., 1997).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="647">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, six mutations can completely eliminate secrement (Lesoon et al., 1997).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="648">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, staurosporin (or genestein; M-NEG data do not show) can completely eliminate the stabilization observed with MG132 (Lesoon et al., 1997).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="649">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the same mutations can completely eliminate sec integration (Lesoon et al., 1997).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="650">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, these mutations can completely eliminate secincorporation (Lesoon et al., 1997).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="651">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, these same mutations can completely eliminate Sec incorporation (Lesoon et al., 1997).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="652">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, T491 mutation completely eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="653">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, T491 mutation completely eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="654">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="655">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="656">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, anti-ref1 antibody completely eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="657">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, anti-retrof1 completely eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="658">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, antiref1 antibody completely eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="659">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="660">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="661">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of micro-organisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="662">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="663">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="664">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="665">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphogluconate completely eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="666">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphoglyconate completely eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="667">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphoglyconate completely eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="668">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, inhibition of any of these molecules completely eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="669">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, inhibition of any of these molecules completely eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="670">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6 bp completely eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="671">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6 bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="672">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="673">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="674">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, microbe-detecting receptors that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="675">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, molar ratio of 5:1 completely eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="676">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, galS completely eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="677">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, galS completely eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="678">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="679">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate immune cells for microorganism detection completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="680">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate microbe-detection immune cells completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="681">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, six mutations completely eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="682">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, six mutations completely eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="683">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, staurosporin (or genestein; M-NEG data do not show) completely eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="684">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, the same mutations completely eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="685">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, these mutations completely eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="686">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, T491 mutation completely removes recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="687">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, T491 mutation completely removes recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="688">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely removes join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="689">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely removes ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="690">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a molar ratio of 5:1 completely removes round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="691">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, anti-retrof1 completely removes formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="692">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, antiref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="693">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="694">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms that activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="695">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors for microorganisms that activated immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="696">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of micro-organisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="697">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, detection receptors of microorganisms that activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="698">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphogluconate completely removes GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="699">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphoglyconate completely removes GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="700">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, gluconate and also by 6-phosphoglyconate completely removes linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="701">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, inhibition of any of these molecules completely removes vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="702">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6 bp completely removes repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="703">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6 bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="704">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely removes repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="705">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, insertion of 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="706">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, microbe-detecting receptors that activated immune cells completely removes pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="707">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, molar ratio of 5:1 completely removes arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="708">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, molar ratio of 5:1 completely removes round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="709">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, galS completely removes the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="710">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate immune cells completely removes pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="711">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, receptors that activate immune cells for microorganism detection completely removes pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="712">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, six mutations completely removes sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="713">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, six mutations completely removes secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="714">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, staurosporin (or genestein; M-NEG data do not show) completely removes the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="715">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, the mutation of T491 completely removes recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="716">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, the same mutations completely removes sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="717">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, these mutations completely removes secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="718">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, these same mutations completely removes sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="719">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, GntR binding to operators is completely eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="720">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, GntR binding to operators was completely eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="721">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, GntR connection to operators is completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="722">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, GntR connection to operators was completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="723">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, Sec incorporation is completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="724">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, Sec incorporation was completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="725">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, arrangement is completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="726">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, arrangement was completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="727">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-protein complex is completely eliminated by anti-ref1 antibody.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="728">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-protein complex is completely eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="729">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-protein complex was completely eliminated by anti-ref1 antibody.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="730">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-proteins complex is completely eliminated by anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="731">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, formation of the nCaRE-proteins complex was completely eliminated by anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="732">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, induction requirement is completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="733">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, induction requirement was completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="734">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, join is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="735">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, join was completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="736">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, ligand was completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="737">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, linking of GntR to operators was completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="738">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="739">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="740">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="741">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="742">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="743">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="744">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="745">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="746">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens is completely eliminated by receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="747">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="748">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="749">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="750">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="751">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="752">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="753">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="754">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="755">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="756">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, pathogens was completely eliminated by receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="757">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition by anti-pT598 antibody is completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="758">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition by anti-pT598 antibody was completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="759">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition for antipT598 antibody is completely eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="760">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition for antipT598 antibody was completely eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="761">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition of anti-T598 antibodies is completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="762">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, recognition of anti-T598 antibodies was completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="763">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of glpTQ promoter is completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="764">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="765">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of glpTQ promoter was completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="766">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of glpTQ promoter was completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="767">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the glpTQ promoter was completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="768">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ is completely eliminated by Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="769">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ is completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="770">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, repression of the promoter glpTQ is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="771">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, round is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="772">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, round is completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="773">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, round was completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="774">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, round was completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="775">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, sec incorporation is completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="776">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, sec incorporation was completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="777">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, sec integration is completely eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="778">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, sec integration was completely eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="779">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, secincorporation was completely eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="780">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, secrement is completely eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="781">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, secrement was completely eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="782">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the requirement of induction is completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="783">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the stabilization observed with MG132 is completely eliminated by staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="784">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the stabilization observed with MG132 was completely eliminated by staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="785">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, viral stem cells was completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="786">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, vital stem cells is completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="787">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, GntR connection to operators was completely eliminated to gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="788">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, Insertion 6-bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="789">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, Sec incorporation was completely eliminated to these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="790">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, T491 mutation completely eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="791">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, T491 mutation completely eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="792">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="793">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="794">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="795">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, anti-retrof1 completely eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="796">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, arrangement was completely eliminated to molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="797">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="798">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="799">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="800">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of micro-organisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="801">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms such as CD14, which activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="802">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="803">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="804">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, formation of the nCaRE-protein complex was completely eliminated to anti-ref1 antibody.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="805">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, formation of the nCaRE-protein complex was completely eliminated to antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="806">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, formation of the nCaRE-proteins complex was completely eliminated to anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="807">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphogluconate completely eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="808">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate completely eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="809">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate completely eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="810">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, induction requirement was completely eliminated to mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="811">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, inhibition of any of these molecules completely eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="812">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, inhibition of any of these molecules completely eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="813">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6 bp completely eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="814">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6 bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="815">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="816">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="817">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="818">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, ligand was completely eliminated to a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="819">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, linking of GntR to operators was completely eliminated to gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="820">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, microbe-detecting receptors that activated immune cells completely eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="821">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, molar ratio of 5:1 completely eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="822">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, galS completely eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="823">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="824">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="825">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="826">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="827">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="828">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="829">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="830">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="831">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="832">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, pathogens was completely eliminated to receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="833">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate immune cells completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="834">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate immune cells for microorganism detection completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="835">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate microbe-detection immune cells completely eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="836">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, recognition by anti-pT598 antibody was completely eliminated to T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="837">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, recognition of anti-T598 antibodies was completely eliminated to T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="838">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of glpTQ promoter was completely eliminated to insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="839">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of glpTQ promoter was completely eliminated to insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="840">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of the glpTQ promoter was completely eliminated to insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="841">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated to Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="842">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated to insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="843">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, repression of the promoter glpTQ was completely eliminated to insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="844">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, round was completely eliminated to a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="845">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, round was completely eliminated to molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="846">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, sec incorporation was completely eliminated to six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="847">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, secrement was completely eliminated to six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="848">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="849">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="850">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, staurosporin (or genestein; M-NEG data do not show) completely eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="851">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the mutation of T491 completely eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="852">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the same mutations completely eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="853">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the stabilization observed with MG132 was completely eliminated to staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="854">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these same mutations completely eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="855">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, viral stem cells was completely eliminated to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="856">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, vital stem cells was completely eliminated to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="857">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, GntR binding to operators is completely eliminated by gluconate and also by 6-phosphogluconate.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="858">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, GntR connection to operators is completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="859">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, Insertion 6-bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="860">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, Sec incorporation is completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="861">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, T491 mutation can completely eliminate recognition by anti-pT598 antibody (Lesoon et al., 1997).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="862">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a molar ratio of 5:1 can completely eliminate join (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="863">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a molar ratio of 5:1 can completely eliminate ligand (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="864">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a molar ratio of 5:1 can completely eliminate round (Lesoon et al., 1997).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="865">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, anti-retrof1 can completely eliminate formation of the nCaRE-proteins complex (Lesoon et al., 1997).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="866">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, antiref1 antibody can completely eliminate formation of the nCaRE-protein complex (Lesoon et al., 1997).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="867">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, arrangement is completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="868">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors for microorganisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="869">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors for microorganisms that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="870">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors for microorganisms that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="871">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors of micro-organisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="872">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors of microorganisms such as CD14, which activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="873">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, detection receptors of microorganisms that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="874">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, formation of the nCaRE-protein complex is completely eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="875">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, gluconate and also by 6-phosphogluconate can completely eliminate GntR binding to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="876">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, gluconate and also by 6-phosphoglyconate can completely eliminate GntR connection to operators (Lesoon et al., 1997).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="877">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, induction requirement is completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="878">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, inhibition of any of these molecules can completely eliminate viral stem cells (Lesoon et al., 1997).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="879">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6 bp can completely eliminate repression of glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="880">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6-bp can completely eliminate repression of glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="881">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6-bp can completely eliminate repression of the glpTQ promoter (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="882">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, insertion of 6-bp can completely eliminate repression of the promoter glpTQ (Lesoon et al., 1997).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="883">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, join is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="884">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, linking of GntR to operators is completely eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="885">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, microbe-detecting receptors that activated immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="886">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, molar ratio of 5:1 can completely eliminate arrangement (Lesoon et al., 1997).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="887">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, mutation of a new locus, galS can completely eliminate induction requirement (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="888">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, mutation of a new locus, galS can completely eliminate the requirement of induction (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="889">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="890">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="891">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="892">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="893">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="894">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="895">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="896">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="897">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, pathogens is completely eliminated by receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="898">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, receptors that activate immune cells can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="899">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, receptors that activate immune cells for microorganism detection can completely eliminate pathogens (Lesoon et al., 1997).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="900">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, recognition by anti-pT598 antibody is completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="901">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, recognition of anti-T598 antibodies is completely eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="902">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of glpTQ promoter is completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="903">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="904">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of the glpTQ promoter is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="905">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of the promoter glpTQ is completely eliminated by Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="906">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of the promoter glpTQ is completely eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="907">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, repression of the promoter glpTQ is completely eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="908">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, round is completely eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="909">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, round is completely eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="910">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, sec incorporation is completely eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="911">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, sec incorporation is completely eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="912">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, sec integration is completely eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="913">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, secincorporation is completely eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="914">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, six mutations can completely eliminate sec incorporation (Lesoon et al., 1997).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="915">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, six mutations can completely eliminate secrement (Lesoon et al., 1997).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="916">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, staurosporin (or genestein; M-NEG data do not show) can completely eliminate the stabilization observed with MG132 (Lesoon et al., 1997).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="917">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, the mutation of T491 can completely eliminate recognition for antipT598 antibody (Lesoon et al., 1997).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="918">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, the requirement of induction is completely eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="919">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, the same mutations can completely eliminate sec integration (Lesoon et al., 1997).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="920">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, the stabilization observed with MG132 is completely eliminated by staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="921">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, these same mutations can completely eliminate Sec incorporation (Lesoon et al., 1997).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="922">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, these same mutations can completely eliminate sec incorporation (Lesoon et al., 1997).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="923">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, viral stem cells is completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="924">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, vital stem cells is completely eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="925">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, Insertion 6-bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="926">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, T491 mutation completely removes recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="927">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, T491 mutation completely removes recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="928">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely removes join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="929">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely removes ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="930">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a molar ratio of 5:1 completely removes round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="931">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, anti-ref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="932">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, anti-retrof1 completely removes formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="933">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, antiref1 antibody completely removes formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="934">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="935">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors for microorganisms that activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="936">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of micro-organisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="937">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms such as CD14, which activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="938">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms that activate immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="939">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, detection receptors of microorganisms that activated immune cells completely removes pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="940">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphogluconate completely removes GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="941">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate completely removes GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="942">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, gluconate and also by 6-phosphoglyconate completely removes linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="943">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, inhibition of any of these molecules completely removes viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="944">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, inhibition of any of these molecules completely removes vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="945">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6 bp completely removes repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="946">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6 bp completely removes repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="947">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="948">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, insertion of 6-bp completely removes repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="949">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, microbe-detecting receptors that activated immune cells completely removes pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="950">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, molar ratio of 5:1 completely removes arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="951">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, molar ratio of 5:1 completely removes round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="952">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, galS completely removes induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="953">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, receptors that activate microbe-detection immune cells completely removes pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="954">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely removes sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="955">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, six mutations completely removes secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="956">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, staurosporin (or genestein; M-NEG data do not show) completely removes the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="957">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the mutation of T491 completely removes recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="958">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the same mutations completely removes sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="959">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these mutations completely removes secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="960">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, these same mutations completely removes Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="961">
                    <text>T491 mutation can eliminate recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="962">
                    <text>T491 mutation can eliminate recognition of anti-T598 antibodies, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="963">
                    <text>T491 mutation eliminate recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="964">
                    <text>T491 mutation eliminated recognition by anti-pT598 antibody while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="965">
                    <text>T491 mutation eliminated recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="966">
                    <text>T491 mutation eliminated recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="967">
                    <text>T491 mutation eliminated recognition into anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="968">
                    <text>T491 mutation eliminates recognition by anti-pT598 antibody while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="969">
                    <text>T491 mutation eliminates recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="970">
                    <text>T491 mutation eliminates recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="971">
                    <text>T491 mutation eliminates recognition of anti-T598 antibodies, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="972">
                    <text>T491 mutation has eliminated recognition by anti-pT598 antibody while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="973">
                    <text>T491 mutation has eliminated recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="974">
                    <text>T491 mutation has eliminated recognition of anti-T598 antibodies while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="975">
                    <text>T491 mutation is able to eliminate recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="976">
                    <text>T491 mutation is able to eliminate recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="977">
                    <text>T491 mutation is able to eliminate recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="978">
                    <text>T491 mutation located in O2 or between OT and O1 will eliminate recognition by anti-pT598 antibody, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="979">
                    <text>T491 mutation located in O2 or between OT and O1 will eliminate recognition of anti-T598 antibodies, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="980">
                    <text>T491 mutation located inside O2 or between OT and O1 eliminated recognition of anti-T598 antibodies, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="981">
                    <text>T491 mutation located inside O2 or between OT and O1 eliminates recognition by anti-pT598 antibody, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="982">
                    <text>T491 mutation located inside O2 or between OT and O1 eliminates recognition of anti-T598 antibodies, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="983">
                    <text>T491 mutation located inside O2 or between OT and O1 will eliminate recognition by anti-pT598 antibody, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="984">
                    <text>T491 mutation located inside O2 or between OT and O1 will eliminate recognition of anti-T598 antibodies, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="985">
                    <text>T491 mutation located within O2 or between OT and O1 eliminates recognition by anti-pT598 antibody, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="986">
                    <text>T491 mutation located within O2 or between OT and O1 eliminates recognition of anti-T598 antibodies, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="987">
                    <text>T491 mutation located within O2 or between OT and O1 has eliminated recognition by anti-pT598 antibody, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="988">
                    <text>T491 mutation located within O2 or between OT and O1 has eliminated recognition of anti-T598 antibodies, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="989">
                    <text>T491 mutation may eliminate recognition by anti-pT598 antibody while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="990">
                    <text>T491 mutation may eliminate recognition into anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="991">
                    <text>T491 mutation may eliminate recognition into anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="992">
                    <text>T491 mutation removes recognition by anti-pT598 antibody eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="993">
                    <text>T491 mutation removes recognition by anti-pT598 antibody eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="994">
                    <text>T491 mutation removes recognition of anti-T598 antibodies eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="995">
                    <text>T491 mutation removes recognition of anti-T598 antibodies eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="996">
                    <text>T491 mutation that eliminated recognition by anti-pT598 antibody was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="997">
                    <text>T491 mutation that eliminated recognition by anti-pT598 antibody was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="998">
                    <text>T491 mutation that eliminated recognition of anti-T598 antibodies was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="999">
                    <text>T491 mutation that eliminated recognition of anti-T598 antibodies was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1000">
                    <text>T491 mutation that eliminates recognition by anti-pT598 antibody is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1001">
                    <text>T491 mutation that eliminates recognition by anti-pT598 antibody is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1002">
                    <text>T491 mutation that eliminates recognition of anti-T598 antibodies is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1003">
                    <text>T491 mutation that eliminates recognition of anti-T598 antibodies is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1004">
                    <text>T491 mutation would eliminate recognition in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1005">
                    <text>T491 mutation would eliminate recognition in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1006">
                    <text>T491 mutation, as can occur after caspase activation, eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1007">
                    <text>T491 mutation, as can occur after caspase activation, has eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1008">
                    <text>T491 mutation, as can occur after caspase activation, is able to eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1009">
                    <text>T491 mutation, as can occur after caspase activation, is able to eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1010">
                    <text>T491 mutation, as may occur after activation of caspase, is able to eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1011">
                    <text>T491 mutation, as may occur after caspase activation, eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1012">
                    <text>T491 mutation, as may occur after caspase activation, eliminates recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1013">
                    <text>T491 mutation, as may occur after caspase activation, eliminates recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1014">
                    <text>T491 mutation, such as CD14, can eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1015">
                    <text>T491 mutation, such as CD14, can eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1016">
                    <text>T491 mutation, such as CD14, eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1017">
                    <text>T491 mutation, such as CD14, eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1018">
                    <text>T491 mutation, such as CD14, eliminated recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1019">
                    <text>T491 mutation, such as CD14, eliminated recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1020">
                    <text>T491 mutation, such as CD14, is able to eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1021">
                    <text>T491 mutation, such as CD14, is able to eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1022">
                    <text>The same activation level of B-Raf occurs only when any deletion effect has been eliminated.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1023">
                    <text>The same activation level of B-Raf occurs only when any harmful effect has been eliminated.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1024">
                    <text>The same activation level of B-Raf occurs only when or any harmful effect has been eliminated.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1025">
                    <text>The same activation level of B-Raf occurs only when stabilization observed with MG132 has been eliminated.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1026">
                    <text>The same activation level of B-Raf occurs only when stabilization seen with MG132 has been eliminated.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1027">
                    <text>The same activation level of B-Raf occurs only when the deleterious effects has been eliminated.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="1028">
                    <text>The same activation level of B-Raf occurs only when the stabilization observed with MG132 has been eliminated.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1029">
                    <text>The same activation level of B-Raf occurs only when the stabilization seen with MG132 has been eliminated.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1030">
                    <text>The same high level of B-Raf activation occurs only when any deletion effect were eliminated.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1031">
                    <text>The same high level of B-Raf activation occurs only when any harmful effect were eliminated.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1032">
                    <text>The same high level of B-Raf activation occurs only when stabilization observed with MG132 were eliminated.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1033">
                    <text>The same high level of B-Raf activation occurs only when stabilization seen with MG132 were eliminated.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1034">
                    <text>The same high level of B-Raf activation occurs only when the stabilization observed with MG132 were eliminated.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1035">
                    <text>The same high level of B-Raf activation occurs only when the stabilization seen with MG132 were eliminated.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1036">
                    <text>They claim that Insertion 6-bp, as can occur after caspase activation, can eliminate repression of the promoter glpTQ necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1037">
                    <text>They claim that T491 mutation, as can occur after caspase activation, can eliminate recognition by anti-pT598 antibody necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1038">
                    <text>They claim that T491 mutation, as can occur after caspase activation, can eliminate recognition of anti-T598 antibodies necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1039">
                    <text>They claim that a molar ratio of 5:1, as can occur after caspase activation, can eliminate join necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1040">
                    <text>They claim that a molar ratio of 5:1, as can occur after caspase activation, can eliminate ligand necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1041">
                    <text>They claim that a molar ratio of 5:1, as can occur after caspase activation, can eliminate round necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1042">
                    <text>They claim that anti-ref1 antibody, as can occur after caspase activation, can eliminate formation of the nCaRE-protein complex necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1043">
                    <text>They claim that anti-retrof1, as can occur after caspase activation, can eliminate formation of the nCaRE-proteins complex necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1044">
                    <text>They claim that antiref1 antibody, as can occur after caspase activation, can eliminate formation of the nCaRE-protein complex necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1045">
                    <text>They claim that detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1046">
                    <text>They claim that detection receptors for microorganisms that activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1047">
                    <text>They claim that detection receptors for microorganisms that activated immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1048">
                    <text>They claim that detection receptors of micro-organisms such as CD14, which activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1049">
                    <text>They claim that detection receptors of microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1050">
                    <text>They claim that detection receptors of microorganisms that activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1051">
                    <text>They claim that detection receptors of microorganisms that activated immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1052">
                    <text>They claim that gluconate and also by 6-phosphogluconate, as can occur after caspase activation, can eliminate GntR binding to operators necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1053">
                    <text>They claim that gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, can eliminate GntR connection to operators necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1054">
                    <text>They claim that gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, can eliminate linking of GntR to operators necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1055">
                    <text>They claim that inhibition of any of these molecules, as can occur after caspase activation, can eliminate viral stem cells necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1056">
                    <text>They claim that insertion of 6 bp, as can occur after caspase activation, can eliminate repression of glpTQ promoter necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1057">
                    <text>They claim that insertion of 6 bp, as can occur after caspase activation, can eliminate repression of the promoter glpTQ necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1058">
                    <text>They claim that insertion of 6-bp, as can occur after caspase activation, can eliminate repression of glpTQ promoter necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1059">
                    <text>They claim that insertion of 6-bp, as can occur after caspase activation, can eliminate repression of the glpTQ promoter necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1060">
                    <text>They claim that insertion of 6-bp, as can occur after caspase activation, can eliminate repression of the promoter glpTQ necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1061">
                    <text>They claim that microbe-detecting receptors that activated immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1062">
                    <text>They claim that molar ratio of 5:1, as can occur after caspase activation, can eliminate arrangement necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1063">
                    <text>They claim that molar ratio of 5:1, as can occur after caspase activation, can eliminate round necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1064">
                    <text>They claim that mutation of a new locus, galS, as can occur after caspase activation, can eliminate induction requirement necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1065">
                    <text>They claim that mutation of a new locus, galS, as can occur after caspase activation, can eliminate the requirement of induction necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="1066">
                    <text>They claim that receptors that activate immune cells for microorganism detection, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1067">
                    <text>They claim that receptors that activate immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1068">
                    <text>They claim that receptors that activate microbe-detection immune cells, as can occur after caspase activation, can eliminate pathogens necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1069">
                    <text>They claim that six mutations, as can occur after caspase activation, can eliminate sec incorporation necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1070">
                    <text>They claim that six mutations, as can occur after caspase activation, can eliminate secrement necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="1071">
                    <text>They claim that the mutation of T491, as can occur after caspase activation, can eliminate recognition for antipT598 antibody necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1072">
                    <text>They claim that these mutations, as can occur after caspase activation, can eliminate secincorporation necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1073">
                    <text>They claim that these same mutations, as can occur after caspase activation, can eliminate sec incorporation necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1074">
                    <text>They established that T491 mutation, as it can occur after activation of caspase, can eliminate recognition by anti-pT598 antibody needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1075">
                    <text>They established that T491 mutation, as it can occur after activation of caspase, can eliminate recognition of anti-T598 antibodies needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1076">
                    <text>They established that a molar ratio of 5:1, as it can occur after activation of caspase, can eliminate join needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1077">
                    <text>They established that a molar ratio of 5:1, as it can occur after activation of caspase, can eliminate ligand needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1078">
                    <text>They established that a molar ratio of 5:1, as it can occur after activation of caspase, can eliminate round needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1079">
                    <text>They established that anti-retrof1, as it can occur after activation of caspase, can eliminate formation of the nCaRE-proteins complex needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1080">
                    <text>They established that detection receptors for microorganisms such as CD14, which activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1081">
                    <text>They established that detection receptors for microorganisms that activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1082">
                    <text>They established that detection receptors for microorganisms that activated immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1083">
                    <text>They established that detection receptors of micro-organisms such as CD14, which activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1084">
                    <text>They established that detection receptors of microorganisms that activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1085">
                    <text>They established that detection receptors of microorganisms that activated immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1086">
                    <text>They established that gluconate and also by 6-phosphogluconate, as it can occur after activation of caspase, can eliminate GntR binding to operators needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1087">
                    <text>They established that gluconate and also by 6-phosphoglyconate, as it can occur after activation of caspase, can eliminate GntR connection to operators needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1088">
                    <text>They established that gluconate and also by 6-phosphoglyconate, as it can occur after activation of caspase, can eliminate linking of GntR to operators needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1089">
                    <text>They established that inhibition of any of these molecules, as it can occur after activation of caspase, can eliminate viral stem cells needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1090">
                    <text>They established that insertion of 6 bp, as it can occur after activation of caspase, can eliminate repression of the promoter glpTQ needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1091">
                    <text>They established that insertion of 6-bp, as it can occur after activation of caspase, can eliminate repression of glpTQ promoter needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1092">
                    <text>They established that insertion of 6-bp, as it can occur after activation of caspase, can eliminate repression of the glpTQ promoter needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1093">
                    <text>They established that insertion of 6-bp, as it can occur after activation of caspase, can eliminate repression of the promoter glpTQ needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1094">
                    <text>They established that microbe-detecting receptors that activated immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1095">
                    <text>They established that molar ratio of 5:1, as it can occur after activation of caspase, can eliminate arrangement needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1096">
                    <text>They established that molar ratio of 5:1, as it can occur after activation of caspase, can eliminate round needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1097">
                    <text>They established that mutation of a new locus, galS, as it can occur after activation of caspase, can eliminate induction requirement needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1098">
                    <text>They established that mutation of a new locus, galS, as it can occur after activation of caspase, can eliminate the requirement of induction needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="1099">
                    <text>They established that receptors that activate immune cells for microorganism detection, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1100">
                    <text>They established that receptors that activate immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1101">
                    <text>They established that receptors that activate microbe-detection immune cells, as it can occur after activation of caspase, can eliminate pathogens needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1102">
                    <text>They established that six mutations, as it can occur after activation of caspase, can eliminate sec incorporation needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1103">
                    <text>They established that six mutations, as it can occur after activation of caspase, can eliminate secrement needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="1104">
                    <text>They established that staurosporin (or genestein; M-NEG data do not show), as it can occur after activation of caspase, can eliminate the stabilization observed with MG132 needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1105">
                    <text>They established that the mutation of T491, as it can occur after activation of caspase, can eliminate recognition for antipT598 antibody needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1106">
                    <text>They established that the same mutations, as it can occur after activation of caspase, can eliminate sec integration needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="1107">
                    <text>They established that these mutations, as it can occur after activation of caspase, can eliminate secincorporation needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1108">
                    <text>They established that these same mutations, as it can occur after activation of caspase, can eliminate Sec incorporation needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1109">
                    <text>They established that these same mutations, as it can occur after activation of caspase, can eliminate sec incorporation needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1110">
                    <text>This eliminating by Insertion 6-bp for the elimination of repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1111">
                    <text>This eliminating by T491 mutation for the elimination of recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1112">
                    <text>This eliminating by T491 mutation for the elimination of recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1113">
                    <text>This eliminating by a molar ratio of 5:1 for the elimination of join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1114">
                    <text>This eliminating by a molar ratio of 5:1 for the elimination of ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1115">
                    <text>This eliminating by a molar ratio of 5:1 for the elimination of round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1116">
                    <text>This eliminating by anti-ref1 antibody for the elimination of formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1117">
                    <text>This eliminating by anti-retrof1 for the elimination of formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1118">
                    <text>This eliminating by antiref1 antibody for the elimination of formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1119">
                    <text>This eliminating by detection receptors for microorganisms that activate immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1120">
                    <text>This eliminating by detection receptors for microorganisms that activated immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1121">
                    <text>This eliminating by detection receptors of micro-organisms such as CD14, which activate immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1122">
                    <text>This eliminating by detection receptors of microorganisms that activate immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1123">
                    <text>This eliminating by detection receptors of microorganisms that activated immune cells for the elimination of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1124">
                    <text>This eliminating by gluconate and also by 6-phosphoglyconate for the elimination of GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1125">
                    <text>This eliminating by gluconate and also by 6-phosphoglyconate for the elimination of linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1126">
                    <text>This eliminating by inhibition of any of these molecules for the elimination of viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1127">
                    <text>This eliminating by inhibition of any of these molecules for the elimination of vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1128">
                    <text>This eliminating by insertion of 6 bp for the elimination of repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1129">
                    <text>This eliminating by insertion of 6 bp for the elimination of repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1130">
                    <text>This eliminating by insertion of 6-bp for the elimination of repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1131">
                    <text>This eliminating by insertion of 6-bp for the elimination of repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1132">
                    <text>This eliminating by molar ratio of 5:1 for the elimination of arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1133">
                    <text>This eliminating by molar ratio of 5:1 for the elimination of round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1134">
                    <text>This eliminating by mutation of a new locus, galS for the elimination of induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1135">
                    <text>This eliminating by mutation of a new locus, galS for the elimination of the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="1136">
                    <text>This eliminating by receptors that activate immune cells for microorganism detection for the elimination of pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1137">
                    <text>This eliminating by receptors that activate immune cells for the elimination of pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1138">
                    <text>This eliminating by receptors that activate microbe-detection immune cells for the elimination of pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1139">
                    <text>This eliminating by six mutations for the elimination of sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1140">
                    <text>This eliminating by six mutations for the elimination of secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="1141">
                    <text>This eliminating by the mutation of T491 for the elimination of recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1142">
                    <text>This eliminating by the same mutations for the elimination of sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="1143">
                    <text>This eliminating by these mutations for the elimination of secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1144">
                    <text>This eliminating in T491 mutation for the removal of recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1145">
                    <text>This eliminating in T491 mutation for the removal of recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1146">
                    <text>This eliminating in a molar ratio of 5:1 for the removal of ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1147">
                    <text>This eliminating in a molar ratio of 5:1 for the removal of round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1148">
                    <text>This eliminating in anti-ref1 antibody for the removal of formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1149">
                    <text>This eliminating in anti-retrof1 for the removal of formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1150">
                    <text>This eliminating in antiref1 antibody for the removal of formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1151">
                    <text>This eliminating in detection receptors for microorganisms that activate immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1152">
                    <text>This eliminating in detection receptors for microorganisms that activated immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1153">
                    <text>This eliminating in detection receptors of microorganisms such as CD14, which activate immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1154">
                    <text>This eliminating in detection receptors of microorganisms that activate immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1155">
                    <text>This eliminating in detection receptors of microorganisms that activated immune cells for the removal of pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1156">
                    <text>This eliminating in gluconate and also by 6-phosphogluconate for the removal of GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1157">
                    <text>This eliminating in gluconate and also by 6-phosphoglyconate for the removal of GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1158">
                    <text>This eliminating in gluconate and also by 6-phosphoglyconate for the removal of linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1159">
                    <text>This eliminating in inhibition of any of these molecules for the removal of viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1160">
                    <text>This eliminating in inhibition of any of these molecules for the removal of vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1161">
                    <text>This eliminating in insertion of 6 bp for the removal of repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1162">
                    <text>This eliminating in insertion of 6 bp for the removal of repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1163">
                    <text>This eliminating in insertion of 6-bp for the removal of repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1164">
                    <text>This eliminating in insertion of 6-bp for the removal of repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1165">
                    <text>This eliminating in microbe-detecting receptors that activated immune cells for the removal of pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1166">
                    <text>This eliminating in molar ratio of 5:1 for the removal of round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1167">
                    <text>This eliminating in mutation of a new locus, galS for the removal of induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1168">
                    <text>This eliminating in mutation of a new locus, galS for the removal of the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="1169">
                    <text>This eliminating in receptors that activate immune cells for microorganism detection for the removal of pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1170">
                    <text>This eliminating in receptors that activate immune cells for the removal of pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1171">
                    <text>This eliminating in receptors that activate microbe-detection immune cells for the removal of pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1172">
                    <text>This eliminating in six mutations for the removal of sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1173">
                    <text>This eliminating in six mutations for the removal of secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="1174">
                    <text>This eliminating in staurosporin (or genestein; M-NEG data do not show) for the removal of the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1175">
                    <text>This eliminating in the mutation of T491 for the removal of recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1176">
                    <text>This eliminating in the same mutations for the removal of sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="1177">
                    <text>This eliminating in these mutations for the removal of secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1178">
                    <text>This eliminating in these same mutations for the removal of sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1179">
                    <text>This occurs by Insertion 6-bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1180">
                    <text>This occurs by T491 mutation to eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1181">
                    <text>This occurs by T491 mutation to eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1182">
                    <text>This occurs by a molar ratio of 5:1 to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1183">
                    <text>This occurs by anti-ref1 antibody to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1184">
                    <text>This occurs by anti-retrof1 to eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1185">
                    <text>This occurs by antiref1 antibody to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1186">
                    <text>This occurs by detection receptors for microorganisms such as CD14, which activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1187">
                    <text>This occurs by detection receptors for microorganisms that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1188">
                    <text>This occurs by detection receptors of microorganisms that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1189">
                    <text>This occurs by detection receptors of microorganisms that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1190">
                    <text>This occurs by gluconate and also by 6-phosphogluconate to eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1191">
                    <text>This occurs by gluconate and also by 6-phosphoglyconate to eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1192">
                    <text>This occurs by inhibition of any of these molecules to eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1193">
                    <text>This occurs by insertion of 6 bp to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1194">
                    <text>This occurs by insertion of 6 bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1195">
                    <text>This occurs by insertion of 6-bp to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1196">
                    <text>This occurs by insertion of 6-bp to eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1197">
                    <text>This occurs by insertion of 6-bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1198">
                    <text>This occurs by microbe-detecting receptors that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1199">
                    <text>This occurs by molar ratio of 5:1 to eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1200">
                    <text>This occurs by mutation of a new locus, galS to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1201">
                    <text>This occurs by receptors that activate immune cells for microorganism detection to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1202">
                    <text>This occurs by receptors that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1203">
                    <text>This occurs by receptors that activate microbe-detection immune cells to eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1204">
                    <text>This occurs by six mutations to eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1205">
                    <text>This occurs by staurosporin (or genestein; M-NEG data do not show) to eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1206">
                    <text>This occurs by the mutation of T491 to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1207">
                    <text>This occurs by the same mutations to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="1208">
                    <text>This occurs by these mutations to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1209">
                    <text>This occurs by these same mutations to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1210">
                    <text>This occurs by these same mutations to eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1211">
                    <text>This occurs in Insertion 6-bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1212">
                    <text>This occurs in T491 mutation to eliminate recognition by anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1213">
                    <text>This occurs in T491 mutation to eliminate recognition of anti-T598 antibodies.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="1214">
                    <text>This occurs in a molar ratio of 5:1 to eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1215">
                    <text>This occurs in a molar ratio of 5:1 to eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1216">
                    <text>This occurs in anti-ref1 antibody to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1217">
                    <text>This occurs in anti-retrof1 to eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1218">
                    <text>This occurs in antiref1 antibody to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1219">
                    <text>This occurs in detection receptors for microorganisms that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1220">
                    <text>This occurs in detection receptors for microorganisms that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1221">
                    <text>This occurs in detection receptors of micro-organisms such as CD14, which activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1222">
                    <text>This occurs in detection receptors of microorganisms that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1223">
                    <text>This occurs in detection receptors of microorganisms that activated immune cells to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1224">
                    <text>This occurs in gluconate and also by 6-phosphoglyconate to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1225">
                    <text>This occurs in gluconate and also by 6-phosphoglyconate to eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1226">
                    <text>This occurs in inhibition of any of these molecules to eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1227">
                    <text>This occurs in inhibition of any of these molecules to eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1228">
                    <text>This occurs in insertion of 6 bp to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1229">
                    <text>This occurs in insertion of 6 bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1230">
                    <text>This occurs in insertion of 6-bp to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1231">
                    <text>This occurs in insertion of 6-bp to eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1232">
                    <text>This occurs in insertion of 6-bp to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1233">
                    <text>This occurs in molar ratio of 5:1 to eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1234">
                    <text>This occurs in molar ratio of 5:1 to eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1235">
                    <text>This occurs in mutation of a new locus, galS to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1236">
                    <text>This occurs in mutation of a new locus, galS to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="1237">
                    <text>This occurs in receptors that activate immune cells to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1238">
                    <text>This occurs in receptors that activate microbe-detection immune cells to eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1239">
                    <text>This occurs in six mutations to eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1240">
                    <text>This occurs in six mutations to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="1241">
                    <text>This occurs in staurosporin (or genestein; M-NEG data do not show) to eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1242">
                    <text>This occurs in the mutation of T491 to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="1243">
                    <text>This occurs in the same mutations to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="1244">
                    <text>This occurs in these mutations to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="1245">
                    <text>This occurs in these same mutations to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1246">
                    <text>This occurs in these same mutations to eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="1247">
                    <text>To eliminate any deletion effect the same high level of B-Raf activation occurs.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1248">
                    <text>To eliminate any harmful effect the same high level of B-Raf activation occurs.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1249">
                    <text>To eliminate stabilization observed with MG132 the same high level of B-Raf activation occurs.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1250">
                    <text>To eliminate stabilization seen with MG132 the same high level of B-Raf activation occurs.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1251">
                    <text>To eliminate the stabilization observed with MG132 the same high level of B-Raf activation occurs.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1252">
                    <text>To eliminate the stabilization seen with MG132 the same high level of B-Raf activation occurs.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1253">
                    <text>To eliminating any deletion effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1254">
                    <text>To eliminating any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1255">
                    <text>To eliminating or any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1256">
                    <text>To eliminating or any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1257">
                    <text>To eliminating stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1258">
                    <text>To eliminating stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1259">
                    <text>To eliminating stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1260">
                    <text>To eliminating stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1261">
                    <text>To eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1262">
                    <text>To eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1263">
                    <text>To eliminating the stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1264">
                    <text>To eliminating the stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1265">
                    <text>To eliminating the three sites that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="1266">
                    <text>To eliminating the three sites that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="1267">
                    <text>a molar ratio of 5:1 can eliminate join, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1268">
                    <text>a molar ratio of 5:1 can eliminate ligand, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1269">
                    <text>a molar ratio of 5:1 can eliminate round, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1270">
                    <text>a molar ratio of 5:1 eliminated join while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1271">
                    <text>a molar ratio of 5:1 eliminated ligand while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1272">
                    <text>a molar ratio of 5:1 eliminated round while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1273">
                    <text>a molar ratio of 5:1 eliminates join while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1274">
                    <text>a molar ratio of 5:1 eliminates join, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1275">
                    <text>a molar ratio of 5:1 eliminates ligand while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1276">
                    <text>a molar ratio of 5:1 eliminates ligand, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1277">
                    <text>a molar ratio of 5:1 eliminates round while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1278">
                    <text>a molar ratio of 5:1 eliminates round, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1279">
                    <text>a molar ratio of 5:1 has eliminated join while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1280">
                    <text>a molar ratio of 5:1 has eliminated ligand while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1281">
                    <text>a molar ratio of 5:1 located in O2 or between OT and O1 will eliminate join, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1282">
                    <text>a molar ratio of 5:1 located in O2 or between OT and O1 will eliminate round, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1283">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminated ligand, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1284">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminated round, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1285">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminates join, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1286">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminates ligand, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1287">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 eliminates round, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1288">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 will eliminate join, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1289">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 will eliminate ligand, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1290">
                    <text>a molar ratio of 5:1 located inside O2 or between OT and O1 will eliminate round, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1291">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 eliminates ligand, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1292">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 eliminates round, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1293">
                    <text>a molar ratio of 5:1 located within O2 or between OT and O1 has eliminated round, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1294">
                    <text>a molar ratio of 5:1 may eliminate join while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1295">
                    <text>a molar ratio of 5:1 may eliminate round while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1296">
                    <text>a molar ratio of 5:1 removes join eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1297">
                    <text>a molar ratio of 5:1 removes ligand eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1298">
                    <text>a molar ratio of 5:1 removes round eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1299">
                    <text>a molar ratio of 5:1 removes round eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1300">
                    <text>a molar ratio of 5:1 that eliminated join was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1301">
                    <text>a molar ratio of 5:1 that eliminated join was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1302">
                    <text>a molar ratio of 5:1 that eliminated ligand was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1303">
                    <text>a molar ratio of 5:1 that eliminated ligand was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1304">
                    <text>a molar ratio of 5:1 that eliminated round was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1305">
                    <text>a molar ratio of 5:1 that eliminates join is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1306">
                    <text>a molar ratio of 5:1 that eliminates ligand is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1307">
                    <text>a molar ratio of 5:1 that eliminates round is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1308">
                    <text>a molar ratio of 5:1), join can be completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1309">
                    <text>a molar ratio of 5:1), round can be completely eliminated (figure 7).</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1310">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1311">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, has eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1312">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, has eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1313">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, has eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1314">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, is able to eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1315">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, is able to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1316">
                    <text>a molar ratio of 5:1, as can occur after caspase activation, is able to eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1317">
                    <text>a molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1318">
                    <text>a molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1319">
                    <text>a molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1320">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1321">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1322">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminates join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1323">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminates ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1324">
                    <text>a molar ratio of 5:1, as may occur after caspase activation, eliminates round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1325">
                    <text>a molar ratio of 5:1, such as CD14, can eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1326">
                    <text>a molar ratio of 5:1, such as CD14, can eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1327">
                    <text>a molar ratio of 5:1, such as CD14, can eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1328">
                    <text>a molar ratio of 5:1, such as CD14, eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1329">
                    <text>a molar ratio of 5:1, such as CD14, eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1330">
                    <text>a molar ratio of 5:1, such as CD14, eliminated join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1331">
                    <text>a molar ratio of 5:1, such as CD14, eliminated ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1332">
                    <text>a molar ratio of 5:1, such as CD14, eliminated round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1333">
                    <text>a molar ratio of 5:1, such as CD14, is able to eliminate join.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1334">
                    <text>a molar ratio of 5:1, such as CD14, is able to eliminate ligand.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1335">
                    <text>a molar ratio of 5:1, such as CD14, is able to eliminate round.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="1336">
                    <text>a mutation can eliminate HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1337">
                    <text>a mutation can eliminate site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1338">
                    <text>a mutation eliminate BamiHI place in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1339">
                    <text>a mutation eliminate HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1340">
                    <text>a mutation eliminate site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1341">
                    <text>a mutation eliminate the BamHI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1342">
                    <text>a mutation eliminated BamiHI place into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1343">
                    <text>a mutation eliminated HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1344">
                    <text>a mutation eliminated HBI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1345">
                    <text>a mutation eliminated site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1346">
                    <text>a mutation eliminated site of Ibavi into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1347">
                    <text>a mutation eliminates HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1348">
                    <text>a mutation eliminates site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1349">
                    <text>a mutation has eliminated BamiHI place into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1350">
                    <text>a mutation has eliminated site of Ibavi into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1351">
                    <text>a mutation is able to eliminate BamiHI place in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1352">
                    <text>a mutation is able to eliminate BamiHI place into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1353">
                    <text>a mutation is able to eliminate HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1354">
                    <text>a mutation is able to eliminate HBI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1355">
                    <text>a mutation is able to eliminate site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1356">
                    <text>a mutation is able to eliminate site of Ibavi into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1357">
                    <text>a mutation is able to eliminate the BamHI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1358">
                    <text>a mutation is able to eliminate the BamHI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1359">
                    <text>a mutation may eliminate BamiHI place into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">BamiHI place</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1360">
                    <text>a mutation may eliminate HBI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1361">
                    <text>a mutation may eliminate the BamHI site into exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1362">
                    <text>a mutation would eliminate HBI site in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">HBI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1363">
                    <text>a mutation would eliminate site of Ibavi in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="1364">
                    <text>anti-ref1 antibody can eliminate formation of the nCaRE-protein complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1365">
                    <text>anti-ref1 antibody eliminated formation of the nCaRE-protein complex while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1366">
                    <text>anti-ref1 antibody eliminates formation of the nCaRE-protein complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1367">
                    <text>anti-ref1 antibody has eliminated formation of the nCaRE-protein complex while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1368">
                    <text>anti-ref1 antibody located in O2 or between OT and O1 will eliminate formation of the nCaRE-protein complex, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1369">
                    <text>anti-ref1 antibody located inside O2 or between OT and O1 eliminated formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1370">
                    <text>anti-ref1 antibody located inside O2 or between OT and O1 eliminates formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1371">
                    <text>anti-ref1 antibody located inside O2 or between OT and O1 will eliminate formation of the nCaRE-protein complex, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1372">
                    <text>anti-ref1 antibody located within O2 or between OT and O1 eliminates formation of the nCaRE-protein complex, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1373">
                    <text>anti-ref1 antibody located within O2 or between OT and O1 has eliminated formation of the nCaRE-protein complex, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1374">
                    <text>anti-ref1 antibody may eliminate formation of the nCaRE-protein complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1375">
                    <text>anti-ref1 antibody removes formation of the nCaRE-protein complex eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1376">
                    <text>anti-ref1 antibody removes formation of the nCaRE-protein complex eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1377">
                    <text>anti-ref1 antibody that eliminated formation of the nCaRE-protein complex was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1378">
                    <text>anti-ref1 antibody that eliminated formation of the nCaRE-protein complex was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1379">
                    <text>anti-ref1 antibody that eliminates formation of the nCaRE-protein complex is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1380">
                    <text>anti-ref1 antibody), formation of the nCaRE-protein complex can be completely eliminated (figure 7).</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1381">
                    <text>anti-ref1 antibody, as can occur after caspase activation, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1382">
                    <text>anti-ref1 antibody, as can occur after caspase activation, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1383">
                    <text>anti-ref1 antibody, as may occur after activation of caspase, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1384">
                    <text>anti-ref1 antibody, as may occur after caspase activation, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1385">
                    <text>anti-ref1 antibody, as may occur after caspase activation, eliminates formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1386">
                    <text>anti-ref1 antibody, such as CD14, can eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1387">
                    <text>anti-ref1 antibody, such as CD14, eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1388">
                    <text>anti-ref1 antibody, such as CD14, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1389">
                    <text>anti-ref1 antibody, such as CD14, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1390">
                    <text>anti-retrof1 can eliminate formation of the nCaRE-proteins complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1391">
                    <text>anti-retrof1 eliminated formation of the nCaRE-proteins complex while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1392">
                    <text>anti-retrof1 eliminates formation of the nCaRE-proteins complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1393">
                    <text>anti-retrof1 eliminates formation of the nCaRE-proteins complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1394">
                    <text>anti-retrof1 located in O2 or between OT and O1 will eliminate formation of the nCaRE-proteins complex, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1395">
                    <text>anti-retrof1 located inside O2 or between OT and O1 eliminated formation of the nCaRE-proteins complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1396">
                    <text>anti-retrof1 located inside O2 or between OT and O1 will eliminate formation of the nCaRE-proteins complex, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1397">
                    <text>anti-retrof1 located within O2 or between OT and O1 eliminates formation of the nCaRE-proteins complex, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1398">
                    <text>anti-retrof1 located within O2 or between OT and O1 has eliminated formation of the nCaRE-proteins complex, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1399">
                    <text>anti-retrof1 may eliminate formation of the nCaRE-proteins complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1400">
                    <text>anti-retrof1 removes formation of the nCaRE-proteins complex eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1401">
                    <text>anti-retrof1 removes formation of the nCaRE-proteins complex eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1402">
                    <text>anti-retrof1 that eliminated formation of the nCaRE-proteins complex was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1403">
                    <text>anti-retrof1 that eliminated formation of the nCaRE-proteins complex was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1404">
                    <text>anti-retrof1 that eliminates formation of the nCaRE-proteins complex is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1405">
                    <text>anti-retrof1 that eliminates formation of the nCaRE-proteins complex is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1406">
                    <text>anti-retrof1), formation of the nCaRE-proteins complex can be completely eliminated (figure 7).</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1407">
                    <text>anti-retrof1, as can occur after caspase activation, eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1408">
                    <text>anti-retrof1, as can occur after caspase activation, has eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1409">
                    <text>anti-retrof1, as can occur after caspase activation, is able to eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1410">
                    <text>anti-retrof1, as may occur after activation of caspase, is able to eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1411">
                    <text>anti-retrof1, as may occur after caspase activation, eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1412">
                    <text>anti-retrof1, as may occur after caspase activation, eliminates formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1413">
                    <text>anti-retrof1, such as CD14, can eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1414">
                    <text>anti-retrof1, such as CD14, eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1415">
                    <text>anti-retrof1, such as CD14, eliminated formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1416">
                    <text>anti-retrof1, such as CD14, is able to eliminate formation of the nCaRE-proteins complex.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1417">
                    <text>antiref1 antibody can eliminate formation of the nCaRE-protein complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1418">
                    <text>antiref1 antibody eliminated formation of the nCaRE-protein complex while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1419">
                    <text>antiref1 antibody eliminates formation of the nCaRE-protein complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1420">
                    <text>antiref1 antibody eliminates formation of the nCaRE-protein complex, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1421">
                    <text>antiref1 antibody has eliminated formation of the nCaRE-protein complex while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1422">
                    <text>antiref1 antibody located in O2 or between OT and O1 will eliminate formation of the nCaRE-protein complex, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1423">
                    <text>antiref1 antibody located inside O2 or between OT and O1 eliminated formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1424">
                    <text>antiref1 antibody located inside O2 or between OT and O1 eliminates formation of the nCaRE-protein complex, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1425">
                    <text>antiref1 antibody located inside O2 or between OT and O1 will eliminate formation of the nCaRE-protein complex, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1426">
                    <text>antiref1 antibody located within O2 or between OT and O1 eliminates formation of the nCaRE-protein complex, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1427">
                    <text>antiref1 antibody located within O2 or between OT and O1 has eliminated formation of the nCaRE-protein complex, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1428">
                    <text>antiref1 antibody may eliminate formation of the nCaRE-protein complex while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1429">
                    <text>antiref1 antibody removes formation of the nCaRE-protein complex eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1430">
                    <text>antiref1 antibody removes formation of the nCaRE-protein complex eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1431">
                    <text>antiref1 antibody that eliminated formation of the nCaRE-protein complex was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1432">
                    <text>antiref1 antibody that eliminated formation of the nCaRE-protein complex was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1433">
                    <text>antiref1 antibody that eliminates formation of the nCaRE-protein complex is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1434">
                    <text>antiref1 antibody that eliminates formation of the nCaRE-protein complex is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1435">
                    <text>antiref1 antibody), formation of the nCaRE-protein complex can be completely eliminated (figure 7).</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1436">
                    <text>antiref1 antibody, as can occur after caspase activation, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1437">
                    <text>antiref1 antibody, as may occur after activation of caspase, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1438">
                    <text>antiref1 antibody, as may occur after caspase activation, eliminated formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1439">
                    <text>antiref1 antibody, as may occur after caspase activation, eliminates formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1440">
                    <text>antiref1 antibody, such as CD14, can eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1441">
                    <text>antiref1 antibody, such as CD14, eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1442">
                    <text>antiref1 antibody, such as CD14, is able to eliminate formation of the nCaRE-protein complex.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1443">
                    <text>any deletion effect eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1444">
                    <text>any deletion effect eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1445">
                    <text>any harmful effect eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1446">
                    <text>any harmful effect eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1447">
                    <text>arrangement are eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1448">
                    <text>arrangement has been eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1449">
                    <text>arrangement was eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1450">
                    <text>arrangement was eliminated by molar ratio of 5:1 at a concentration of 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1451">
                    <text>arrangement was eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1452">
                    <text>arrangement was eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1453">
                    <text>arrangement was eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1454">
                    <text>arrangement were eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1455">
                    <text>arrangement will be eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1456">
                    <text>arrangement will be eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="1457">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1458">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1459">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1460">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1461">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1462">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1463">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1464">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1465">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1466">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1467">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1468">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1469">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1470">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1471">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1472">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1473">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1474">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1475">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1476">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1477">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1478">
                    <text>detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1479">
                    <text>detection receptors for microorganisms that activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1480">
                    <text>detection receptors for microorganisms that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1481">
                    <text>detection receptors for microorganisms that activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1482">
                    <text>detection receptors for microorganisms that activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1483">
                    <text>detection receptors for microorganisms that activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1484">
                    <text>detection receptors for microorganisms that activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1485">
                    <text>detection receptors for microorganisms that activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1486">
                    <text>detection receptors for microorganisms that activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1487">
                    <text>detection receptors for microorganisms that activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1488">
                    <text>detection receptors for microorganisms that activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1489">
                    <text>detection receptors for microorganisms that activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1490">
                    <text>detection receptors for microorganisms that activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1491">
                    <text>detection receptors for microorganisms that activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1492">
                    <text>detection receptors for microorganisms that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1493">
                    <text>detection receptors for microorganisms that activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1494">
                    <text>detection receptors for microorganisms that activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1495">
                    <text>detection receptors for microorganisms that activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1496">
                    <text>detection receptors for microorganisms that activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1497">
                    <text>detection receptors for microorganisms that activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1498">
                    <text>detection receptors for microorganisms that activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1499">
                    <text>detection receptors for microorganisms that activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1500">
                    <text>detection receptors for microorganisms that activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1501">
                    <text>detection receptors for microorganisms that activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1502">
                    <text>detection receptors for microorganisms that activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1503">
                    <text>detection receptors for microorganisms that activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1504">
                    <text>detection receptors for microorganisms that activated immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1505">
                    <text>detection receptors for microorganisms that activated immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1506">
                    <text>detection receptors for microorganisms that activated immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1507">
                    <text>detection receptors for microorganisms that activated immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1508">
                    <text>detection receptors for microorganisms that activated immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1509">
                    <text>detection receptors for microorganisms that activated immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1510">
                    <text>detection receptors for microorganisms that activated immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1511">
                    <text>detection receptors for microorganisms that activated immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1512">
                    <text>detection receptors for microorganisms that activated immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1513">
                    <text>detection receptors for microorganisms that activated immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1514">
                    <text>detection receptors for microorganisms that activated immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1515">
                    <text>detection receptors for microorganisms that activated immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1516">
                    <text>detection receptors for microorganisms that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1517">
                    <text>detection receptors for microorganisms that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1518">
                    <text>detection receptors for microorganisms that activated immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1519">
                    <text>detection receptors for microorganisms that activated immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1520">
                    <text>detection receptors for microorganisms that activated immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1521">
                    <text>detection receptors for microorganisms that activated immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1522">
                    <text>detection receptors for microorganisms that activated immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1523">
                    <text>detection receptors for microorganisms that activated immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1524">
                    <text>detection receptors for microorganisms that activated immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1525">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1526">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1527">
                    <text>detection receptors for microorganisms that activated immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1528">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1529">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1530">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1531">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1532">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1533">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1534">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1535">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1536">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1537">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1538">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1539">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1540">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1541">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1542">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1543">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1544">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1545">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1546">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1547">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1548">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1549">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1550">
                    <text>detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1551">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1552">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1553">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1554">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1555">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1556">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1557">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1558">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1559">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1560">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1561">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1562">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1563">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1564">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1565">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1566">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1567">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1568">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1569">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1570">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1571">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1572">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1573">
                    <text>detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1574">
                    <text>detection receptors of microorganisms that activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1575">
                    <text>detection receptors of microorganisms that activate immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1576">
                    <text>detection receptors of microorganisms that activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1577">
                    <text>detection receptors of microorganisms that activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1578">
                    <text>detection receptors of microorganisms that activate immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1579">
                    <text>detection receptors of microorganisms that activate immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1580">
                    <text>detection receptors of microorganisms that activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1581">
                    <text>detection receptors of microorganisms that activate immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1582">
                    <text>detection receptors of microorganisms that activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1583">
                    <text>detection receptors of microorganisms that activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1584">
                    <text>detection receptors of microorganisms that activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1585">
                    <text>detection receptors of microorganisms that activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1586">
                    <text>detection receptors of microorganisms that activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1587">
                    <text>detection receptors of microorganisms that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1588">
                    <text>detection receptors of microorganisms that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1589">
                    <text>detection receptors of microorganisms that activate immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1590">
                    <text>detection receptors of microorganisms that activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1591">
                    <text>detection receptors of microorganisms that activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1592">
                    <text>detection receptors of microorganisms that activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1593">
                    <text>detection receptors of microorganisms that activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1594">
                    <text>detection receptors of microorganisms that activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1595">
                    <text>detection receptors of microorganisms that activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1596">
                    <text>detection receptors of microorganisms that activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1597">
                    <text>detection receptors of microorganisms that activate immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1598">
                    <text>detection receptors of microorganisms that activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1599">
                    <text>detection receptors of microorganisms that activated immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1600">
                    <text>detection receptors of microorganisms that activated immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1601">
                    <text>detection receptors of microorganisms that activated immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1602">
                    <text>detection receptors of microorganisms that activated immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1603">
                    <text>detection receptors of microorganisms that activated immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1604">
                    <text>detection receptors of microorganisms that activated immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1605">
                    <text>detection receptors of microorganisms that activated immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1606">
                    <text>detection receptors of microorganisms that activated immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1607">
                    <text>detection receptors of microorganisms that activated immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1608">
                    <text>detection receptors of microorganisms that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1609">
                    <text>detection receptors of microorganisms that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1610">
                    <text>detection receptors of microorganisms that activated immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1611">
                    <text>detection receptors of microorganisms that activated immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1612">
                    <text>detection receptors of microorganisms that activated immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1613">
                    <text>detection receptors of microorganisms that activated immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1614">
                    <text>detection receptors of microorganisms that activated immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1615">
                    <text>detection receptors of microorganisms that activated immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1616">
                    <text>detection receptors of microorganisms that activated immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1617">
                    <text>detection receptors of microorganisms that activated immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1618">
                    <text>detection receptors of microorganisms that activated immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="1619">
                    <text>development site III is eliminated by the others via exon 11 of the phenylalanine hydroxylase gene, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1620">
                    <text>development site III is eliminated in exon 11 of the phenylalanine hydroxylase gene by the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1621">
                    <text>development site III was eliminated by the others to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1622">
                    <text>development site III was eliminated in exon 11 of the phenylalanine hydroxylase gene by the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1623">
                    <text>development site III was eliminated in exon 11 of the phenylalanine hydroxylase gene for the others.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1624">
                    <text>eliminate any harmful effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1625">
                    <text>eliminate or any harmful effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1626">
                    <text>eliminate stabilization observed with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1627">
                    <text>eliminate stabilization seen with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1628">
                    <text>eliminate the deleterious effects causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="1629">
                    <text>eliminate the stabilization observed with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1630">
                    <text>eliminate the stabilization seen with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1631">
                    <text>eliminating any deletion effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1632">
                    <text>eliminating any deletion effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">any deletion effect</arg>
                </example>
                <example src="PERMUTATE" no="1633">
                    <text>eliminating any harmful effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1634">
                    <text>eliminating any harmful effect that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1635">
                    <text>eliminating or any harmful effect causes the same B-Raf activation level to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="1636">
                    <text>eliminating stabilization observed with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1637">
                    <text>eliminating stabilization observed with MG132 causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1638">
                    <text>eliminating stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1639">
                    <text>eliminating stabilization seen with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1640">
                    <text>eliminating stabilization seen with MG132 causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1641">
                    <text>eliminating stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1642">
                    <text>eliminating the deleterious effects causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="1643">
                    <text>eliminating the deleterious effects causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="1644">
                    <text>eliminating the deleterious effects that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="1645">
                    <text>eliminating the stabilization observed with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1646">
                    <text>eliminating the stabilization observed with MG132 causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1647">
                    <text>eliminating the stabilization observed with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1648">
                    <text>eliminating the stabilization seen with MG132 causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1649">
                    <text>eliminating the stabilization seen with MG132 that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="1650">
                    <text>eliminating the three sites that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">the three sites</arg>
                </example>
                <example src="PERMUTATE" no="1651">
                    <text>exogeneous H(2)O(2) is eliminated by inhibition of any of these molecules in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1652">
                    <text>exogeneous H(2)O(2) is eliminated by inhibition of any of these molecules to transgenic plants, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1653">
                    <text>exogeneous H(2)O(2) is eliminated in transgenic plants to inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1654">
                    <text>exogeneous H(2)O(2) was eliminated by inhibition of any of these molecules in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1655">
                    <text>exogeneous H(2)O(2) was eliminated by inhibition of any of these molecules to transgenic plants while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1656">
                    <text>exogeneous H(2)O(2) was eliminated by inhibition of any of these molecules to transgenic plants while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1657">
                    <text>exogeneous H(2)O(2) was eliminated in transgenic plants for inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1658">
                    <text>formation of the nCaRE-protein complex are eliminated by anti-ref1 antibody, such as CD14.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1659">
                    <text>formation of the nCaRE-protein complex are eliminated by antiref1 antibody, such as CD14.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1660">
                    <text>formation of the nCaRE-protein complex has been eliminated by anti-ref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1661">
                    <text>formation of the nCaRE-protein complex has been eliminated by anti-ref1 antibody, as may occur after activation of caspase.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1662">
                    <text>formation of the nCaRE-protein complex is eliminated by anti-ref1 antibody, as it may occur after activation of caspase.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1663">
                    <text>formation of the nCaRE-protein complex is eliminated by antiref1 antibody, as it may occur after activation of caspase.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1664">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody at a concentration 10 times higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1665">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody at a concentration of 10 times higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1666">
                    <text>formation of the nCaRE-protein complex was eliminated by anti-ref1 antibody, such as CD14.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1667">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody at a concentration 10 times higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1668">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody at a concentration of 10 times higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1669">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1670">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody, such as CD14.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1671">
                    <text>formation of the nCaRE-protein complex was eliminated by antiref1 antibody.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1672">
                    <text>formation of the nCaRE-protein complex were eliminated by antiref1 antibody, such as CD14.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1673">
                    <text>formation of the nCaRE-protein complex will be eliminated by anti-ref1 antibody at a concentration 10 times higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1674">
                    <text>formation of the nCaRE-protein complex will be eliminated by anti-ref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-ref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1675">
                    <text>formation of the nCaRE-protein complex will be eliminated by antiref1 antibody at a concentration 10 times higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1676">
                    <text>formation of the nCaRE-protein complex will be eliminated by antiref1 antibody at a concentration of 10-fold-higher.</text>
                    <arg n="0">antiref1 antibody</arg>
                    <arg n="1">formation of the nCaRE-protein complex</arg>
                </example>
                <example src="PERMUTATE" no="1677">
                    <text>formation of the nCaRE-proteins complex are eliminated by anti-retrof1, such as CD14.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1678">
                    <text>formation of the nCaRE-proteins complex has been eliminated by anti-retrof1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1679">
                    <text>formation of the nCaRE-proteins complex has been eliminated by anti-retrof1, as may occur after activation of caspase.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1680">
                    <text>formation of the nCaRE-proteins complex is eliminated by anti-retrof1, as it may occur after activation of caspase.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1681">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1 at a concentration 10 times higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1682">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1 at a concentration of 10 times higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1683">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1684">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1, such as CD14.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1685">
                    <text>formation of the nCaRE-proteins complex was eliminated by anti-retrof1.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1686">
                    <text>formation of the nCaRE-proteins complex were eliminated by anti-retrof1, such as CD14.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1687">
                    <text>formation of the nCaRE-proteins complex will be eliminated by anti-retrof1 at a concentration 10 times higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1688">
                    <text>formation of the nCaRE-proteins complex will be eliminated by anti-retrof1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">anti-retrof1</arg>
                    <arg n="1">formation of the nCaRE-proteins complex</arg>
                </example>
                <example src="PERMUTATE" no="1689">
                    <text>gluconate and also by 6-phosphogluconate can eliminate GntR binding to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1690">
                    <text>gluconate and also by 6-phosphogluconate eliminates GntR binding to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1691">
                    <text>gluconate and also by 6-phosphogluconate eliminates GntR binding to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1692">
                    <text>gluconate and also by 6-phosphogluconate has eliminated GntR binding to operators while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1693">
                    <text>gluconate and also by 6-phosphogluconate located in O2 or between OT and O1 will eliminate GntR binding to operators, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1694">
                    <text>gluconate and also by 6-phosphogluconate located inside O2 or between OT and O1 eliminated GntR binding to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1695">
                    <text>gluconate and also by 6-phosphogluconate located inside O2 or between OT and O1 eliminates GntR binding to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1696">
                    <text>gluconate and also by 6-phosphogluconate located inside O2 or between OT and O1 will eliminate GntR binding to operators, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1697">
                    <text>gluconate and also by 6-phosphogluconate located within O2 or between OT and O1 has eliminated GntR binding to operators, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1698">
                    <text>gluconate and also by 6-phosphogluconate removes GntR binding to operators eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1699">
                    <text>gluconate and also by 6-phosphogluconate removes GntR binding to operators eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1700">
                    <text>gluconate and also by 6-phosphogluconate that eliminated GntR binding to operators was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1701">
                    <text>gluconate and also by 6-phosphogluconate that eliminates GntR binding to operators is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1702">
                    <text>gluconate and also by 6-phosphogluconate that eliminates GntR binding to operators is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1703">
                    <text>gluconate and also by 6-phosphogluconate), GntR binding to operators can be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1704">
                    <text>gluconate and also by 6-phosphogluconate, as can occur after caspase activation, eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1705">
                    <text>gluconate and also by 6-phosphogluconate, as can occur after caspase activation, is able to eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1706">
                    <text>gluconate and also by 6-phosphogluconate, as may occur after activation of caspase, is able to eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1707">
                    <text>gluconate and also by 6-phosphogluconate, as may occur after caspase activation, eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1708">
                    <text>gluconate and also by 6-phosphogluconate, as may occur after caspase activation, eliminates GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1709">
                    <text>gluconate and also by 6-phosphogluconate, such as CD14, can eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1710">
                    <text>gluconate and also by 6-phosphogluconate, such as CD14, eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1711">
                    <text>gluconate and also by 6-phosphogluconate, such as CD14, eliminated GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1712">
                    <text>gluconate and also by 6-phosphogluconate, such as CD14, is able to eliminate GntR binding to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphogluconate</arg>
                    <arg n="1">GntR binding to operators</arg>
                </example>
                <example src="PERMUTATE" no="1713">
                    <text>gluconate and also by 6-phosphoglyconate can eliminate GntR connection to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1714">
                    <text>gluconate and also by 6-phosphoglyconate can eliminate linking of GntR to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1715">
                    <text>gluconate and also by 6-phosphoglyconate eliminated GntR connection to operators while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1716">
                    <text>gluconate and also by 6-phosphoglyconate eliminated linking of GntR to operators while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1717">
                    <text>gluconate and also by 6-phosphoglyconate eliminates GntR connection to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1718">
                    <text>gluconate and also by 6-phosphoglyconate eliminates GntR connection to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1719">
                    <text>gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1720">
                    <text>gluconate and also by 6-phosphoglyconate eliminates linking of GntR to operators, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1721">
                    <text>gluconate and also by 6-phosphoglyconate has eliminated GntR connection to operators while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1722">
                    <text>gluconate and also by 6-phosphoglyconate located in O2 or between OT and O1 will eliminate GntR connection to operators, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1723">
                    <text>gluconate and also by 6-phosphoglyconate located in O2 or between OT and O1 will eliminate linking of GntR to operators, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1724">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 eliminated GntR connection to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1725">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 eliminated linking of GntR to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1726">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 eliminates GntR connection to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1727">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 eliminates linking of GntR to operators, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1728">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 will eliminate GntR connection to operators, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1729">
                    <text>gluconate and also by 6-phosphoglyconate located inside O2 or between OT and O1 will eliminate linking of GntR to operators, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1730">
                    <text>gluconate and also by 6-phosphoglyconate located within O2 or between OT and O1 eliminates GntR connection to operators, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1731">
                    <text>gluconate and also by 6-phosphoglyconate located within O2 or between OT and O1 has eliminated GntR connection to operators, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1732">
                    <text>gluconate and also by 6-phosphoglyconate may eliminate GntR connection to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1733">
                    <text>gluconate and also by 6-phosphoglyconate may eliminate linking of GntR to operators while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1734">
                    <text>gluconate and also by 6-phosphoglyconate removes GntR connection to operators eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1735">
                    <text>gluconate and also by 6-phosphoglyconate removes GntR connection to operators eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1736">
                    <text>gluconate and also by 6-phosphoglyconate removes linking of GntR to operators eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1737">
                    <text>gluconate and also by 6-phosphoglyconate removes linking of GntR to operators eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1738">
                    <text>gluconate and also by 6-phosphoglyconate that eliminated GntR connection to operators was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1739">
                    <text>gluconate and also by 6-phosphoglyconate that eliminated GntR connection to operators was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1740">
                    <text>gluconate and also by 6-phosphoglyconate that eliminated linking of GntR to operators was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1741">
                    <text>gluconate and also by 6-phosphoglyconate that eliminated linking of GntR to operators was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1742">
                    <text>gluconate and also by 6-phosphoglyconate that eliminates GntR connection to operators is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1743">
                    <text>gluconate and also by 6-phosphoglyconate that eliminates GntR connection to operators is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1744">
                    <text>gluconate and also by 6-phosphoglyconate that eliminates linking of GntR to operators is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1745">
                    <text>gluconate and also by 6-phosphoglyconate that eliminates linking of GntR to operators is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1746">
                    <text>gluconate and also by 6-phosphoglyconate), GntR connection to operators can be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1747">
                    <text>gluconate and also by 6-phosphoglyconate), linking of GntR to operators can be completely eliminated (figure 7).</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1748">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1749">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, has eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1750">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, has eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1751">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, is able to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1752">
                    <text>gluconate and also by 6-phosphoglyconate, as can occur after caspase activation, is able to eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1753">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after activation of caspase, is able to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1754">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after activation of caspase, is able to eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1755">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after caspase activation, eliminated GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1756">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after caspase activation, eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1757">
                    <text>gluconate and also by 6-phosphoglyconate, as may occur after caspase activation, eliminates GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1758">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, can eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1759">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, can eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1760">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1761">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, eliminate linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1762">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, eliminated linking of GntR to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="1763">
                    <text>gluconate and also by 6-phosphoglyconate, such as CD14, is able to eliminate GntR connection to operators.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">GntR connection to operators</arg>
                </example>
                <example src="PERMUTATE" no="1764">
                    <text>hindIII is eliminated by the other to exon 11 of the gene phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1765">
                    <text>hindIII is eliminated by the other via exon 11 of the gene phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1766">
                    <text>hindIII is eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1767">
                    <text>hindIII is eliminated in exon 11 of the gene phenylalanine hydroxylase to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1768">
                    <text>hindIII site is eliminated by other to exon 11 of the gene for hydroxylase phenylalanine, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1769">
                    <text>hindIII site is eliminated by the other in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1770">
                    <text>hindIII site is eliminated by the other in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1771">
                    <text>hindIII site is eliminated by the other in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1772">
                    <text>hindIII site is eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1773">
                    <text>hindIII site is eliminated by the other to exon 11 of the gene phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1774">
                    <text>hindIII site is eliminated by the other to exon 11 of the phenylalanine hydroxylase gene, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1775">
                    <text>hindIII site is eliminated by the other via exon 11 of the gene for phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1776">
                    <text>hindIII site is eliminated by the other via exon 11 of the gene phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1777">
                    <text>hindIII site is eliminated in exon 11 of the gene for hydroxylase phenylalanine by other.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1778">
                    <text>hindIII site is eliminated in exon 11 of the gene for hydroxylase phenylalanine to other.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1779">
                    <text>hindIII site is eliminated in exon 11 of the gene for phenylalanine hydroxylase to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1780">
                    <text>hindIII site is eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1781">
                    <text>hindIII site is eliminated in exon 11 of the gene phenylalanine hydroxylase to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1782">
                    <text>hindIII site is eliminated in exon 11 of the phenylalanine hydroxylase gene by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1783">
                    <text>hindIII site is eliminated in exon 11 of the phenylalanine hydroxylase gene to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1784">
                    <text>hindIII site was eliminated by other in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1785">
                    <text>hindIII site was eliminated by other to exon 11 of the gene for hydroxylase phenylalanine while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1786">
                    <text>hindIII site was eliminated by other to exon 11 of the gene for hydroxylase phenylalanine while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1787">
                    <text>hindIII site was eliminated by the other in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1788">
                    <text>hindIII site was eliminated by the other in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1789">
                    <text>hindIII site was eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1790">
                    <text>hindIII site was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1791">
                    <text>hindIII site was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1792">
                    <text>hindIII site was eliminated by the other to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1793">
                    <text>hindIII site was eliminated by the other to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1794">
                    <text>hindIII site was eliminated in exon 11 of the gene for hydroxylase phenylalanine for other.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="1795">
                    <text>hindIII site was eliminated in exon 11 of the gene for phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1796">
                    <text>hindIII site was eliminated in exon 11 of the gene for phenylalanine hydroxylase for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1797">
                    <text>hindIII site was eliminated in exon 11 of the phenylalanine hydroxylase gene by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1798">
                    <text>hindIII site was eliminated in exon 11 of the phenylalanine hydroxylase gene for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="1799">
                    <text>hindIII was eliminated by the other in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1800">
                    <text>hindIII was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1801">
                    <text>hindIII was eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1802">
                    <text>hindIII was eliminated in exon 11 of the gene phenylalanine hydroxylase for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="1803">
                    <text>induction requirement are eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1804">
                    <text>induction requirement has been eliminated by mutation of a new locus, galS, as may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1805">
                    <text>induction requirement is eliminated by mutation of a new locus, galS, as it may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1806">
                    <text>induction requirement is eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1807">
                    <text>induction requirement was eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1808">
                    <text>induction requirement was eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1809">
                    <text>induction requirement was eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1810">
                    <text>induction requirement was eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1811">
                    <text>induction requirement were eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1812">
                    <text>induction requirement will be eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="1813">
                    <text>inhibition of any of these molecules can eliminate exogeneous H(2)O(2) in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1814">
                    <text>inhibition of any of these molecules can eliminate viral stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1815">
                    <text>inhibition of any of these molecules can eliminate vital stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1816">
                    <text>inhibition of any of these molecules eliminated exogeneous H(2)O(2) into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1817">
                    <text>inhibition of any of these molecules eliminated viral stem cells while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1818">
                    <text>inhibition of any of these molecules eliminated vital stem cells while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1819">
                    <text>inhibition of any of these molecules eliminates H(2)O(2) exogenous in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1820">
                    <text>inhibition of any of these molecules eliminates exogeneous H(2)O(2) in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1821">
                    <text>inhibition of any of these molecules eliminates viral stem cells while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1822">
                    <text>inhibition of any of these molecules eliminates viral stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1823">
                    <text>inhibition of any of these molecules eliminates vital stem cells while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1824">
                    <text>inhibition of any of these molecules eliminates vital stem cells, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1825">
                    <text>inhibition of any of these molecules has eliminated H(2)O(2) exogenous into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1826">
                    <text>inhibition of any of these molecules has eliminated exogeneous H(2)O(2) into transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1827">
                    <text>inhibition of any of these molecules has eliminated viral stem cells while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1828">
                    <text>inhibition of any of these molecules has eliminated vital stem cells while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1829">
                    <text>inhibition of any of these molecules is able to eliminate exogeneous H(2)O(2) in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1830">
                    <text>inhibition of any of these molecules located in O2 or between OT and O1 will eliminate vital stem cells, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1831">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminated viral stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1832">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminates viral stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1833">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 eliminates vital stem cells, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1834">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 will eliminate viral stem cells, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1835">
                    <text>inhibition of any of these molecules located inside O2 or between OT and O1 will eliminate vital stem cells, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1836">
                    <text>inhibition of any of these molecules located within O2 or between OT and O1 eliminates vital stem cells, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1837">
                    <text>inhibition of any of these molecules located within O2 or between OT and O1 has eliminated vital stem cells, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1838">
                    <text>inhibition of any of these molecules may eliminate viral stem cells while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1839">
                    <text>inhibition of any of these molecules may eliminate vital stem cells while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1840">
                    <text>inhibition of any of these molecules removes viral stem cells eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1841">
                    <text>inhibition of any of these molecules removes viral stem cells eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1842">
                    <text>inhibition of any of these molecules removes vital stem cells eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1843">
                    <text>inhibition of any of these molecules removes vital stem cells eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1844">
                    <text>inhibition of any of these molecules that eliminated vital stem cells was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1845">
                    <text>inhibition of any of these molecules that eliminates viral stem cells is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1846">
                    <text>inhibition of any of these molecules that eliminates viral stem cells is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1847">
                    <text>inhibition of any of these molecules that eliminates vital stem cells is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1848">
                    <text>inhibition of any of these molecules would eliminate H(2)O(2) exogenous in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">H(2)O(2) exogenous</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1849">
                    <text>inhibition of any of these molecules would eliminate exogeneous H(2)O(2) in transgenic plants.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="1850">
                    <text>inhibition of any of these molecules), viral stem cells can be completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1851">
                    <text>inhibition of any of these molecules), vital stem cells can be completely eliminated (figure 7).</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1852">
                    <text>inhibition of any of these molecules, as can occur after caspase activation, has eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1853">
                    <text>inhibition of any of these molecules, as can occur after caspase activation, is able to eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1854">
                    <text>inhibition of any of these molecules, as may occur after activation of caspase, is able to eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1855">
                    <text>inhibition of any of these molecules, as may occur after caspase activation, eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1856">
                    <text>inhibition of any of these molecules, such as CD14, can eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1857">
                    <text>inhibition of any of these molecules, such as CD14, eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1858">
                    <text>inhibition of any of these molecules, such as CD14, eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1859">
                    <text>inhibition of any of these molecules, such as CD14, eliminated viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1860">
                    <text>inhibition of any of these molecules, such as CD14, eliminated vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1861">
                    <text>inhibition of any of these molecules, such as CD14, is able to eliminate viral stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1862">
                    <text>inhibition of any of these molecules, such as CD14, is able to eliminate vital stem cells.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="1863">
                    <text>insertion of 6 bp can eliminate repression of glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1864">
                    <text>insertion of 6 bp can eliminate repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1865">
                    <text>insertion of 6 bp eliminated repression of glpTQ promoter while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1866">
                    <text>insertion of 6 bp eliminated repression of the promoter glpTQ while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1867">
                    <text>insertion of 6 bp eliminates repression of glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1868">
                    <text>insertion of 6 bp eliminates repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1869">
                    <text>insertion of 6 bp has eliminated repression of glpTQ promoter while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1870">
                    <text>insertion of 6 bp has eliminated repression of the promoter glpTQ while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1871">
                    <text>insertion of 6 bp located in O2 or between OT and O1 will eliminate repression of glpTQ promoter, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1872">
                    <text>insertion of 6 bp located in O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1873">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 eliminated repression of glpTQ promoter, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1874">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 eliminated repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1875">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 eliminates repression of glpTQ promoter, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1876">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 eliminates repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1877">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 will eliminate repression of glpTQ promoter, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1878">
                    <text>insertion of 6 bp located inside O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1879">
                    <text>insertion of 6 bp located within O2 or between OT and O1 eliminates repression of the promoter glpTQ, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1880">
                    <text>insertion of 6 bp may eliminate repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1881">
                    <text>insertion of 6 bp removes repression of glpTQ promoter eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1882">
                    <text>insertion of 6 bp removes repression of glpTQ promoter eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1883">
                    <text>insertion of 6 bp removes repression of the promoter glpTQ eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1884">
                    <text>insertion of 6 bp removes repression of the promoter glpTQ eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1885">
                    <text>insertion of 6 bp that eliminated repression of glpTQ promoter was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1886">
                    <text>insertion of 6 bp that eliminated repression of glpTQ promoter was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1887">
                    <text>insertion of 6 bp that eliminated repression of the promoter glpTQ was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1888">
                    <text>insertion of 6 bp that eliminates repression of glpTQ promoter is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1889">
                    <text>insertion of 6 bp that eliminates repression of the promoter glpTQ is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1890">
                    <text>insertion of 6 bp that eliminates repression of the promoter glpTQ is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1891">
                    <text>insertion of 6 bp), repression of glpTQ promoter can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1892">
                    <text>insertion of 6 bp), repression of the promoter glpTQ can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1893">
                    <text>insertion of 6 bp, as can occur after caspase activation, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1894">
                    <text>insertion of 6 bp, as can occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1895">
                    <text>insertion of 6 bp, as can occur after caspase activation, has eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1896">
                    <text>insertion of 6 bp, as can occur after caspase activation, has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1897">
                    <text>insertion of 6 bp, as can occur after caspase activation, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1898">
                    <text>insertion of 6 bp, as can occur after caspase activation, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1899">
                    <text>insertion of 6 bp, as may occur after activation of caspase, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1900">
                    <text>insertion of 6 bp, as may occur after activation of caspase, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1901">
                    <text>insertion of 6 bp, as may occur after caspase activation, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1902">
                    <text>insertion of 6 bp, as may occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1903">
                    <text>insertion of 6 bp, as may occur after caspase activation, eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1904">
                    <text>insertion of 6 bp, as may occur after caspase activation, eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1905">
                    <text>insertion of 6 bp, such as CD14, can eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1906">
                    <text>insertion of 6 bp, such as CD14, can eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1907">
                    <text>insertion of 6 bp, such as CD14, eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1908">
                    <text>insertion of 6 bp, such as CD14, eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1909">
                    <text>insertion of 6 bp, such as CD14, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1910">
                    <text>insertion of 6 bp, such as CD14, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1911">
                    <text>insertion of 6 bp, such as CD14, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1912">
                    <text>insertion of 6-bp can eliminate repression of the glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1913">
                    <text>insertion of 6-bp can eliminate repression of the promoter glpTQ, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1914">
                    <text>insertion of 6-bp eliminated repression of glpTQ promoter while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1915">
                    <text>insertion of 6-bp eliminated repression of the glpTQ promoter while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1916">
                    <text>insertion of 6-bp eliminated repression of the promoter glpTQ while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1917">
                    <text>insertion of 6-bp eliminates repression of glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1918">
                    <text>insertion of 6-bp eliminates repression of glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1919">
                    <text>insertion of 6-bp eliminates repression of the glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1920">
                    <text>insertion of 6-bp eliminates repression of the glpTQ promoter, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1921">
                    <text>insertion of 6-bp eliminates repression of the promoter glpTQ while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1922">
                    <text>insertion of 6-bp has eliminated repression of glpTQ promoter while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1923">
                    <text>insertion of 6-bp has eliminated repression of the glpTQ promoter while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1924">
                    <text>insertion of 6-bp has eliminated repression of the promoter glpTQ while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1925">
                    <text>insertion of 6-bp located in O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1926">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminated repression of the glpTQ promoter, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1927">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminated repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1928">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminates repression of the glpTQ promoter, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1929">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 eliminates repression of the promoter glpTQ, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1930">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 will eliminate repression of the glpTQ promoter, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1931">
                    <text>insertion of 6-bp located inside O2 or between OT and O1 will eliminate repression of the promoter glpTQ, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1932">
                    <text>insertion of 6-bp located within O2 or between OT and O1 eliminates repression of glpTQ promoter, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1933">
                    <text>insertion of 6-bp located within O2 or between OT and O1 eliminates repression of the glpTQ promoter, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1934">
                    <text>insertion of 6-bp located within O2 or between OT and O1 eliminates repression of the promoter glpTQ, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1935">
                    <text>insertion of 6-bp located within O2 or between OT and O1 has eliminated repression of glpTQ promoter, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1936">
                    <text>insertion of 6-bp located within O2 or between OT and O1 has eliminated repression of the promoter glpTQ, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1937">
                    <text>insertion of 6-bp may eliminate repression of glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1938">
                    <text>insertion of 6-bp may eliminate repression of the glpTQ promoter while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1939">
                    <text>insertion of 6-bp removes repression of glpTQ promoter eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1940">
                    <text>insertion of 6-bp removes repression of glpTQ promoter eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1941">
                    <text>insertion of 6-bp removes repression of the glpTQ promoter eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1942">
                    <text>insertion of 6-bp removes repression of the promoter glpTQ eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1943">
                    <text>insertion of 6-bp that eliminated repression of glpTQ promoter was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1944">
                    <text>insertion of 6-bp that eliminated repression of glpTQ promoter was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1945">
                    <text>insertion of 6-bp that eliminated repression of the glpTQ promoter was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1946">
                    <text>insertion of 6-bp that eliminated repression of the glpTQ promoter was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1947">
                    <text>insertion of 6-bp that eliminated repression of the promoter glpTQ was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1948">
                    <text>insertion of 6-bp that eliminates repression of glpTQ promoter is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1949">
                    <text>insertion of 6-bp that eliminates repression of glpTQ promoter is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1950">
                    <text>insertion of 6-bp that eliminates repression of the glpTQ promoter is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1951">
                    <text>insertion of 6-bp that eliminates repression of the glpTQ promoter is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1952">
                    <text>insertion of 6-bp that eliminates repression of the promoter glpTQ is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1953">
                    <text>insertion of 6-bp), repression of glpTQ promoter can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1954">
                    <text>insertion of 6-bp), repression of the glpTQ promoter can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1955">
                    <text>insertion of 6-bp), repression of the promoter glpTQ can be completely eliminated (figure 7).</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1956">
                    <text>insertion of 6-bp, as can occur after caspase activation, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1957">
                    <text>insertion of 6-bp, as can occur after caspase activation, eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1958">
                    <text>insertion of 6-bp, as can occur after caspase activation, has eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1959">
                    <text>insertion of 6-bp, as can occur after caspase activation, has eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1960">
                    <text>insertion of 6-bp, as can occur after caspase activation, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1961">
                    <text>insertion of 6-bp, as can occur after caspase activation, is able to eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1962">
                    <text>insertion of 6-bp, as can occur after caspase activation, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1963">
                    <text>insertion of 6-bp, as may occur after activation of caspase, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1964">
                    <text>insertion of 6-bp, as may occur after activation of caspase, is able to eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1965">
                    <text>insertion of 6-bp, as may occur after activation of caspase, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1966">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1967">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1968">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminates repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1969">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminates repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1970">
                    <text>insertion of 6-bp, as may occur after caspase activation, eliminates repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1971">
                    <text>insertion of 6-bp, such as CD14, can eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1972">
                    <text>insertion of 6-bp, such as CD14, can eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1973">
                    <text>insertion of 6-bp, such as CD14, eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1974">
                    <text>insertion of 6-bp, such as CD14, eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1975">
                    <text>insertion of 6-bp, such as CD14, eliminated repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1976">
                    <text>insertion of 6-bp, such as CD14, eliminated repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1977">
                    <text>insertion of 6-bp, such as CD14, eliminated repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1978">
                    <text>insertion of 6-bp, such as CD14, is able to eliminate repression of glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1979">
                    <text>insertion of 6-bp, such as CD14, is able to eliminate repression of the glpTQ promoter.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="1980">
                    <text>insertion of 6-bp, such as CD14, is able to eliminate repression of the promoter glpTQ.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="1981">
                    <text>join are eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1982">
                    <text>join is eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1983">
                    <text>join was eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1984">
                    <text>join was eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1985">
                    <text>join was eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1986">
                    <text>join was eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1987">
                    <text>join were eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1988">
                    <text>join will be eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1989">
                    <text>join will be eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">join</arg>
                </example>
                <example src="PERMUTATE" no="1990">
                    <text>ligand are eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1991">
                    <text>ligand has been eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1992">
                    <text>ligand has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1993">
                    <text>ligand is eliminated by a molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1994">
                    <text>ligand is eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1995">
                    <text>ligand was eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1996">
                    <text>ligand was eliminated by a molar ratio of 5:1 at a concentration of 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1997">
                    <text>ligand was eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1998">
                    <text>ligand was eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="1999">
                    <text>ligand was eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="2000">
                    <text>ligand will be eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="2001">
                    <text>ligand will be eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">ligand</arg>
                </example>
                <example src="PERMUTATE" no="2002">
                    <text>linking of GntR to operators has been eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2003">
                    <text>linking of GntR to operators has been eliminated by gluconate and also by 6-phosphoglyconate, as may occur after activation of caspase.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2004">
                    <text>linking of GntR to operators is eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2005">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10 times higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2006">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2007">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate, such as CD14.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2008">
                    <text>linking of GntR to operators was eliminated by gluconate and also by 6-phosphoglyconate.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2009">
                    <text>linking of GntR to operators will be eliminated by gluconate and also by 6-phosphoglyconate at a concentration of 10-fold-higher.</text>
                    <arg n="0">gluconate and also by 6-phosphoglyconate</arg>
                    <arg n="1">linking of GntR to operators</arg>
                </example>
                <example src="PERMUTATE" no="2010">
                    <text>microbe-detecting receptors that activated immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2011">
                    <text>microbe-detecting receptors that activated immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2012">
                    <text>microbe-detecting receptors that activated immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2013">
                    <text>microbe-detecting receptors that activated immune cells has eliminated pathogens while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2014">
                    <text>microbe-detecting receptors that activated immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2015">
                    <text>microbe-detecting receptors that activated immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2016">
                    <text>microbe-detecting receptors that activated immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2017">
                    <text>microbe-detecting receptors that activated immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2018">
                    <text>microbe-detecting receptors that activated immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2019">
                    <text>microbe-detecting receptors that activated immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2020">
                    <text>microbe-detecting receptors that activated immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2021">
                    <text>microbe-detecting receptors that activated immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2022">
                    <text>microbe-detecting receptors that activated immune cells that eliminated pathogens was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2023">
                    <text>microbe-detecting receptors that activated immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2024">
                    <text>microbe-detecting receptors that activated immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2025">
                    <text>microbe-detecting receptors that activated immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2026">
                    <text>microbe-detecting receptors that activated immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2027">
                    <text>microbe-detecting receptors that activated immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2028">
                    <text>microbe-detecting receptors that activated immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2029">
                    <text>microbe-detecting receptors that activated immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2030">
                    <text>microbe-detecting receptors that activated immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2031">
                    <text>microbe-detecting receptors that activated immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2032">
                    <text>microbe-detecting receptors that activated immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2033">
                    <text>molar ratio of 5:1 eliminated arrangement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2034">
                    <text>molar ratio of 5:1 eliminated round while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2035">
                    <text>molar ratio of 5:1 eliminates arrangement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2036">
                    <text>molar ratio of 5:1 eliminates round while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2037">
                    <text>molar ratio of 5:1 eliminates round, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2038">
                    <text>molar ratio of 5:1 has eliminated arrangement while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2039">
                    <text>molar ratio of 5:1 has eliminated round while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2040">
                    <text>molar ratio of 5:1 located in O2 or between OT and O1 will eliminate arrangement, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2041">
                    <text>molar ratio of 5:1 located in O2 or between OT and O1 will eliminate round, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2042">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 eliminated arrangement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2043">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 eliminated round, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2044">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 eliminates arrangement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2045">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 eliminates round, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2046">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 will eliminate arrangement, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2047">
                    <text>molar ratio of 5:1 located inside O2 or between OT and O1 will eliminate round, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2048">
                    <text>molar ratio of 5:1 located within O2 or between OT and O1 eliminates arrangement, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2049">
                    <text>molar ratio of 5:1 located within O2 or between OT and O1 eliminates round, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2050">
                    <text>molar ratio of 5:1 located within O2 or between OT and O1 has eliminated arrangement, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2051">
                    <text>molar ratio of 5:1 located within O2 or between OT and O1 has eliminated round, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2052">
                    <text>molar ratio of 5:1 may eliminate arrangement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2053">
                    <text>molar ratio of 5:1 may eliminate round while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2054">
                    <text>molar ratio of 5:1 removes arrangement eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2055">
                    <text>molar ratio of 5:1 removes arrangement eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2056">
                    <text>molar ratio of 5:1 removes round eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2057">
                    <text>molar ratio of 5:1 removes round eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2058">
                    <text>molar ratio of 5:1 that eliminated arrangement was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2059">
                    <text>molar ratio of 5:1 that eliminated arrangement was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2060">
                    <text>molar ratio of 5:1 that eliminated round was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2061">
                    <text>molar ratio of 5:1 that eliminated round was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2062">
                    <text>molar ratio of 5:1 that eliminates arrangement is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2063">
                    <text>molar ratio of 5:1 that eliminates arrangement is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2064">
                    <text>molar ratio of 5:1 that eliminates round is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2065">
                    <text>molar ratio of 5:1 that eliminates round is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2066">
                    <text>molar ratio of 5:1, as can occur after caspase activation, eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2067">
                    <text>molar ratio of 5:1, as can occur after caspase activation, has eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2068">
                    <text>molar ratio of 5:1, as can occur after caspase activation, is able to eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2069">
                    <text>molar ratio of 5:1, as can occur after caspase activation, is able to eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2070">
                    <text>molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2071">
                    <text>molar ratio of 5:1, as may occur after activation of caspase, is able to eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2072">
                    <text>molar ratio of 5:1, as may occur after caspase activation, eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2073">
                    <text>molar ratio of 5:1, as may occur after caspase activation, eliminates arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2074">
                    <text>molar ratio of 5:1, as may occur after caspase activation, eliminates round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2075">
                    <text>molar ratio of 5:1, such as CD14, can eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2076">
                    <text>molar ratio of 5:1, such as CD14, eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2077">
                    <text>molar ratio of 5:1, such as CD14, eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2078">
                    <text>molar ratio of 5:1, such as CD14, eliminated arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2079">
                    <text>molar ratio of 5:1, such as CD14, eliminated round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2080">
                    <text>molar ratio of 5:1, such as CD14, is able to eliminate arrangement.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">arrangement</arg>
                </example>
                <example src="PERMUTATE" no="2081">
                    <text>molar ratio of 5:1, such as CD14, is able to eliminate round.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2082">
                    <text>mutation from T491 can eliminate recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2083">
                    <text>mutation from T491 eliminate recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2084">
                    <text>mutation from T491 eliminated recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2085">
                    <text>mutation from T491 eliminated recognition into antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2086">
                    <text>mutation from T491 eliminates recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2087">
                    <text>mutation from T491 has eliminated recognition into antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2088">
                    <text>mutation from T491 is able to eliminate recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2089">
                    <text>mutation from T491 is able to eliminate recognition into antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2090">
                    <text>mutation from T491 may eliminate recognition into antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2091">
                    <text>mutation from T491 would eliminate recognition in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2092">
                    <text>mutation of a new locus, galS can eliminate induction requirement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2093">
                    <text>mutation of a new locus, galS can eliminate the requirement of induction, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2094">
                    <text>mutation of a new locus, galS eliminated induction requirement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2095">
                    <text>mutation of a new locus, galS eliminated the requirement of induction while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2096">
                    <text>mutation of a new locus, galS eliminates induction requirement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2097">
                    <text>mutation of a new locus, galS eliminates the requirement of induction while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2098">
                    <text>mutation of a new locus, galS eliminates the requirement of induction, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2099">
                    <text>mutation of a new locus, galS has eliminated induction requirement while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2100">
                    <text>mutation of a new locus, galS located in O2 or between OT and O1 will eliminate the requirement of induction, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2101">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 eliminated induction requirement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2102">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 eliminated the requirement of induction, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2103">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 eliminates induction requirement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2104">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 eliminates the requirement of induction, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2105">
                    <text>mutation of a new locus, galS located inside O2 or between OT and O1 will eliminate the requirement of induction, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2106">
                    <text>mutation of a new locus, galS located within O2 or between OT and O1 eliminates induction requirement, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2107">
                    <text>mutation of a new locus, galS located within O2 or between OT and O1 eliminates the requirement of induction, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2108">
                    <text>mutation of a new locus, galS located within O2 or between OT and O1 has eliminated induction requirement, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2109">
                    <text>mutation of a new locus, galS located within O2 or between OT and O1 has eliminated the requirement of induction, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2110">
                    <text>mutation of a new locus, galS may eliminate induction requirement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2111">
                    <text>mutation of a new locus, galS may eliminate the requirement of induction while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2112">
                    <text>mutation of a new locus, galS removes induction requirement eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2113">
                    <text>mutation of a new locus, galS removes the requirement of induction eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2114">
                    <text>mutation of a new locus, galS that eliminated the requirement of induction was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2115">
                    <text>mutation of a new locus, galS that eliminates induction requirement is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2116">
                    <text>mutation of a new locus, galS that eliminates the requirement of induction is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2117">
                    <text>mutation of a new locus, galS that eliminates the requirement of induction is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2118">
                    <text>mutation of a new locus, galS), the requirement of induction can be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2119">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2120">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, has eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2121">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, has eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2122">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, is able to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2123">
                    <text>mutation of a new locus, galS, as can occur after caspase activation, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2124">
                    <text>mutation of a new locus, galS, as may occur after activation of caspase, is able to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2125">
                    <text>mutation of a new locus, galS, as may occur after activation of caspase, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2126">
                    <text>mutation of a new locus, galS, as may occur after caspase activation, eliminated induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2127">
                    <text>mutation of a new locus, galS, as may occur after caspase activation, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2128">
                    <text>mutation of a new locus, galS, as may occur after caspase activation, eliminates induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2129">
                    <text>mutation of a new locus, galS, as may occur after caspase activation, eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2130">
                    <text>mutation of a new locus, galS, such as CD14, can eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2131">
                    <text>mutation of a new locus, galS, such as CD14, can eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2132">
                    <text>mutation of a new locus, galS, such as CD14, eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2133">
                    <text>mutation of a new locus, galS, such as CD14, eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2134">
                    <text>mutation of a new locus, galS, such as CD14, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2135">
                    <text>mutation of a new locus, galS, such as CD14, is able to eliminate induction requirement.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">induction requirement</arg>
                </example>
                <example src="PERMUTATE" no="2136">
                    <text>mutation of a new locus, galS, such as CD14, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2137">
                    <text>or any harmful effect eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="2138">
                    <text>or any harmful effect eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">or any harmful effect</arg>
                </example>
                <example src="PERMUTATE" no="2139">
                    <text>other eliminated hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2140">
                    <text>other eliminated hindIII site into exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2141">
                    <text>other eliminates hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2142">
                    <text>other has eliminated hindIII site into exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2143">
                    <text>other is able to eliminate hindIII site into exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2144">
                    <text>other may eliminate hindIII site into exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2145">
                    <text>other would eliminate hindIII site in exon 11 of the gene for hydroxylase phenylalanine.</text>
                    <arg n="0">other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for hydroxylase phenylalanine</arg>
                </example>
                <example src="PERMUTATE" no="2146">
                    <text>pathogens are eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2147">
                    <text>pathogens are eliminated by detection receptors for microorganisms that activated immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2148">
                    <text>pathogens are eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2149">
                    <text>pathogens are eliminated by detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2150">
                    <text>pathogens are eliminated by detection receptors of microorganisms that activated immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2151">
                    <text>pathogens are eliminated by microbe-detecting receptors that activated immune cells, such as CD14.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2152">
                    <text>pathogens are eliminated by receptors that activate immune cells for microorganism detection, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2153">
                    <text>pathogens are eliminated by receptors that activate immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2154">
                    <text>pathogens are eliminated by receptors that activate microbe-detection immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2155">
                    <text>pathogens has been eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2156">
                    <text>pathogens has been eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2157">
                    <text>pathogens has been eliminated by detection receptors for microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2158">
                    <text>pathogens has been eliminated by detection receptors for microorganisms that activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2159">
                    <text>pathogens has been eliminated by detection receptors for microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2160">
                    <text>pathogens has been eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2161">
                    <text>pathogens has been eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2162">
                    <text>pathogens has been eliminated by detection receptors of microorganisms such as CD14, which activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2163">
                    <text>pathogens has been eliminated by detection receptors of microorganisms that activate immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2164">
                    <text>pathogens has been eliminated by microbe-detecting receptors that activated immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2165">
                    <text>pathogens has been eliminated by receptors that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2166">
                    <text>pathogens has been eliminated by receptors that activate immune cells for microorganism detection at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2167">
                    <text>pathogens has been eliminated by receptors that activate immune cells for microorganism detection, as may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2168">
                    <text>pathogens has been eliminated by receptors that activate microbe-detection immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2169">
                    <text>pathogens has been eliminated by receptors that activate microbe-detection immune cells, as may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2170">
                    <text>pathogens is eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2171">
                    <text>pathogens is eliminated by detection receptors for microorganisms that activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2172">
                    <text>pathogens is eliminated by detection receptors for microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2173">
                    <text>pathogens is eliminated by detection receptors for microorganisms that activated immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2174">
                    <text>pathogens is eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2175">
                    <text>pathogens is eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2176">
                    <text>pathogens is eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2177">
                    <text>pathogens is eliminated by detection receptors of microorganisms such as CD14, which activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2178">
                    <text>pathogens is eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2179">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2180">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2181">
                    <text>pathogens is eliminated by detection receptors of microorganisms that activated immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2182">
                    <text>pathogens is eliminated by microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2183">
                    <text>pathogens is eliminated by receptors that activate immune cells for microorganism detection, as it may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2184">
                    <text>pathogens is eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2185">
                    <text>pathogens is eliminated by receptors that activate immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2186">
                    <text>pathogens is eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2187">
                    <text>pathogens is eliminated by receptors that activate microbe-detection immune cells, as it may occur after activation of caspase.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2188">
                    <text>pathogens was eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2189">
                    <text>pathogens was eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2190">
                    <text>pathogens was eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2191">
                    <text>pathogens was eliminated by detection receptors for microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2192">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2193">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2194">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2195">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2196">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2197">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activated immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2198">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activated immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2199">
                    <text>pathogens was eliminated by detection receptors for microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2200">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2201">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2202">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2203">
                    <text>pathogens was eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2204">
                    <text>pathogens was eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2205">
                    <text>pathogens was eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2206">
                    <text>pathogens was eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2207">
                    <text>pathogens was eliminated by detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2208">
                    <text>pathogens was eliminated by detection receptors of microorganisms such as CD14, which activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2209">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2210">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2211">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2212">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2213">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activate immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2214">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2215">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activated immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2216">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2217">
                    <text>pathogens was eliminated by detection receptors of microorganisms that activated immune cells.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2218">
                    <text>pathogens was eliminated by microbe-detecting receptors that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2219">
                    <text>pathogens was eliminated by microbe-detecting receptors that activated immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2220">
                    <text>pathogens was eliminated by microbe-detecting receptors that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2221">
                    <text>pathogens was eliminated by microbe-detecting receptors that activated immune cells.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2222">
                    <text>pathogens was eliminated by receptors that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2223">
                    <text>pathogens was eliminated by receptors that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2224">
                    <text>pathogens was eliminated by receptors that activate immune cells for microorganism detection at a concentration of 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2225">
                    <text>pathogens was eliminated by receptors that activate immune cells for microorganism detection, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2226">
                    <text>pathogens was eliminated by receptors that activate immune cells for microorganism detection.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2227">
                    <text>pathogens was eliminated by receptors that activate immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2228">
                    <text>pathogens was eliminated by receptors that activate immune cells.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2229">
                    <text>pathogens was eliminated by receptors that activate microbe-detection immune cells at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2230">
                    <text>pathogens was eliminated by receptors that activate microbe-detection immune cells at a concentration of 10 times higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2231">
                    <text>pathogens was eliminated by receptors that activate microbe-detection immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2232">
                    <text>pathogens was eliminated by receptors that activate microbe-detection immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2233">
                    <text>pathogens was eliminated by receptors that activate microbe-detection immune cells.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2234">
                    <text>pathogens were eliminated by detection receptors for microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2235">
                    <text>pathogens were eliminated by detection receptors for microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2236">
                    <text>pathogens were eliminated by detection receptors of micro-organisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of micro-organisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2237">
                    <text>pathogens were eliminated by detection receptors of microorganisms such as CD14, which activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2238">
                    <text>pathogens were eliminated by detection receptors of microorganisms that activate immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2239">
                    <text>pathogens were eliminated by detection receptors of microorganisms that activated immune cells, such as CD14.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2240">
                    <text>pathogens were eliminated by microbe-detecting receptors that activated immune cells, such as CD14.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2241">
                    <text>pathogens were eliminated by receptors that activate immune cells for microorganism detection, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2242">
                    <text>pathogens were eliminated by receptors that activate immune cells, such as CD14.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2243">
                    <text>pathogens will be eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2244">
                    <text>pathogens will be eliminated by detection receptors for microorganisms such as CD14, which activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2245">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2246">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2247">
                    <text>pathogens will be eliminated by detection receptors for microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors for microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2248">
                    <text>pathogens will be eliminated by detection receptors of microorganisms such as CD14, which activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms such as CD14, which activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2249">
                    <text>pathogens will be eliminated by detection receptors of microorganisms that activate immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2250">
                    <text>pathogens will be eliminated by detection receptors of microorganisms that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2251">
                    <text>pathogens will be eliminated by detection receptors of microorganisms that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2252">
                    <text>pathogens will be eliminated by detection receptors of microorganisms that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">detection receptors of microorganisms that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2253">
                    <text>pathogens will be eliminated by microbe-detecting receptors that activated immune cells at a concentration 10 times higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2254">
                    <text>pathogens will be eliminated by microbe-detecting receptors that activated immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">microbe-detecting receptors that activated immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2255">
                    <text>pathogens will be eliminated by receptors that activate immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2256">
                    <text>pathogens will be eliminated by receptors that activate immune cells for microorganism detection at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2257">
                    <text>pathogens will be eliminated by receptors that activate immune cells for microorganism detection at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2258">
                    <text>pathogens will be eliminated by receptors that activate microbe-detection immune cells at a concentration 10 times higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2259">
                    <text>pathogens will be eliminated by receptors that activate microbe-detection immune cells at a concentration of 10-fold-higher.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2260">
                    <text>receptors that activate immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2261">
                    <text>receptors that activate immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2262">
                    <text>receptors that activate immune cells eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2263">
                    <text>receptors that activate immune cells for microorganism detection can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2264">
                    <text>receptors that activate immune cells for microorganism detection eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2265">
                    <text>receptors that activate immune cells for microorganism detection eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2266">
                    <text>receptors that activate immune cells for microorganism detection eliminates pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2267">
                    <text>receptors that activate immune cells for microorganism detection located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2268">
                    <text>receptors that activate immune cells for microorganism detection located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2269">
                    <text>receptors that activate immune cells for microorganism detection located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2270">
                    <text>receptors that activate immune cells for microorganism detection located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2271">
                    <text>receptors that activate immune cells for microorganism detection may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2272">
                    <text>receptors that activate immune cells for microorganism detection removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2273">
                    <text>receptors that activate immune cells for microorganism detection removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2274">
                    <text>receptors that activate immune cells for microorganism detection that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2275">
                    <text>receptors that activate immune cells for microorganism detection that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2276">
                    <text>receptors that activate immune cells for microorganism detection that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2277">
                    <text>receptors that activate immune cells for microorganism detection), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2278">
                    <text>receptors that activate immune cells for microorganism detection, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2279">
                    <text>receptors that activate immune cells for microorganism detection, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2280">
                    <text>receptors that activate immune cells for microorganism detection, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2281">
                    <text>receptors that activate immune cells for microorganism detection, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2282">
                    <text>receptors that activate immune cells for microorganism detection, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2283">
                    <text>receptors that activate immune cells for microorganism detection, such as CD14, eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2284">
                    <text>receptors that activate immune cells for microorganism detection, such as CD14, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2285">
                    <text>receptors that activate immune cells for microorganism detection, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells for microorganism detection</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2286">
                    <text>receptors that activate immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2287">
                    <text>receptors that activate immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2288">
                    <text>receptors that activate immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2289">
                    <text>receptors that activate immune cells may eliminate pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2290">
                    <text>receptors that activate immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2291">
                    <text>receptors that activate immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2292">
                    <text>receptors that activate immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2293">
                    <text>receptors that activate immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2294">
                    <text>receptors that activate immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2295">
                    <text>receptors that activate immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2296">
                    <text>receptors that activate immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2297">
                    <text>receptors that activate immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2298">
                    <text>receptors that activate immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2299">
                    <text>receptors that activate immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2300">
                    <text>receptors that activate immune cells, such as CD14, can eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2301">
                    <text>receptors that activate immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2302">
                    <text>receptors that activate immune cells, such as CD14, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2303">
                    <text>receptors that activate microbe-detection immune cells can eliminate pathogens, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2304">
                    <text>receptors that activate microbe-detection immune cells eliminated pathogens while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2305">
                    <text>receptors that activate microbe-detection immune cells eliminates pathogens while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2306">
                    <text>receptors that activate microbe-detection immune cells located in O2 or between OT and O1 will eliminate pathogens, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2307">
                    <text>receptors that activate microbe-detection immune cells located inside O2 or between OT and O1 eliminated pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2308">
                    <text>receptors that activate microbe-detection immune cells located inside O2 or between OT and O1 eliminates pathogens, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2309">
                    <text>receptors that activate microbe-detection immune cells located inside O2 or between OT and O1 will eliminate pathogens, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2310">
                    <text>receptors that activate microbe-detection immune cells located within O2 or between OT and O1 eliminates pathogens, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2311">
                    <text>receptors that activate microbe-detection immune cells located within O2 or between OT and O1 has eliminated pathogens, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2312">
                    <text>receptors that activate microbe-detection immune cells removes pathogens eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2313">
                    <text>receptors that activate microbe-detection immune cells removes pathogens eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2314">
                    <text>receptors that activate microbe-detection immune cells that eliminated pathogens was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2315">
                    <text>receptors that activate microbe-detection immune cells that eliminates pathogens is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2316">
                    <text>receptors that activate microbe-detection immune cells that eliminates pathogens is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2317">
                    <text>receptors that activate microbe-detection immune cells), pathogens can be completely eliminated (figure 7).</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2318">
                    <text>receptors that activate microbe-detection immune cells, as can occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2319">
                    <text>receptors that activate microbe-detection immune cells, as can occur after caspase activation, has eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2320">
                    <text>receptors that activate microbe-detection immune cells, as can occur after caspase activation, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2321">
                    <text>receptors that activate microbe-detection immune cells, as may occur after activation of caspase, is able to eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2322">
                    <text>receptors that activate microbe-detection immune cells, as may occur after caspase activation, eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2323">
                    <text>receptors that activate microbe-detection immune cells, as may occur after caspase activation, eliminates pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2324">
                    <text>receptors that activate microbe-detection immune cells, such as CD14, eliminate pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2325">
                    <text>receptors that activate microbe-detection immune cells, such as CD14, eliminated pathogens.</text>
                    <arg n="0">receptors that activate microbe-detection immune cells</arg>
                    <arg n="1">pathogens</arg>
                </example>
                <example src="PERMUTATE" no="2326">
                    <text>recognition by anti-pT598 antibody are eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2327">
                    <text>recognition by anti-pT598 antibody has been eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2328">
                    <text>recognition by anti-pT598 antibody has been eliminated by T491 mutation, as may occur after activation of caspase.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2329">
                    <text>recognition by anti-pT598 antibody is eliminated by T491 mutation, as it may occur after activation of caspase.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2330">
                    <text>recognition by anti-pT598 antibody is eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2331">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation at a concentration 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2332">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation at a concentration of 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2333">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2334">
                    <text>recognition by anti-pT598 antibody was eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2335">
                    <text>recognition by anti-pT598 antibody were eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2336">
                    <text>recognition by anti-pT598 antibody will be eliminated by T491 mutation at a concentration 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2337">
                    <text>recognition by anti-pT598 antibody will be eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition by anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2338">
                    <text>recognition for antipT598 antibody are eliminated by the mutation of T491, such as CD14.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2339">
                    <text>recognition for antipT598 antibody has been eliminated by the mutation of T491, as may occur after activation of caspase.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2340">
                    <text>recognition for antipT598 antibody is eliminated by the mutation of T491, as it may occur after activation of caspase.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2341">
                    <text>recognition for antipT598 antibody is eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2342">
                    <text>recognition for antipT598 antibody was eliminated by the mutation of T491 at a concentration of 10 times higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2343">
                    <text>recognition for antipT598 antibody was eliminated by the mutation of T491 at a concentration of 10-fold-higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2344">
                    <text>recognition for antipT598 antibody was eliminated by the mutation of T491, such as CD14.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2345">
                    <text>recognition for antipT598 antibody was eliminated by the mutation of T491.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2346">
                    <text>recognition for antipT598 antibody were eliminated by the mutation of T491, such as CD14.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2347">
                    <text>recognition for antipT598 antibody will be eliminated by the mutation of T491 at a concentration 10 times higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2348">
                    <text>recognition for antipT598 antibody will be eliminated by the mutation of T491 at a concentration of 10-fold-higher.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2349">
                    <text>recognition is eliminated by T491 mutation in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2350">
                    <text>recognition is eliminated by T491 mutation in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2351">
                    <text>recognition is eliminated by T491 mutation to anti-pT598 antibody, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2352">
                    <text>recognition is eliminated by T491 mutation via anti-T598 antibody, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2353">
                    <text>recognition is eliminated by mutation from T491 via antipT598 antibody, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2354">
                    <text>recognition is eliminated in anti-T598 antibody by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2355">
                    <text>recognition is eliminated in anti-T598 antibody to T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2356">
                    <text>recognition is eliminated in anti-pT598 antibody by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2357">
                    <text>recognition is eliminated in anti-pT598 antibody to T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2358">
                    <text>recognition is eliminated in antipT598 antibody by mutation from T491.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2359">
                    <text>recognition is eliminated in antipT598 antibody to mutation from T491.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2360">
                    <text>recognition of anti-T598 antibodies are eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2361">
                    <text>recognition of anti-T598 antibodies has been eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2362">
                    <text>recognition of anti-T598 antibodies has been eliminated by T491 mutation, as may occur after activation of caspase.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2363">
                    <text>recognition of anti-T598 antibodies is eliminated by T491 mutation, as it may occur after activation of caspase.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2364">
                    <text>recognition of anti-T598 antibodies is eliminated by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2365">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation at a concentration 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2366">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation at a concentration of 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2367">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2368">
                    <text>recognition of anti-T598 antibodies was eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2369">
                    <text>recognition of anti-T598 antibodies were eliminated by T491 mutation, such as CD14.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2370">
                    <text>recognition of anti-T598 antibodies will be eliminated by T491 mutation at a concentration 10 times higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2371">
                    <text>recognition of anti-T598 antibodies will be eliminated by T491 mutation at a concentration of 10-fold-higher.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition of anti-T598 antibodies</arg>
                </example>
                <example src="PERMUTATE" no="2372">
                    <text>recognition was eliminated by T491 mutation in anti-T598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2373">
                    <text>recognition was eliminated by T491 mutation in anti-pT598 antibody.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2374">
                    <text>recognition was eliminated by T491 mutation to anti-T598 antibody while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2375">
                    <text>recognition was eliminated by T491 mutation to anti-pT598 antibody while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2376">
                    <text>recognition was eliminated by T491 mutation to anti-pT598 antibody while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2377">
                    <text>recognition was eliminated by mutation from T491 in antipT598 antibody.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2378">
                    <text>recognition was eliminated by mutation from T491 to antipT598 antibody while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2379">
                    <text>recognition was eliminated in anti-T598 antibody by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2380">
                    <text>recognition was eliminated in anti-T598 antibody for T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-T598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2381">
                    <text>recognition was eliminated in anti-pT598 antibody by T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2382">
                    <text>recognition was eliminated in anti-pT598 antibody for T491 mutation.</text>
                    <arg n="0">T491 mutation</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">anti-pT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2383">
                    <text>recognition was eliminated in antipT598 antibody by mutation from T491.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2384">
                    <text>recognition was eliminated in antipT598 antibody for mutation from T491.</text>
                    <arg n="0">mutation from T491</arg>
                    <arg n="1">recognition</arg>
                    <arg n="2">antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2385">
                    <text>repression of glpTQ promoter are eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2386">
                    <text>repression of glpTQ promoter are eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2387">
                    <text>repression of glpTQ promoter has been eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2388">
                    <text>repression of glpTQ promoter has been eliminated by insertion of 6 bp, as may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2389">
                    <text>repression of glpTQ promoter has been eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2390">
                    <text>repression of glpTQ promoter has been eliminated by insertion of 6-bp, as may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2391">
                    <text>repression of glpTQ promoter is eliminated by insertion of 6 bp, as it may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2392">
                    <text>repression of glpTQ promoter is eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2393">
                    <text>repression of glpTQ promoter is eliminated by insertion of 6-bp, as it may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2394">
                    <text>repression of glpTQ promoter is eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2395">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2396">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp at a concentration of 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2397">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2398">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2399">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2400">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2401">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6-bp at a concentration of 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2402">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2403">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2404">
                    <text>repression of glpTQ promoter was eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2405">
                    <text>repression of glpTQ promoter were eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2406">
                    <text>repression of glpTQ promoter were eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2407">
                    <text>repression of glpTQ promoter will be eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2408">
                    <text>repression of glpTQ promoter will be eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2409">
                    <text>repression of glpTQ promoter will be eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2410">
                    <text>repression of glpTQ promoter will be eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2411">
                    <text>repression of the glpTQ promoter are eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2412">
                    <text>repression of the glpTQ promoter has been eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2413">
                    <text>repression of the glpTQ promoter has been eliminated by insertion of 6-bp, as may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2414">
                    <text>repression of the glpTQ promoter is eliminated by insertion of 6-bp, as it may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2415">
                    <text>repression of the glpTQ promoter is eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2416">
                    <text>repression of the glpTQ promoter was eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2417">
                    <text>repression of the glpTQ promoter was eliminated by insertion of 6-bp at a concentration of 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2418">
                    <text>repression of the glpTQ promoter was eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2419">
                    <text>repression of the glpTQ promoter was eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2420">
                    <text>repression of the glpTQ promoter was eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2421">
                    <text>repression of the glpTQ promoter were eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2422">
                    <text>repression of the glpTQ promoter will be eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2423">
                    <text>repression of the glpTQ promoter will be eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the glpTQ promoter</arg>
                </example>
                <example src="PERMUTATE" no="2424">
                    <text>repression of the promoter glpTQ are eliminated by Insertion 6-bp, such as CD14.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2425">
                    <text>repression of the promoter glpTQ are eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2426">
                    <text>repression of the promoter glpTQ are eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2427">
                    <text>repression of the promoter glpTQ has been eliminated by Insertion 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2428">
                    <text>repression of the promoter glpTQ has been eliminated by Insertion 6-bp, as may occur after activation of caspase.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2429">
                    <text>repression of the promoter glpTQ has been eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2430">
                    <text>repression of the promoter glpTQ has been eliminated by insertion of 6 bp, as may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2431">
                    <text>repression of the promoter glpTQ has been eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2432">
                    <text>repression of the promoter glpTQ has been eliminated by insertion of 6-bp, as may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2433">
                    <text>repression of the promoter glpTQ is eliminated by Insertion 6-bp, as it may occur after activation of caspase.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2434">
                    <text>repression of the promoter glpTQ is eliminated by Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2435">
                    <text>repression of the promoter glpTQ is eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2436">
                    <text>repression of the promoter glpTQ is eliminated by insertion of 6-bp, as it may occur after activation of caspase.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2437">
                    <text>repression of the promoter glpTQ is eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2438">
                    <text>repression of the promoter glpTQ was eliminated by Insertion 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2439">
                    <text>repression of the promoter glpTQ was eliminated by Insertion 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2440">
                    <text>repression of the promoter glpTQ was eliminated by Insertion 6-bp, such as CD14.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2441">
                    <text>repression of the promoter glpTQ was eliminated by Insertion 6-bp.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2442">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2443">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp at a concentration of 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2444">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2445">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6 bp.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2446">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2447">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp at a concentration of 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2448">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2449">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2450">
                    <text>repression of the promoter glpTQ was eliminated by insertion of 6-bp.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2451">
                    <text>repression of the promoter glpTQ were eliminated by insertion of 6 bp, such as CD14.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2452">
                    <text>repression of the promoter glpTQ were eliminated by insertion of 6-bp, such as CD14.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2453">
                    <text>repression of the promoter glpTQ will be eliminated by Insertion 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">Insertion 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2454">
                    <text>repression of the promoter glpTQ will be eliminated by insertion of 6 bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2455">
                    <text>repression of the promoter glpTQ will be eliminated by insertion of 6 bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6 bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2456">
                    <text>repression of the promoter glpTQ will be eliminated by insertion of 6-bp at a concentration 10 times higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2457">
                    <text>repression of the promoter glpTQ will be eliminated by insertion of 6-bp at a concentration of 10-fold-higher.</text>
                    <arg n="0">insertion of 6-bp</arg>
                    <arg n="1">repression of the promoter glpTQ</arg>
                </example>
                <example src="PERMUTATE" no="2458">
                    <text>round are eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2459">
                    <text>round are eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2460">
                    <text>round has been eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2461">
                    <text>round has been eliminated by a molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2462">
                    <text>round has been eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2463">
                    <text>round has been eliminated by molar ratio of 5:1, as may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2464">
                    <text>round is eliminated by a molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2465">
                    <text>round is eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2466">
                    <text>round is eliminated by molar ratio of 5:1, as it may occur after activation of caspase.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2467">
                    <text>round is eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2468">
                    <text>round was eliminated by a molar ratio of 5:1 at a concentration of 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2469">
                    <text>round was eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2470">
                    <text>round was eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2471">
                    <text>round was eliminated by a molar ratio of 5:1.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2472">
                    <text>round was eliminated by molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2473">
                    <text>round was eliminated by molar ratio of 5:1 at a concentration of 10 times higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2474">
                    <text>round was eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2475">
                    <text>round was eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2476">
                    <text>round was eliminated by molar ratio of 5:1.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2477">
                    <text>round were eliminated by a molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2478">
                    <text>round were eliminated by molar ratio of 5:1, such as CD14.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2479">
                    <text>round will be eliminated by a molar ratio of 5:1 at a concentration 10 times higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2480">
                    <text>round will be eliminated by a molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">a molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2481">
                    <text>round will be eliminated by molar ratio of 5:1 at a concentration of 10-fold-higher.</text>
                    <arg n="0">molar ratio of 5:1</arg>
                    <arg n="1">round</arg>
                </example>
                <example src="PERMUTATE" no="2482">
                    <text>sec incorporation are eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2483">
                    <text>sec incorporation are eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2484">
                    <text>sec incorporation has been eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2485">
                    <text>sec incorporation has been eliminated by six mutations, as may occur after activation of caspase.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2486">
                    <text>sec incorporation has been eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2487">
                    <text>sec incorporation has been eliminated by these same mutations, as may occur after activation of caspase.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2488">
                    <text>sec incorporation is eliminated by six mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2489">
                    <text>sec incorporation is eliminated by these same mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2490">
                    <text>sec incorporation is eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2491">
                    <text>sec incorporation was eliminated by six mutations at a concentration of 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2492">
                    <text>sec incorporation was eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2493">
                    <text>sec incorporation was eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2494">
                    <text>sec incorporation was eliminated by these same mutations at a concentration 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2495">
                    <text>sec incorporation was eliminated by these same mutations at a concentration of 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2496">
                    <text>sec incorporation was eliminated by these same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2497">
                    <text>sec incorporation was eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2498">
                    <text>sec incorporation was eliminated by these same mutations.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2499">
                    <text>sec incorporation were eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2500">
                    <text>sec incorporation were eliminated by these same mutations, such as CD14.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2501">
                    <text>sec incorporation will be eliminated by six mutations at a concentration 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2502">
                    <text>sec incorporation will be eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2503">
                    <text>sec incorporation will be eliminated by these same mutations at a concentration 10 times higher.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2504">
                    <text>sec integration are eliminated by the same mutations, such as CD14.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2505">
                    <text>sec integration has been eliminated by the same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2506">
                    <text>sec integration has been eliminated by the same mutations, as may occur after activation of caspase.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2507">
                    <text>sec integration is eliminated by the same mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2508">
                    <text>sec integration is eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2509">
                    <text>sec integration was eliminated by the same mutations at a concentration 10 times higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2510">
                    <text>sec integration was eliminated by the same mutations at a concentration of 10 times higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2511">
                    <text>sec integration was eliminated by the same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2512">
                    <text>sec integration was eliminated by the same mutations, such as CD14.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2513">
                    <text>sec integration was eliminated by the same mutations.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2514">
                    <text>sec integration were eliminated by the same mutations, such as CD14.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2515">
                    <text>sec integration will be eliminated by the same mutations at a concentration 10 times higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2516">
                    <text>sec integration will be eliminated by the same mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2517">
                    <text>secincorporation are eliminated by these mutations, such as CD14.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2518">
                    <text>secincorporation has been eliminated by these mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2519">
                    <text>secincorporation is eliminated by these mutations, as it may occur after activation of caspase.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2520">
                    <text>secincorporation is eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2521">
                    <text>secincorporation was eliminated by these mutations at a concentration of 10 times higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2522">
                    <text>secincorporation was eliminated by these mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2523">
                    <text>secincorporation was eliminated by these mutations.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2524">
                    <text>secincorporation were eliminated by these mutations, such as CD14.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2525">
                    <text>secincorporation will be eliminated by these mutations at a concentration 10 times higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2526">
                    <text>secincorporation will be eliminated by these mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2527">
                    <text>secrement are eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2528">
                    <text>secrement has been eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2529">
                    <text>secrement has been eliminated by six mutations, as may occur after activation of caspase.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2530">
                    <text>secrement is eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2531">
                    <text>secrement was eliminated by six mutations at a concentration 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2532">
                    <text>secrement was eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2533">
                    <text>secrement was eliminated by six mutations.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2534">
                    <text>secrement were eliminated by six mutations, such as CD14.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2535">
                    <text>secrement will be eliminated by six mutations at a concentration 10 times higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2536">
                    <text>secrement will be eliminated by six mutations at a concentration of 10-fold-higher.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2537">
                    <text>site HindIII is eliminated by the other in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2538">
                    <text>site HindIII is eliminated by the other to exon 11 of the phenylalanine hydroxylase gene, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2539">
                    <text>site HindIII is eliminated by the other via exon 11 of the phenylalanine hydroxylase gene, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2540">
                    <text>site HindIII is eliminated in exon 11 of the phenylalanine hydroxylase gene by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2541">
                    <text>site HindIII was eliminated by the other in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2542">
                    <text>site HindIII was eliminated by the other to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2543">
                    <text>site HindIII was eliminated by the other to exon 11 of the phenylalanine hydroxylase gene while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2544">
                    <text>site HindIII was eliminated in exon 11 of the phenylalanine hydroxylase gene by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2545">
                    <text>site of Ibavi is eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2546">
                    <text>site of Ibavi is eliminated by a mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2547">
                    <text>site of Ibavi is eliminated by a mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2548">
                    <text>site of Ibavi is eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2549">
                    <text>site of Ibavi is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2550">
                    <text>site of Ibavi was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2551">
                    <text>site of Ibavi was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">site of Ibavi</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2552">
                    <text>site of Ibavirin is eliminated by A mutation in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2553">
                    <text>site of Ibavirin is eliminated in exon 7 to A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2554">
                    <text>site of Ibavirin was eliminated by A mutation in exon 7.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2555">
                    <text>site of Ibavirin was eliminated by A mutation to exon 7 while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2556">
                    <text>site of Ibavirin was eliminated by A mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2557">
                    <text>site of Ibavirin was eliminated in exon 7 for A mutation.</text>
                    <arg n="0">A mutation</arg>
                    <arg n="1">site of Ibavirin</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2558">
                    <text>six mutations can eliminate sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2559">
                    <text>six mutations can eliminate secrement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2560">
                    <text>six mutations eliminated secrement while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2561">
                    <text>six mutations eliminates sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2562">
                    <text>six mutations eliminates sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2563">
                    <text>six mutations eliminates secrement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2564">
                    <text>six mutations eliminates secrement, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2565">
                    <text>six mutations has eliminated sec incorporation while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2566">
                    <text>six mutations has eliminated secrement while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2567">
                    <text>six mutations located in O2 or between OT and O1 will eliminate secrement, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2568">
                    <text>six mutations located inside O2 or between OT and O1 eliminated sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2569">
                    <text>six mutations located inside O2 or between OT and O1 eliminated secrement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2570">
                    <text>six mutations located inside O2 or between OT and O1 eliminates sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2571">
                    <text>six mutations located inside O2 or between OT and O1 eliminates secrement, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2572">
                    <text>six mutations located inside O2 or between OT and O1 will eliminate sec incorporation, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2573">
                    <text>six mutations located inside O2 or between OT and O1 will eliminate secrement, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2574">
                    <text>six mutations located within O2 or between OT and O1 eliminates sec incorporation, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2575">
                    <text>six mutations located within O2 or between OT and O1 eliminates secrement, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2576">
                    <text>six mutations located within O2 or between OT and O1 has eliminated sec incorporation, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2577">
                    <text>six mutations may eliminate secrement while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2578">
                    <text>six mutations removes sec incorporation eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2579">
                    <text>six mutations removes secrement eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2580">
                    <text>six mutations removes secrement eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2581">
                    <text>six mutations that eliminated sec incorporation was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2582">
                    <text>six mutations that eliminated sec incorporation was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2583">
                    <text>six mutations that eliminated secrement was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2584">
                    <text>six mutations that eliminates secrement is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2585">
                    <text>six mutations), sec incorporation can be completely eliminated (figure 7).</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2586">
                    <text>six mutations, as can occur after caspase activation, eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2587">
                    <text>six mutations, as can occur after caspase activation, eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2588">
                    <text>six mutations, as can occur after caspase activation, has eliminated sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2589">
                    <text>six mutations, as can occur after caspase activation, has eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2590">
                    <text>six mutations, as can occur after caspase activation, is able to eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2591">
                    <text>six mutations, as can occur after caspase activation, is able to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2592">
                    <text>six mutations, as may occur after activation of caspase, is able to eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2593">
                    <text>six mutations, as may occur after activation of caspase, is able to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2594">
                    <text>six mutations, as may occur after caspase activation, eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2595">
                    <text>six mutations, as may occur after caspase activation, eliminates sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2596">
                    <text>six mutations, as may occur after caspase activation, eliminates secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2597">
                    <text>six mutations, such as CD14, can eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2598">
                    <text>six mutations, such as CD14, can eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2599">
                    <text>six mutations, such as CD14, eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2600">
                    <text>six mutations, such as CD14, eliminated secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2601">
                    <text>six mutations, such as CD14, is able to eliminate sec incorporation.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2602">
                    <text>six mutations, such as CD14, is able to eliminate secrement.</text>
                    <arg n="0">six mutations</arg>
                    <arg n="1">secrement</arg>
                </example>
                <example src="PERMUTATE" no="2603">
                    <text>stabilization observed with MG132 eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2604">
                    <text>stabilization observed with MG132 eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2605">
                    <text>stabilization seen with MG132 eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2606">
                    <text>staurosporin (or genestein; M-NEG data do not show) can eliminate the stabilization observed with MG132, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2607">
                    <text>staurosporin (or genestein; M-NEG data do not show) eliminated the stabilization observed with MG132 while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2608">
                    <text>staurosporin (or genestein; M-NEG data do not show) eliminates the stabilization observed with MG132 while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2609">
                    <text>staurosporin (or genestein; M-NEG data do not show) has eliminated the stabilization observed with MG132 while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2610">
                    <text>staurosporin (or genestein; M-NEG data do not show) located inside O2 or between OT and O1 eliminated the stabilization observed with MG132, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2611">
                    <text>staurosporin (or genestein; M-NEG data do not show) located inside O2 or between OT and O1 eliminates the stabilization observed with MG132, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2612">
                    <text>staurosporin (or genestein; M-NEG data do not show) located within O2 or between OT and O1 eliminates the stabilization observed with MG132, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2613">
                    <text>staurosporin (or genestein; M-NEG data do not show) located within O2 or between OT and O1 has eliminated the stabilization observed with MG132, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2614">
                    <text>staurosporin (or genestein; M-NEG data do not show) may eliminate the stabilization observed with MG132 while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2615">
                    <text>staurosporin (or genestein; M-NEG data do not show) removes the stabilization observed with MG132 eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2616">
                    <text>staurosporin (or genestein; M-NEG data do not show) that eliminated the stabilization observed with MG132 was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2617">
                    <text>staurosporin (or genestein; M-NEG data do not show) that eliminated the stabilization observed with MG132 was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2618">
                    <text>staurosporin (or genestein; M-NEG data do not show) that eliminates the stabilization observed with MG132 is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2619">
                    <text>staurosporin (or genestein; M-NEG data do not show), as can occur after caspase activation, eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2620">
                    <text>staurosporin (or genestein; M-NEG data do not show), as can occur after caspase activation, has eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2621">
                    <text>staurosporin (or genestein; M-NEG data do not show), as may occur after activation of caspase, is able to eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2622">
                    <text>staurosporin (or genestein; M-NEG data do not show), as may occur after caspase activation, eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2623">
                    <text>staurosporin (or genestein; M-NEG data do not show), as may occur after caspase activation, eliminates the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2624">
                    <text>staurosporin (or genestein; M-NEG data do not show), such as CD14, can eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2625">
                    <text>staurosporin (or genestein; M-NEG data do not show), such as CD14, eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2626">
                    <text>staurosporin (or genestein; M-NEG data do not show), such as CD14, eliminated the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2627">
                    <text>staurosporin (or genestein; M-NEG data do not show), such as CD14, is able to eliminate the stabilization observed with MG132.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2628">
                    <text>the BamHI site is eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2629">
                    <text>the BamHI site is eliminated by a mutation to exon 7, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2630">
                    <text>the BamHI site is eliminated by a mutation via exon 7, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2631">
                    <text>the BamHI site is eliminated in exon 7 to a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2632">
                    <text>the BamHI site was eliminated by a mutation in exon 7.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2633">
                    <text>the BamHI site was eliminated by a mutation to exon 7 while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2634">
                    <text>the BamHI site was eliminated in exon 7 by a mutation.</text>
                    <arg n="0">a mutation</arg>
                    <arg n="1">the BamHI site</arg>
                    <arg n="2">exon 7</arg>
                </example>
                <example src="PERMUTATE" no="2635">
                    <text>the HindIII site is eliminated by the other in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2636">
                    <text>the HindIII site is eliminated by the other in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2637">
                    <text>the HindIII site is eliminated by the other to exon 11 of the gene for phenylalanine hydroxylase, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2638">
                    <text>the HindIII site is eliminated by the other via exon 11 of the gene for phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2639">
                    <text>the HindIII site is eliminated by the other via exon 11 of the gene phenylalanine hydroxylase, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2640">
                    <text>the HindIII site is eliminated in exon 11 of the gene for phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2641">
                    <text>the HindIII site is eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2642">
                    <text>the HindIII site is eliminated in exon 11 of the gene phenylalanine hydroxylase to the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2643">
                    <text>the HindIII site was eliminated by the other in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2644">
                    <text>the HindIII site was eliminated by the other in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2645">
                    <text>the HindIII site was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2646">
                    <text>the HindIII site was eliminated by the other to exon 11 of the gene phenylalanine hydroxylase while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2647">
                    <text>the HindIII site was eliminated in exon 11 of the gene for phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2648">
                    <text>the HindIII site was eliminated in exon 11 of the gene for phenylalanine hydroxylase for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2649">
                    <text>the HindIII site was eliminated in exon 11 of the gene phenylalanine hydroxylase by the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2650">
                    <text>the HindIII site was eliminated in exon 11 of the gene phenylalanine hydroxylase for the other.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2651">
                    <text>the deleterious effects eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="2652">
                    <text>the deleterious effects eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the deleterious effects</arg>
                </example>
                <example src="PERMUTATE" no="2653">
                    <text>the mutation of T491 can eliminate recognition for antipT598 antibody, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2654">
                    <text>the mutation of T491 eliminated recognition for antipT598 antibody while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2655">
                    <text>the mutation of T491 eliminates recognition for antipT598 antibody, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2656">
                    <text>the mutation of T491 located in O2 or between OT and O1 will eliminate recognition for antipT598 antibody, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2657">
                    <text>the mutation of T491 located inside O2 or between OT and O1 will eliminate recognition for antipT598 antibody, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2658">
                    <text>the mutation of T491 located within O2 or between OT and O1 eliminates recognition for antipT598 antibody, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2659">
                    <text>the mutation of T491 located within O2 or between OT and O1 has eliminated recognition for antipT598 antibody, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2660">
                    <text>the mutation of T491 may eliminate recognition for antipT598 antibody while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2661">
                    <text>the mutation of T491 removes recognition for antipT598 antibody eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2662">
                    <text>the mutation of T491 removes recognition for antipT598 antibody eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2663">
                    <text>the mutation of T491 that eliminated recognition for antipT598 antibody was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2664">
                    <text>the mutation of T491 that eliminated recognition for antipT598 antibody was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2665">
                    <text>the mutation of T491 that eliminates recognition for antipT598 antibody is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2666">
                    <text>the mutation of T491 that eliminates recognition for antipT598 antibody is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2667">
                    <text>the mutation of T491), recognition for antipT598 antibody can be completely eliminated (figure 7).</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2668">
                    <text>the mutation of T491, as can occur after caspase activation, eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2669">
                    <text>the mutation of T491, as can occur after caspase activation, has eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2670">
                    <text>the mutation of T491, as can occur after caspase activation, is able to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2671">
                    <text>the mutation of T491, as may occur after activation of caspase, is able to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2672">
                    <text>the mutation of T491, as may occur after caspase activation, eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2673">
                    <text>the mutation of T491, such as CD14, can eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2674">
                    <text>the mutation of T491, such as CD14, eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2675">
                    <text>the mutation of T491, such as CD14, eliminated recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2676">
                    <text>the mutation of T491, such as CD14, is able to eliminate recognition for antipT598 antibody.</text>
                    <arg n="0">the mutation of T491</arg>
                    <arg n="1">recognition for antipT598 antibody</arg>
                </example>
                <example src="PERMUTATE" no="2677">
                    <text>the other can eliminate hindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2678">
                    <text>the other can eliminate hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2679">
                    <text>the other can eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2680">
                    <text>the other can eliminate the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2681">
                    <text>the other eliminate hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2682">
                    <text>the other eliminate hindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2683">
                    <text>the other eliminate hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2684">
                    <text>the other eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2685">
                    <text>the other eliminate site HindIII in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2686">
                    <text>the other eliminate the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2687">
                    <text>the other eliminate the HindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2688">
                    <text>the other eliminated hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2689">
                    <text>the other eliminated hindIII into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2690">
                    <text>the other eliminated hindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2691">
                    <text>the other eliminated hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2692">
                    <text>the other eliminated hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2693">
                    <text>the other eliminated hindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2694">
                    <text>the other eliminated hindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2695">
                    <text>the other eliminated site HindIII in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2696">
                    <text>the other eliminated site HindIII into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2697">
                    <text>the other eliminated the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2698">
                    <text>the other eliminated the HindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2699">
                    <text>the other eliminates hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2700">
                    <text>the other eliminates hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2701">
                    <text>the other eliminates hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2702">
                    <text>the other eliminates site HindIII in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2703">
                    <text>the other eliminates the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2704">
                    <text>the other has eliminated hindIII into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2705">
                    <text>the other has eliminated hindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2706">
                    <text>the other has eliminated hindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2707">
                    <text>the other has eliminated hindIII site into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2708">
                    <text>the other has eliminated site HindIII into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2709">
                    <text>the other has eliminated the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2710">
                    <text>the other has eliminated the HindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2711">
                    <text>the other is able to eliminate hindIII in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2712">
                    <text>the other is able to eliminate hindIII into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2713">
                    <text>the other is able to eliminate hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2714">
                    <text>the other is able to eliminate hindIII site in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2715">
                    <text>the other is able to eliminate hindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2716">
                    <text>the other is able to eliminate hindIII site into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2717">
                    <text>the other is able to eliminate site HindIII in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2718">
                    <text>the other is able to eliminate site HindIII into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2719">
                    <text>the other is able to eliminate the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2720">
                    <text>the other is able to eliminate the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2721">
                    <text>the other is able to eliminate the HindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2722">
                    <text>the other may eliminate hindIII into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2723">
                    <text>the other may eliminate hindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2724">
                    <text>the other may eliminate hindIII site into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2725">
                    <text>the other may eliminate site HindIII into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2726">
                    <text>the other may eliminate the HindIII site into exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2727">
                    <text>the other may eliminate the HindIII site into exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2728">
                    <text>the other would eliminate hindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2729">
                    <text>the other would eliminate hindIII site in exon 11 of the gene phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">hindIII site</arg>
                    <arg n="2">exon 11 of the gene phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2730">
                    <text>the other would eliminate site HindIII in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">site HindIII</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2731">
                    <text>the other would eliminate the HindIII site in exon 11 of the gene for phenylalanine hydroxylase.</text>
                    <arg n="0">the other</arg>
                    <arg n="1">the HindIII site</arg>
                    <arg n="2">exon 11 of the gene for phenylalanine hydroxylase</arg>
                </example>
                <example src="PERMUTATE" no="2732">
                    <text>the others eliminate development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2733">
                    <text>the others eliminated development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2734">
                    <text>the others eliminated development site III into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2735">
                    <text>the others eliminates development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2736">
                    <text>the others has eliminated development site III into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2737">
                    <text>the others is able to eliminate development site III in exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2738">
                    <text>the others is able to eliminate development site III into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2739">
                    <text>the others may eliminate development site III into exon 11 of the phenylalanine hydroxylase gene.</text>
                    <arg n="0">the others</arg>
                    <arg n="1">development site III</arg>
                    <arg n="2">exon 11 of the phenylalanine hydroxylase gene</arg>
                </example>
                <example src="PERMUTATE" no="2740">
                    <text>the requirement of induction are eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2741">
                    <text>the requirement of induction has been eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2742">
                    <text>the requirement of induction has been eliminated by mutation of a new locus, galS, as may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2743">
                    <text>the requirement of induction is eliminated by mutation of a new locus, galS.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2744">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS at a concentration of 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2745">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2746">
                    <text>the requirement of induction was eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2747">
                    <text>the requirement of induction were eliminated by mutation of a new locus, galS, such as CD14.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2748">
                    <text>the requirement of induction will be eliminated by mutation of a new locus, galS at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, galS</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="PERMUTATE" no="2749">
                    <text>the same mutations can eliminate sec integration, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2750">
                    <text>the same mutations eliminated sec integration while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2751">
                    <text>the same mutations eliminates sec integration while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2752">
                    <text>the same mutations eliminates sec integration, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2753">
                    <text>the same mutations located in O2 or between OT and O1 will eliminate sec integration, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2754">
                    <text>the same mutations located inside O2 or between OT and O1 eliminated sec integration, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2755">
                    <text>the same mutations located inside O2 or between OT and O1 eliminates sec integration, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2756">
                    <text>the same mutations located inside O2 or between OT and O1 will eliminate sec integration, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2757">
                    <text>the same mutations located within O2 or between OT and O1 has eliminated sec integration, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2758">
                    <text>the same mutations may eliminate sec integration while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2759">
                    <text>the same mutations removes sec integration eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2760">
                    <text>the same mutations that eliminated sec integration was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2761">
                    <text>the same mutations that eliminates sec integration is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2762">
                    <text>the same mutations that eliminates sec integration is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2763">
                    <text>the same mutations, as can occur after caspase activation, is able to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2764">
                    <text>the same mutations, as may occur after activation of caspase, is able to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2765">
                    <text>the same mutations, as may occur after caspase activation, eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2766">
                    <text>the same mutations, as may occur after caspase activation, eliminates sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2767">
                    <text>the same mutations, such as CD14, eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2768">
                    <text>the same mutations, such as CD14, eliminated sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2769">
                    <text>the same mutations, such as CD14, is able to eliminate sec integration.</text>
                    <arg n="0">the same mutations</arg>
                    <arg n="1">sec integration</arg>
                </example>
                <example src="PERMUTATE" no="2770">
                    <text>the stabilization observed with MG132 are eliminated by staurosporin (or genestein; M-NEG data do not show), such as CD14.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2771">
                    <text>the stabilization observed with MG132 eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2772">
                    <text>the stabilization observed with MG132 eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2773">
                    <text>the stabilization observed with MG132 has been eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration of 10-fold-higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2774">
                    <text>the stabilization observed with MG132 is eliminated by staurosporin (or genestein; M-NEG data do not show), as it may occur after activation of caspase.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2775">
                    <text>the stabilization observed with MG132 is eliminated by staurosporin (or genestein; M-NEG data do not show).</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2776">
                    <text>the stabilization observed with MG132 was eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration 10 times higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2777">
                    <text>the stabilization observed with MG132 was eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration of 10 times higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2778">
                    <text>the stabilization observed with MG132 was eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration of 10-fold-higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2779">
                    <text>the stabilization observed with MG132 was eliminated by staurosporin (or genestein; M-NEG data do not show), such as CD14.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2780">
                    <text>the stabilization observed with MG132 were eliminated by staurosporin (or genestein; M-NEG data do not show), such as CD14.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2781">
                    <text>the stabilization observed with MG132 will be eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration 10 times higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2782">
                    <text>the stabilization observed with MG132 will be eliminated by staurosporin (or genestein; M-NEG data do not show) at a concentration of 10-fold-higher.</text>
                    <arg n="0">staurosporin (or genestein; M-NEG data do not show)</arg>
                    <arg n="1">the stabilization observed with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2783">
                    <text>the stabilization seen with MG132 eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2784">
                    <text>the stabilization seen with MG132 eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">the stabilization seen with MG132</arg>
                </example>
                <example src="PERMUTATE" no="2785">
                    <text>these mutations can eliminate secincorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2786">
                    <text>these mutations eliminated secincorporation while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2787">
                    <text>these mutations eliminates secincorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2788">
                    <text>these mutations has eliminated secincorporation while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2789">
                    <text>these mutations located in O2 or between OT and O1 will eliminate secincorporation, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2790">
                    <text>these mutations located inside O2 or between OT and O1 eliminated secincorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2791">
                    <text>these mutations located inside O2 or between OT and O1 eliminates secincorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2792">
                    <text>these mutations located inside O2 or between OT and O1 will eliminate secincorporation, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2793">
                    <text>these mutations located within O2 or between OT and O1 eliminates secincorporation, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2794">
                    <text>these mutations located within O2 or between OT and O1 has eliminated secincorporation, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2795">
                    <text>these mutations may eliminate secincorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2796">
                    <text>these mutations removes secincorporation eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2797">
                    <text>these mutations removes secincorporation eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2798">
                    <text>these mutations that eliminated secincorporation was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2799">
                    <text>these mutations that eliminates secincorporation is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2800">
                    <text>these mutations), secincorporation can be completely eliminated (figure 7).</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2801">
                    <text>these mutations, as can occur after caspase activation, eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2802">
                    <text>these mutations, as can occur after caspase activation, has eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2803">
                    <text>these mutations, as can occur after caspase activation, is able to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2804">
                    <text>these mutations, as may occur after activation of caspase, is able to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2805">
                    <text>these mutations, as may occur after caspase activation, eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2806">
                    <text>these mutations, as may occur after caspase activation, eliminates secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2807">
                    <text>these mutations, such as CD14, can eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2808">
                    <text>these mutations, such as CD14, eliminated secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2809">
                    <text>these mutations, such as CD14, is able to eliminate secincorporation.</text>
                    <arg n="0">these mutations</arg>
                    <arg n="1">secincorporation</arg>
                </example>
                <example src="PERMUTATE" no="2810">
                    <text>these same mutations can eliminate Sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2811">
                    <text>these same mutations can eliminate sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2812">
                    <text>these same mutations eliminated sec incorporation while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2813">
                    <text>these same mutations eliminates Sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2814">
                    <text>these same mutations eliminates Sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2815">
                    <text>these same mutations eliminates sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2816">
                    <text>these same mutations eliminates sec incorporation, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2817">
                    <text>these same mutations has eliminated Sec incorporation while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2818">
                    <text>these same mutations has eliminated sec incorporation while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2819">
                    <text>these same mutations located in O2 or between OT and O1 will eliminate sec incorporation, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2820">
                    <text>these same mutations located inside O2 or between OT and O1 eliminated Sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2821">
                    <text>these same mutations located inside O2 or between OT and O1 eliminated sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2822">
                    <text>these same mutations located inside O2 or between OT and O1 eliminates Sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2823">
                    <text>these same mutations located inside O2 or between OT and O1 eliminates sec incorporation, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2824">
                    <text>these same mutations located inside O2 or between OT and O1 will eliminate Sec incorporation, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2825">
                    <text>these same mutations located inside O2 or between OT and O1 will eliminate sec incorporation, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2826">
                    <text>these same mutations located within O2 or between OT and O1 eliminates Sec incorporation, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2827">
                    <text>these same mutations located within O2 or between OT and O1 eliminates sec incorporation, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2828">
                    <text>these same mutations located within O2 or between OT and O1 has eliminated Sec incorporation, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2829">
                    <text>these same mutations located within O2 or between OT and O1 has eliminated sec incorporation, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2830">
                    <text>these same mutations may eliminate Sec incorporation while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2831">
                    <text>these same mutations removes Sec incorporation eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2832">
                    <text>these same mutations removes sec incorporation eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2833">
                    <text>these same mutations that eliminated Sec incorporation was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2834">
                    <text>these same mutations that eliminated sec incorporation was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2835">
                    <text>these same mutations that eliminated sec incorporation was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2836">
                    <text>these same mutations that eliminates Sec incorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2837">
                    <text>these same mutations that eliminates Sec incorporation is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2838">
                    <text>these same mutations that eliminates sec incorporation is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2839">
                    <text>these same mutations that eliminates sec incorporation is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2840">
                    <text>these same mutations), Sec incorporation can be completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2841">
                    <text>these same mutations), sec incorporation can be completely eliminated (figure 7).</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2842">
                    <text>these same mutations, as can occur after caspase activation, eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2843">
                    <text>these same mutations, as can occur after caspase activation, eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2844">
                    <text>these same mutations, as can occur after caspase activation, has eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2845">
                    <text>these same mutations, as can occur after caspase activation, has eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2846">
                    <text>these same mutations, as can occur after caspase activation, is able to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2847">
                    <text>these same mutations, as can occur after caspase activation, is able to eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2848">
                    <text>these same mutations, as may occur after activation of caspase, is able to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2849">
                    <text>these same mutations, as may occur after activation of caspase, is able to eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2850">
                    <text>these same mutations, as may occur after caspase activation, eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2851">
                    <text>these same mutations, as may occur after caspase activation, eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2852">
                    <text>these same mutations, as may occur after caspase activation, eliminates Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2853">
                    <text>these same mutations, as may occur after caspase activation, eliminates sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2854">
                    <text>these same mutations, such as CD14, can eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2855">
                    <text>these same mutations, such as CD14, can eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2856">
                    <text>these same mutations, such as CD14, eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2857">
                    <text>these same mutations, such as CD14, eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2858">
                    <text>these same mutations, such as CD14, eliminated Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2859">
                    <text>these same mutations, such as CD14, eliminated sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2860">
                    <text>these same mutations, such as CD14, is able to eliminate Sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">Sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2861">
                    <text>these same mutations, such as CD14, is able to eliminate sec incorporation.</text>
                    <arg n="0">these same mutations</arg>
                    <arg n="1">sec incorporation</arg>
                </example>
                <example src="PERMUTATE" no="2862">
                    <text>transgenic plants eliminating AtNDK1 under the control of promoter of CaMV 35S showed paraquatic tolerance and high removal capacity of exogenous exogeneous H(2)O(2).</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                    <arg n="2">transgenic plants</arg>
                </example>
                <example src="PERMUTATE" no="2863">
                    <text>viral stem cells are eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2864">
                    <text>viral stem cells has been eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2865">
                    <text>viral stem cells has been eliminated by inhibition of any of these molecules, as may occur after activation of caspase.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2866">
                    <text>viral stem cells is eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2867">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules at a concentration 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2868">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules at a concentration of 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2869">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2870">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2871">
                    <text>viral stem cells was eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2872">
                    <text>viral stem cells were eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2873">
                    <text>viral stem cells will be eliminated by inhibition of any of these molecules at a concentration 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2874">
                    <text>viral stem cells will be eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">viral stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2875">
                    <text>vital stem cells are eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2876">
                    <text>vital stem cells has been eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2877">
                    <text>vital stem cells was eliminated by inhibition of any of these molecules at a concentration of 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2878">
                    <text>vital stem cells was eliminated by inhibition of any of these molecules at a concentration of 10-fold-higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2879">
                    <text>vital stem cells was eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2880">
                    <text>vital stem cells was eliminated by inhibition of any of these molecules.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2881">
                    <text>vital stem cells were eliminated by inhibition of any of these molecules, such as CD14.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="PERMUTATE" no="2882">
                    <text>vital stem cells will be eliminated by inhibition of any of these molecules at a concentration 10 times higher.</text>
                    <arg n="0">inhibition of any of these molecules</arg>
                    <arg n="1">vital stem cells</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>As illustrated in Figure 1, a 3 bp deletion in frames eliminates a sparring residue .</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>As illustrated in Figure 1, a 3 bp deletion in frames eliminates an asparaginal residue .</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>As illustrated in Figure 1, a 3 bp deletion in the graph eliminates asparagine residues .</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>As illustrated in Figure 1, a 3-bp deletion in the chart eliminates asparagine residue .</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>As illustrated in Figure 1, a 3-bp deletion in the table eliminates asparagine residue .</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>As illustrated in Figure 1, a 3bp deletion in frames eliminates a sparring residue .</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>As illustrated in Figure 1, a 3bp deletion in frames eliminates an asparagine residue .</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>As illustrated in Figure 1, exogeneous H(2)O(2) will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>As illustrated in Figure 1, inhibiating phosphorylation will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>As illustrated in Figure 1, inhibiting phosphorylation will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation was eliminated by A0 (staurosporin or genestein; no data is displayed.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>As illustrated in Figure 1, inhibitory phosphorylation will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>As illustrated in Figure 1, inhibits phosphorylation is no eliminated by A0 (staurosporin or genestein; the M-NEG data (no) presented.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>As illustrated in Figure 1, inhibits phosphorylation is not eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>As illustrated in Figure 1, inhibits phosphorylation was no eliminated by A0 (staurosporin or generécia; M-NEG data (no) presented.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>As illustrated in Figure 1, inhibits phosphorylation will be eliminated by A0 (staurosporin (or genestein; data from no presented.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>As illustrated in Figure 1, inhibits phosphorylation will be eliminated by A0 (staurosporin (or genestein; the not data displayed) .</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>As illustrated in Figure 1, mutation of a new locus, gals eliminates the requirement of induction .</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>By eliminating the exogeneous H(2)O(2) that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>By eliminating the inhibiating phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>By eliminating the inhibitory phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>By eliminating the inhibits phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we use the ability of HOX proteins to passively translocate across cell membranes.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>In a 3 bp deletion in frames , a sparring residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>In a 3 bp deletion in frames , a sparring residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>In a 3 bp deletion in frames , an asparaginal residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>In a 3 bp deletion in frames , an asparaginal residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>In a 3 bp deletion in frames , an asparaginal residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>In a 3 bp deletion in frames , it is observed that a sparring residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>In a 3 bp deletion in frames , it is observed that an asparaginal residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>In a 3 bp deletion in frames, a sparring residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>In a 3 bp deletion in frames, a sparring residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>In a 3 bp deletion in frames, an asparaginal residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>In a 3 bp deletion in frames, it is observed that a sparring residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>In a 3 bp deletion in frames, it is observed that an asparaginal residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>In a 3 bp deletion in the graph , asparagine residues can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>In a 3 bp deletion in the graph , asparagine residues will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>In a 3 bp deletion in the graph , it is observed that asparagine residues is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>In a 3 bp deletion in the graph, asparagine residues is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>In a 3 bp deletion in the graph, asparagine residues will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>In a 3 bp deletion in the graph, it is observed that asparagine residues is completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>In a 3-bp deletion in the chart , asparagine residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>In a 3-bp deletion in the chart , asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>In a 3-bp deletion in the chart , asparagine residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>In a 3-bp deletion in the chart , it is observed that asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>In a 3-bp deletion in the chart, asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>In a 3-bp deletion in the chart, asparagine residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>In a 3-bp deletion in the table , asparagine residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>In a 3-bp deletion in the table , asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>In a 3-bp deletion in the table , asparagine residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>In a 3-bp deletion in the table , it is observed that asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>In a 3-bp deletion in the table, asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>In a 3-bp deletion in the table, it is observed that asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>In a 3bp deletion in frames , a sparring residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>In a 3bp deletion in frames , a sparring residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>In a 3bp deletion in frames , a sparring residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>In a 3bp deletion in frames , an asparagine residue can be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>In a 3bp deletion in frames , an asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>In a 3bp deletion in frames , an asparagine residue will be completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>In a 3bp deletion in frames , it is observed that a sparring residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>In a 3bp deletion in frames , it is observed that an asparagine residue is completely eliminated (Figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>In a 3bp deletion in frames, a sparring residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>In a 3bp deletion in frames, a sparring residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>In a 3bp deletion in frames, an asparagine residue will be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>In a 3bp deletion in frames, it is observed that an asparagine residue is completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>In mutation of a new locus, gals , it is observed that the requirement of induction is completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>In mutation of a new locus, gals , the requirement of induction can be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>In mutation of a new locus, gals , the requirement of induction will be completely eliminated (Figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>In mutation of a new locus, gals, it is observed that the requirement of induction is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>In mutation of a new locus, gals, the requirement of induction is completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>In mutation of a new locus, gals, the requirement of induction will be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>In the gel-shift assay, a 3 bp deletion in frames eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>In the gel-shift assay, a 3 bp deletion in frames will eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>In the gel-shift assay, a 3 bp deletion in frames will eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>In the gel-shift assay, a 3 bp deletion in the graph eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>In the gel-shift assay, a 3 bp deletion in the graph will eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>In the gel-shift assay, a 3-bp deletion in the chart eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>In the gel-shift assay, a 3-bp deletion in the chart will eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>In the gel-shift assay, a 3-bp deletion in the table eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>In the gel-shift assay, a 3-bp deletion in the table will eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>In the gel-shift assay, a 3bp deletion in frames eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>In the gel-shift assay, a 3bp deletion in frames eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>In the gel-shift assay, a 3bp deletion in frames will eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>In the gel-shift assay, a 3bp deletion in frames will eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>In the gel-shift assay, mutation of a new locus, gals eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>In the gel-shift assay, mutation of a new locus, gals will eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In the ice change trial, a 3 bp deletion in frames has eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In the ice change trial, a 3 bp deletion in frames has eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In the ice change trial, a 3 bp deletion in the graph has eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In the ice change trial, a 3-bp deletion in the chart has eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>In the ice change trial, a 3-bp deletion in the table has eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>In the ice change trial, a 3bp deletion in frames has eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>In the ice change trial, a 3bp deletion in frames has eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>In the ice change trial, mutation of a new locus, gals has eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>In the ice shift test, a 3 bp deletion in frames eliminates a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>In the ice shift test, a 3-bp deletion in the chart eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>In the ice shift test, a 3-bp deletion in the table eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>In the ice shift test, a 3bp deletion in frames eliminates a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>In the ice shift test, a 3bp deletion in frames eliminates an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>In the ice shift test, mutation of a new locus, gals eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>In the ice-change test, a 3 bp deletion in frames will eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>In the ice-change test, a 3 bp deletion in the graph will eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>In the ice-change test, a 3-bp deletion in the table will eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>In the ice-change test, a 3bp deletion in frames will eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>In the ice-change test, a 3bp deletion in frames will eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>In the shift gel assay, a 3 bp deletion in frames eliminates a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>In the shift gel assay, a 3 bp deletion in frames eliminates an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>In the shift gel assay, a 3 bp deletion in the graph eliminates asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>In the shift gel assay, a 3-bp deletion in the chart eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>In the shift gel assay, a 3-bp deletion in the table eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>In the shift gel assay, a 3bp deletion in frames eliminates a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>In the shift gel assay, a 3bp deletion in frames eliminates an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>In the shift gel assay, mutation of a new locus, gals eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3 bp deletion in frames can completely eliminate an asparaginal residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3 bp deletion in the graph can completely eliminate asparagine residues (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3bp deletion in frames can completely eliminate a sparring residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a 3bp deletion in frames can completely eliminate an asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>Second, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, mutation of a new locus, gals can completely eliminate the requirement of induction (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in frames completely eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in frames completely eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in the graph completely eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3-bp deletion in the chart completely eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3bp deletion in frames completely eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>Secondly, the SBP2 binding activity is not affected by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, gals completely eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in frames completely removes a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3 bp deletion in the graph completely removes asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3-bp deletion in the chart completely removes asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, a 3bp deletion in frames completely removes a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>Secondly, the SBP2 binding activity is not eliminated by mutations in the tetraadenosine element of the terminal region of PHGPx 3 UTR, mutation of a new locus, gals completely removes the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue is completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue is completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue was completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, a sparring residue was completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, an asparaginal residue is completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, an asparaginal residue was completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, an asparagine residue is completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, an asparagine residue was completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residue is completely eliminated by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residue is completely eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residue was completely eliminated by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residue was completely eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residues is completely eliminated by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, asparagine residues was completely eliminated by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine in the PHGPx terminal region UTR, the requirement of induction is completely eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in frames completely eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in frames completely eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in the graph completely eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3-bp deletion in the chart completely eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3-bp deletion in the table completely eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3bp deletion in frames completely eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a sparring residue was completely eliminated to a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, an asparaginal residue was completely eliminated to a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, an asparagine residue was completely eliminated to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, asparagine residue was completely eliminated to a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, asparagine residue was completely eliminated to a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, asparagine residues was completely eliminated to a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, gals completely eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the element tetraadenosine of the PHGPx terminal region UTR, the requirement of induction was completely eliminated to mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3 bp deletion in the graph can completely eliminate asparagine residues (Lesoon et al., 1997).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3-bp deletion in the chart can completely eliminate asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3-bp deletion in the table can completely eliminate asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3bp deletion in frames can completely eliminate a sparring residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a 3bp deletion in frames can completely eliminate an asparagine residue (Lesoon et al., 1997).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a sparring residue is completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, a sparring residue is completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, an asparaginal residue is completely eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, an asparagine residue is completely eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, asparagine residue is completely eliminated by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, asparagine residue is completely eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, asparagine residues is completely eliminated by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, mutation of a new locus, gals can completely eliminate the requirement of induction (Lesoon et al., 1997).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>Secondly, the binding activity of SBP2 is not affected by mutations in the tetraadenosine element in the terminal region of PHGPx UTR, the requirement of induction is completely eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in frames completely removes a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3 bp deletion in the graph completely removes asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3-bp deletion in the chart completely removes asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3-bp deletion in the table completely removes asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, a 3bp deletion in frames completely removes a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>Secondly, the binding activity of SBP2 is not eliminated by mutations in the element tetraadenosine of the PHGPx terminal region UTR, mutation of a new locus, gals completely removes the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>The same activation level of B-Raf occurs only when exogeneous H(2)O(2) has been eliminated.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>The same activation level of B-Raf occurs only when inhibiating phosphorylation has been eliminated.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>The same activation level of B-Raf occurs only when inhibitory phosphorylation has been eliminated.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>The same activation level of B-Raf occurs only when inhibits phosphorylation has been eliminated.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>The same high level of B-Raf activation occurs only when exogeneous H(2)O(2) were eliminated.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>The same high level of B-Raf activation occurs only when inhibiating phosphorylation were eliminated.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>The same high level of B-Raf activation occurs only when inhibiting phosphorylation were eliminated.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>The same high level of B-Raf activation occurs only when inhibitory phosphorylation were eliminated.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>The same high level of B-Raf activation occurs only when inhibits phosphorylation were eliminated.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>They claim that a 3 bp deletion in frames, as can occur after caspase activation, can eliminate a sparring residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>They claim that a 3 bp deletion in the graph, as can occur after caspase activation, can eliminate asparagine residues necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>They claim that a 3-bp deletion in the chart, as can occur after caspase activation, can eliminate asparagine residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>They claim that a 3bp deletion in frames, as can occur after caspase activation, can eliminate an asparagine residue necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>They claim that mutation of a new locus, gals, as can occur after caspase activation, can eliminate the requirement of induction necessary for skeletal muscle regeneration during chronic catabolic conditions.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>They established that a 3 bp deletion in frames, as it can occur after activation of caspase, can eliminate a sparring residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>They established that a 3 bp deletion in frames, as it can occur after activation of caspase, can eliminate an asparaginal residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>They established that a 3 bp deletion in the graph, as it can occur after activation of caspase, can eliminate asparagine residues needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>They established that a 3-bp deletion in the chart, as it can occur after activation of caspase, can eliminate asparagine residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>They established that a 3-bp deletion in the table, as it can occur after activation of caspase, can eliminate asparagine residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>They established that a 3bp deletion in frames, as it can occur after activation of caspase, can eliminate a sparring residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>They established that a 3bp deletion in frames, as it can occur after activation of caspase, can eliminate an asparagine residue needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>They established that mutation of a new locus, gals, as it can occur after activation of caspase, can eliminate the requirement of induction needed for skeletal muscle regeneration during chronic conditions of catabolization.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>This eliminating by a 3 bp deletion in frames for the elimination of a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>This eliminating by a 3 bp deletion in frames for the elimination of an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>This eliminating by a 3 bp deletion in the graph for the elimination of asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>This eliminating by a 3-bp deletion in the chart for the elimination of asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>This eliminating by a 3-bp deletion in the table for the elimination of asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>This eliminating by a 3bp deletion in frames for the elimination of a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>This eliminating by a 3bp deletion in frames for the elimination of an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>This eliminating by mutation of a new locus, gals for the elimination of the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>This eliminating in a 3 bp deletion in frames for the removal of a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>This eliminating in a 3 bp deletion in frames for the removal of an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>This eliminating in a 3 bp deletion in the graph for the removal of asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>This eliminating in a 3-bp deletion in the chart for the removal of asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>This eliminating in a 3-bp deletion in the table for the removal of asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>This eliminating in a 3bp deletion in frames for the removal of an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>This eliminating in mutation of a new locus, gals for the removal of the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>This occurs by a 3 bp deletion in frames to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>This occurs by a 3 bp deletion in frames to eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>This occurs by a 3-bp deletion in the chart to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>This occurs by a 3-bp deletion in the table to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>This occurs by a 3bp deletion in frames to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>This occurs by a 3bp deletion in frames to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>This occurs by mutation of a new locus, gals to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>This occurs in a 3 bp deletion in frames to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>This occurs in a 3-bp deletion in the table to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>This occurs in a 3bp deletion in frames to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>This occurs in a 3bp deletion in frames to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>This occurs in mutation of a new locus, gals to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>To eliminate exogeneous H(2)O(2) the same high level of B-Raf activation occurs.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>To eliminate inhibiating phosphorylation the same high level of B-Raf activation occurs.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>To eliminate inhibiting phosphorylation the same high level of B-Raf activation occurs.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>To eliminate inhibitory phosphorylation the same high level of B-Raf activation occurs.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>To eliminate inhibits phosphorylation the same high level of B-Raf activation occurs.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>To eliminating exogeneous H(2)O(2) that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>To eliminating exogeneous H(2)O(2) that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>To eliminating inhibiating phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>To eliminating inhibiating phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>To eliminating inhibiting phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>To eliminating inhibiting phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>To eliminating inhibitory phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>To eliminating inhibitory phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>To eliminating inhibits phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to passively transload through cell membranes.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>To eliminating inhibits phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we used the ability of HOX proteins to translocate passively through cell membranes.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>a 3 bp deletion in frames can eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>a 3 bp deletion in frames can eliminate a sparring residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>a 3 bp deletion in frames can eliminate an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>a 3 bp deletion in frames can eliminate an asparaginal residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>a 3 bp deletion in frames eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>a 3 bp deletion in frames eliminate an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>a 3 bp deletion in frames eliminated a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>a 3 bp deletion in frames eliminated a sparring residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>a 3 bp deletion in frames eliminated an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>a 3 bp deletion in frames eliminated an asparaginal residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>a 3 bp deletion in frames eliminated an asparaginal residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>a 3 bp deletion in frames eliminates a sparring residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>a 3 bp deletion in frames eliminates an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>a 3 bp deletion in frames eliminates an asparaginal residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>a 3 bp deletion in frames eliminates an asparaginal residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>a 3 bp deletion in frames has eliminated a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>a 3 bp deletion in frames has eliminated a sparring residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>a 3 bp deletion in frames has eliminated an asparaginal residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>a 3 bp deletion in frames is able to eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>a 3 bp deletion in frames is able to eliminate a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>a 3 bp deletion in frames is able to eliminate an asparaginal residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>a 3 bp deletion in frames is able to eliminate an asparaginal residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>a 3 bp deletion in frames located in O2 or between OT and O1 will eliminate a sparring residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>a 3 bp deletion in frames located in O2 or between OT and O1 will eliminate an asparaginal residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 eliminated a sparring residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 eliminated an asparaginal residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 eliminates a sparring residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 eliminates an asparaginal residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 will eliminate a sparring residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>a 3 bp deletion in frames located inside O2 or between OT and O1 will eliminate an asparaginal residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>a 3 bp deletion in frames located within O2 or between OT and O1 eliminates a sparring residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>a 3 bp deletion in frames located within O2 or between OT and O1 eliminates an asparaginal residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>a 3 bp deletion in frames located within O2 or between OT and O1 has eliminated a sparring residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>a 3 bp deletion in frames located within O2 or between OT and O1 has eliminated an asparaginal residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>a 3 bp deletion in frames may eliminate a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>a 3 bp deletion in frames may eliminate a sparring residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>a 3 bp deletion in frames may eliminate an asparaginal residue into a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>a 3 bp deletion in frames removes a sparring residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>a 3 bp deletion in frames removes a sparring residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>a 3 bp deletion in frames removes an asparaginal residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>a 3 bp deletion in frames removes an asparaginal residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>a 3 bp deletion in frames that eliminated a sparring residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>a 3 bp deletion in frames that eliminated a sparring residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>a 3 bp deletion in frames that eliminated an asparaginal residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>a 3 bp deletion in frames that eliminated an asparaginal residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>a 3 bp deletion in frames that eliminates a sparring residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>a 3 bp deletion in frames that eliminates a sparring residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>a 3 bp deletion in frames that eliminates an asparaginal residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>a 3 bp deletion in frames that eliminates an asparaginal residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>a 3 bp deletion in frames would eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>a 3 bp deletion in frames), a sparring residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>a 3 bp deletion in frames), an asparaginal residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, has eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, has eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>a 3 bp deletion in frames, as can occur after caspase activation, is able to eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>a 3 bp deletion in frames, as may occur after activation of caspase, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>a 3 bp deletion in frames, as may occur after activation of caspase, is able to eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>a 3 bp deletion in frames, as may occur after caspase activation, eliminates an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>a 3 bp deletion in frames, such as CD14, can eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>a 3 bp deletion in frames, such as CD14, can eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>a 3 bp deletion in frames, such as CD14, eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>a 3 bp deletion in frames, such as CD14, eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>a 3 bp deletion in frames, such as CD14, eliminated a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>a 3 bp deletion in frames, such as CD14, eliminated an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>a 3 bp deletion in frames, such as CD14, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>a 3 bp deletion in frames, such as CD14, is able to eliminate an asparaginal residue.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>a 3 bp deletion in the graph can eliminate asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>a 3 bp deletion in the graph can eliminate asparagine residues, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="331">
                    <text>a 3 bp deletion in the graph eliminate asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="332">
                    <text>a 3 bp deletion in the graph eliminated asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="333">
                    <text>a 3 bp deletion in the graph eliminated asparagine residues while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="334">
                    <text>a 3 bp deletion in the graph eliminates asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="335">
                    <text>a 3 bp deletion in the graph eliminates asparagine residues while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="336">
                    <text>a 3 bp deletion in the graph eliminates asparagine residues, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="337">
                    <text>a 3 bp deletion in the graph has eliminated asparagine residues into product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="338">
                    <text>a 3 bp deletion in the graph has eliminated asparagine residues while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="339">
                    <text>a 3 bp deletion in the graph is able to eliminate asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="340">
                    <text>a 3 bp deletion in the graph is able to eliminate asparagine residues into product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="341">
                    <text>a 3 bp deletion in the graph located in O2 or between OT and O1 will eliminate asparagine residues, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="342">
                    <text>a 3 bp deletion in the graph located inside O2 or between OT and O1 eliminates asparagine residues, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="343">
                    <text>a 3 bp deletion in the graph located inside O2 or between OT and O1 will eliminate asparagine residues, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="344">
                    <text>a 3 bp deletion in the graph located within O2 or between OT and O1 eliminates asparagine residues, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="345">
                    <text>a 3 bp deletion in the graph located within O2 or between OT and O1 has eliminated asparagine residues, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="346">
                    <text>a 3 bp deletion in the graph may eliminate asparagine residues into product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="347">
                    <text>a 3 bp deletion in the graph may eliminate asparagine residues while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="348">
                    <text>a 3 bp deletion in the graph removes asparagine residues eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="349">
                    <text>a 3 bp deletion in the graph removes asparagine residues eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="350">
                    <text>a 3 bp deletion in the graph that eliminated asparagine residues was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="351">
                    <text>a 3 bp deletion in the graph that eliminated asparagine residues was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="352">
                    <text>a 3 bp deletion in the graph that eliminates asparagine residues is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="353">
                    <text>a 3 bp deletion in the graph that eliminates asparagine residues is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="354">
                    <text>a 3 bp deletion in the graph would eliminate asparagine residues in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="355">
                    <text>a 3 bp deletion in the graph), asparagine residues can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="356">
                    <text>a 3 bp deletion in the graph, as can occur after caspase activation, eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="357">
                    <text>a 3 bp deletion in the graph, as can occur after caspase activation, has eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="358">
                    <text>a 3 bp deletion in the graph, as can occur after caspase activation, is able to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="359">
                    <text>a 3 bp deletion in the graph, as may occur after activation of caspase, is able to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="360">
                    <text>a 3 bp deletion in the graph, as may occur after caspase activation, eliminated asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="361">
                    <text>a 3 bp deletion in the graph, as may occur after caspase activation, eliminates asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="362">
                    <text>a 3 bp deletion in the graph, such as CD14, can eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="363">
                    <text>a 3 bp deletion in the graph, such as CD14, is able to eliminate asparagine residues.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="364">
                    <text>a 3-bp deletion in the chart can eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="365">
                    <text>a 3-bp deletion in the chart eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="366">
                    <text>a 3-bp deletion in the chart eliminated asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="367">
                    <text>a 3-bp deletion in the chart eliminated asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="368">
                    <text>a 3-bp deletion in the chart eliminated asparagine residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="369">
                    <text>a 3-bp deletion in the chart eliminates asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="370">
                    <text>a 3-bp deletion in the chart eliminates asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="371">
                    <text>a 3-bp deletion in the chart has eliminated asparagine residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="372">
                    <text>a 3-bp deletion in the chart is able to eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="373">
                    <text>a 3-bp deletion in the chart is able to eliminate asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="374">
                    <text>a 3-bp deletion in the chart located inside O2 or between OT and O1 eliminates asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="375">
                    <text>a 3-bp deletion in the chart located inside O2 or between OT and O1 will eliminate asparagine residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="376">
                    <text>a 3-bp deletion in the chart located within O2 or between OT and O1 eliminates asparagine residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="377">
                    <text>a 3-bp deletion in the chart located within O2 or between OT and O1 has eliminated asparagine residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="378">
                    <text>a 3-bp deletion in the chart may eliminate asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="379">
                    <text>a 3-bp deletion in the chart may eliminate asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="380">
                    <text>a 3-bp deletion in the chart removes asparagine residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="381">
                    <text>a 3-bp deletion in the chart removes asparagine residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="382">
                    <text>a 3-bp deletion in the chart that eliminated asparagine residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="383">
                    <text>a 3-bp deletion in the chart that eliminates asparagine residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="384">
                    <text>a 3-bp deletion in the chart that eliminates asparagine residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="385">
                    <text>a 3-bp deletion in the chart), asparagine residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="386">
                    <text>a 3-bp deletion in the chart, as can occur after caspase activation, has eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="387">
                    <text>a 3-bp deletion in the chart, as can occur after caspase activation, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="388">
                    <text>a 3-bp deletion in the chart, as may occur after activation of caspase, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="389">
                    <text>a 3-bp deletion in the chart, as may occur after caspase activation, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="390">
                    <text>a 3-bp deletion in the chart, as may occur after caspase activation, eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="391">
                    <text>a 3-bp deletion in the chart, such as CD14, can eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="392">
                    <text>a 3-bp deletion in the chart, such as CD14, eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="393">
                    <text>a 3-bp deletion in the chart, such as CD14, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="394">
                    <text>a 3-bp deletion in the chart, such as CD14, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="395">
                    <text>a 3-bp deletion in the table can eliminate asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="396">
                    <text>a 3-bp deletion in the table eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="397">
                    <text>a 3-bp deletion in the table eliminated asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="398">
                    <text>a 3-bp deletion in the table eliminated asparagine residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="399">
                    <text>a 3-bp deletion in the table eliminates asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="400">
                    <text>a 3-bp deletion in the table eliminates asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="401">
                    <text>a 3-bp deletion in the table eliminates asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="402">
                    <text>a 3-bp deletion in the table has eliminated asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="403">
                    <text>a 3-bp deletion in the table has eliminated asparagine residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="404">
                    <text>a 3-bp deletion in the table is able to eliminate asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="405">
                    <text>a 3-bp deletion in the table located in O2 or between OT and O1 will eliminate asparagine residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="406">
                    <text>a 3-bp deletion in the table located inside O2 or between OT and O1 eliminates asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="407">
                    <text>a 3-bp deletion in the table located inside O2 or between OT and O1 will eliminate asparagine residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="408">
                    <text>a 3-bp deletion in the table located within O2 or between OT and O1 eliminates asparagine residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="409">
                    <text>a 3-bp deletion in the table located within O2 or between OT and O1 has eliminated asparagine residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="410">
                    <text>a 3-bp deletion in the table may eliminate asparagine residue into product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="411">
                    <text>a 3-bp deletion in the table may eliminate asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="412">
                    <text>a 3-bp deletion in the table removes asparagine residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="413">
                    <text>a 3-bp deletion in the table that eliminated asparagine residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="414">
                    <text>a 3-bp deletion in the table that eliminated asparagine residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="415">
                    <text>a 3-bp deletion in the table that eliminates asparagine residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="416">
                    <text>a 3-bp deletion in the table that eliminates asparagine residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="417">
                    <text>a 3-bp deletion in the table would eliminate asparagine residue in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="418">
                    <text>a 3-bp deletion in the table), asparagine residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="419">
                    <text>a 3-bp deletion in the table, as can occur after caspase activation, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="420">
                    <text>a 3-bp deletion in the table, as can occur after caspase activation, has eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="421">
                    <text>a 3-bp deletion in the table, as can occur after caspase activation, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="422">
                    <text>a 3-bp deletion in the table, as may occur after activation of caspase, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="423">
                    <text>a 3-bp deletion in the table, as may occur after caspase activation, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="424">
                    <text>a 3-bp deletion in the table, as may occur after caspase activation, eliminates asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="425">
                    <text>a 3-bp deletion in the table, such as CD14, can eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="426">
                    <text>a 3-bp deletion in the table, such as CD14, eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="427">
                    <text>a 3-bp deletion in the table, such as CD14, eliminated asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="428">
                    <text>a 3-bp deletion in the table, such as CD14, is able to eliminate asparagine residue.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="429">
                    <text>a 3bp deletion in frames can eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="430">
                    <text>a 3bp deletion in frames can eliminate a sparring residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="431">
                    <text>a 3bp deletion in frames can eliminate an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="432">
                    <text>a 3bp deletion in frames can eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="433">
                    <text>a 3bp deletion in frames can eliminate an asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="434">
                    <text>a 3bp deletion in frames eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="435">
                    <text>a 3bp deletion in frames eliminate an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="436">
                    <text>a 3bp deletion in frames eliminated a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="437">
                    <text>a 3bp deletion in frames eliminated a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="438">
                    <text>a 3bp deletion in frames eliminated a sparring residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="439">
                    <text>a 3bp deletion in frames eliminated an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="440">
                    <text>a 3bp deletion in frames eliminated an asparagine residue into a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="441">
                    <text>a 3bp deletion in frames eliminated an asparagine residue while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="442">
                    <text>a 3bp deletion in frames eliminates a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="443">
                    <text>a 3bp deletion in frames eliminates a sparring residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="444">
                    <text>a 3bp deletion in frames eliminates a sparring residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="445">
                    <text>a 3bp deletion in frames eliminates an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="446">
                    <text>a 3bp deletion in frames eliminates an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="447">
                    <text>a 3bp deletion in frames eliminates an asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="448">
                    <text>a 3bp deletion in frames eliminates an asparagine residue, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="449">
                    <text>a 3bp deletion in frames has eliminated a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="450">
                    <text>a 3bp deletion in frames has eliminated a sparring residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="451">
                    <text>a 3bp deletion in frames has eliminated an asparagine residue into a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="452">
                    <text>a 3bp deletion in frames has eliminated an asparagine residue while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="453">
                    <text>a 3bp deletion in frames is able to eliminate a sparring residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="454">
                    <text>a 3bp deletion in frames is able to eliminate a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="455">
                    <text>a 3bp deletion in frames is able to eliminate an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="456">
                    <text>a 3bp deletion in frames is able to eliminate an asparagine residue in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="457">
                    <text>a 3bp deletion in frames is able to eliminate an asparagine residue into a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="458">
                    <text>a 3bp deletion in frames located in O2 or between OT and O1 will eliminate a sparring residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="459">
                    <text>a 3bp deletion in frames located in O2 or between OT and O1 will eliminate an asparagine residue, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="460">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 eliminated a sparring residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="461">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 eliminated an asparagine residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="462">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 eliminates a sparring residue, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="463">
                    <text>a 3bp deletion in frames located inside O2 or between OT and O1 will eliminate an asparagine residue, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="464">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 eliminates a sparring residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="465">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 eliminates an asparagine residue, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="466">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 has eliminated a sparring residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="467">
                    <text>a 3bp deletion in frames located within O2 or between OT and O1 has eliminated an asparagine residue, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="468">
                    <text>a 3bp deletion in frames may eliminate a sparring residue into a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="469">
                    <text>a 3bp deletion in frames may eliminate a sparring residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="470">
                    <text>a 3bp deletion in frames may eliminate an asparagine residue into a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="471">
                    <text>a 3bp deletion in frames may eliminate an asparagine residue while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="472">
                    <text>a 3bp deletion in frames removes a sparring residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="473">
                    <text>a 3bp deletion in frames removes a sparring residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="474">
                    <text>a 3bp deletion in frames removes an asparagine residue eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="475">
                    <text>a 3bp deletion in frames removes an asparagine residue eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="476">
                    <text>a 3bp deletion in frames that eliminated a sparring residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="477">
                    <text>a 3bp deletion in frames that eliminated a sparring residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="478">
                    <text>a 3bp deletion in frames that eliminated an asparagine residue was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="479">
                    <text>a 3bp deletion in frames that eliminated an asparagine residue was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="480">
                    <text>a 3bp deletion in frames that eliminates a sparring residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="481">
                    <text>a 3bp deletion in frames that eliminates a sparring residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="482">
                    <text>a 3bp deletion in frames that eliminates an asparagine residue is located within O2 or between OT and O1, while maintaining significant repression in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="483">
                    <text>a 3bp deletion in frames that eliminates an asparagine residue is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="484">
                    <text>a 3bp deletion in frames would eliminate an asparagine residue in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="485">
                    <text>a 3bp deletion in frames), a sparring residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="486">
                    <text>a 3bp deletion in frames), an asparagine residue can be completely eliminated (figure 7).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="487">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="488">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, has eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="489">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, has eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="490">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="491">
                    <text>a 3bp deletion in frames, as can occur after caspase activation, is able to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="492">
                    <text>a 3bp deletion in frames, as may occur after activation of caspase, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="493">
                    <text>a 3bp deletion in frames, as may occur after caspase activation, eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="494">
                    <text>a 3bp deletion in frames, as may occur after caspase activation, eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="495">
                    <text>a 3bp deletion in frames, as may occur after caspase activation, eliminates a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="496">
                    <text>a 3bp deletion in frames, as may occur after caspase activation, eliminates an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="497">
                    <text>a 3bp deletion in frames, such as CD14, can eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="498">
                    <text>a 3bp deletion in frames, such as CD14, can eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="499">
                    <text>a 3bp deletion in frames, such as CD14, eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="500">
                    <text>a 3bp deletion in frames, such as CD14, eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="501">
                    <text>a 3bp deletion in frames, such as CD14, eliminated a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="502">
                    <text>a 3bp deletion in frames, such as CD14, eliminated an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="503">
                    <text>a 3bp deletion in frames, such as CD14, is able to eliminate a sparring residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="504">
                    <text>a 3bp deletion in frames, such as CD14, is able to eliminate an asparagine residue.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="505">
                    <text>a sparring residue are eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="506">
                    <text>a sparring residue are eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="507">
                    <text>a sparring residue has been eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="508">
                    <text>a sparring residue has been eliminated by a 3 bp deletion in frames, as may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="509">
                    <text>a sparring residue has been eliminated by a 3bp deletion in frames, as may occur after activation of caspase.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="510">
                    <text>a sparring residue is eliminated by a 3 bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="511">
                    <text>a sparring residue is eliminated by a 3 bp deletion in frames to a product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="512">
                    <text>a sparring residue is eliminated by a 3 bp deletion in frames via a product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="513">
                    <text>a sparring residue is eliminated by a 3 bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="514">
                    <text>a sparring residue is eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="515">
                    <text>a sparring residue is eliminated by a 3bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="516">
                    <text>a sparring residue is eliminated by a 3bp deletion in frames via a product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="517">
                    <text>a sparring residue is eliminated in a product kinase domain by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="518">
                    <text>a sparring residue is eliminated in a product kinase domain to a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="519">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames at a concentration of 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="520">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="521">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="522">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="523">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="524">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="525">
                    <text>a sparring residue was eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="526">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="527">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames at a concentration of 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="528">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="529">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="530">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="531">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="532">
                    <text>a sparring residue was eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="533">
                    <text>a sparring residue was eliminated in a product kinase domain by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="534">
                    <text>a sparring residue was eliminated in a product kinase domain for a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="535">
                    <text>a sparring residue was eliminated in a product kinase domain for a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="536">
                    <text>a sparring residue were eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="537">
                    <text>a sparring residue were eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="538">
                    <text>a sparring residue will be eliminated by a 3 bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="539">
                    <text>a sparring residue will be eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="540">
                    <text>a sparring residue will be eliminated by a 3bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="541">
                    <text>a sparring residue will be eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">a sparring residue</arg>
                </example>
                <example src="REPLACE" no="542">
                    <text>an asparaginal residue are eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="543">
                    <text>an asparaginal residue has been eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="544">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="545">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames to a product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="546">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames via a product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="547">
                    <text>an asparaginal residue is eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="548">
                    <text>an asparaginal residue is eliminated in a product kinase domain by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="549">
                    <text>an asparaginal residue is eliminated in a product kinase domain to a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="550">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="551">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames at a concentration of 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="552">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="553">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="554">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="555">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="556">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="557">
                    <text>an asparaginal residue was eliminated by a 3 bp deletion in frames.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="558">
                    <text>an asparaginal residue were eliminated by a 3 bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="559">
                    <text>an asparaginal residue will be eliminated by a 3 bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="560">
                    <text>an asparaginal residue will be eliminated by a 3 bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in frames</arg>
                    <arg n="1">an asparaginal residue</arg>
                </example>
                <example src="REPLACE" no="561">
                    <text>an asparagine residue are eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="562">
                    <text>an asparagine residue has been eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="563">
                    <text>an asparagine residue has been eliminated by a 3bp deletion in frames, as may occur after activation of caspase.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="564">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="565">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="566">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames to a kinase domain of the product, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="567">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames via a kinase domain of the product, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="568">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames via a product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="569">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="570">
                    <text>an asparagine residue is eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="571">
                    <text>an asparagine residue is eliminated in a kinase domain of the product by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="572">
                    <text>an asparagine residue is eliminated in a kinase domain of the product to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="573">
                    <text>an asparagine residue is eliminated in a product kinase domain by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="574">
                    <text>an asparagine residue is eliminated in a product kinase domain to a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="575">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames at a concentration of 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="576">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="577">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames in a kinase domain of the product.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="578">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames in a product kinase domain.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="579">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames to a kinase domain of the product while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="580">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames to a kinase domain of the product while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="581">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames to a product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="582">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="583">
                    <text>an asparagine residue was eliminated by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="584">
                    <text>an asparagine residue was eliminated in a kinase domain of the product by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="585">
                    <text>an asparagine residue was eliminated in a kinase domain of the product for a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a kinase domain of the product</arg>
                </example>
                <example src="REPLACE" no="586">
                    <text>an asparagine residue was eliminated in a product kinase domain by a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="587">
                    <text>an asparagine residue was eliminated in a product kinase domain for a 3bp deletion in frames.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                    <arg n="2">a product kinase domain</arg>
                </example>
                <example src="REPLACE" no="588">
                    <text>an asparagine residue were eliminated by a 3bp deletion in frames, such as CD14.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="589">
                    <text>an asparagine residue will be eliminated by a 3bp deletion in frames at a concentration 10 times higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="590">
                    <text>an asparagine residue will be eliminated by a 3bp deletion in frames at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3bp deletion in frames</arg>
                    <arg n="1">an asparagine residue</arg>
                </example>
                <example src="REPLACE" no="591">
                    <text>asparagine residue are eliminated by a 3-bp deletion in the chart, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="592">
                    <text>asparagine residue are eliminated by a 3-bp deletion in the table, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="593">
                    <text>asparagine residue has been eliminated by a 3-bp deletion in the chart at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="594">
                    <text>asparagine residue has been eliminated by a 3-bp deletion in the chart, as may occur after activation of caspase.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="595">
                    <text>asparagine residue has been eliminated by a 3-bp deletion in the table at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="596">
                    <text>asparagine residue has been eliminated by a 3-bp deletion in the table, as may occur after activation of caspase.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="597">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="598">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart to product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="599">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart via product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="600">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="601">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="602">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="603">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table to product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="604">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table via product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="605">
                    <text>asparagine residue is eliminated by a 3-bp deletion in the table, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="606">
                    <text>asparagine residue is eliminated in product kinase domain by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="607">
                    <text>asparagine residue is eliminated in product kinase domain by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="608">
                    <text>asparagine residue is eliminated in product kinase domain to a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="609">
                    <text>asparagine residue is eliminated in product kinase domain to a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="610">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart at a concentration 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="611">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart at a concentration of 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="612">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="613">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart to product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="614">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart to product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="615">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="616">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="617">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table at a concentration of 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="618">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="619">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table in product kinase domain.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="620">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table to product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="621">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table to product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="622">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="623">
                    <text>asparagine residue was eliminated by a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="624">
                    <text>asparagine residue was eliminated in product kinase domain by a 3-bp deletion in the chart.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="625">
                    <text>asparagine residue was eliminated in product kinase domain for a 3-bp deletion in the table.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="626">
                    <text>asparagine residue were eliminated by a 3-bp deletion in the chart, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="627">
                    <text>asparagine residue were eliminated by a 3-bp deletion in the table, such as CD14.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="628">
                    <text>asparagine residue will be eliminated by a 3-bp deletion in the chart at a concentration 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="629">
                    <text>asparagine residue will be eliminated by a 3-bp deletion in the chart at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the chart</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="630">
                    <text>asparagine residue will be eliminated by a 3-bp deletion in the table at a concentration 10 times higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="631">
                    <text>asparagine residue will be eliminated by a 3-bp deletion in the table at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3-bp deletion in the table</arg>
                    <arg n="1">asparagine residue</arg>
                </example>
                <example src="REPLACE" no="632">
                    <text>asparagine residues are eliminated by a 3 bp deletion in the graph, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="633">
                    <text>asparagine residues has been eliminated by a 3 bp deletion in the graph at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="634">
                    <text>asparagine residues is eliminated by a 3 bp deletion in the graph in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="635">
                    <text>asparagine residues is eliminated by a 3 bp deletion in the graph to product kinase domain, while the mutation to S494 has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="636">
                    <text>asparagine residues is eliminated by a 3 bp deletion in the graph via product kinase domain, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="637">
                    <text>asparagine residues is eliminated by a 3 bp deletion in the graph, as it may occur after activation of caspase.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="638">
                    <text>asparagine residues is eliminated by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="639">
                    <text>asparagine residues is eliminated in product kinase domain by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="640">
                    <text>asparagine residues is eliminated in product kinase domain to a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="641">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph at a concentration 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="642">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph at a concentration of 10 times higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="643">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="644">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph in product kinase domain.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="645">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph to product kinase domain while the mutation to S494 had no effect (Figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="646">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph to product kinase domain while the mutation to S494 had no effect (figure 2C).</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="647">
                    <text>asparagine residues was eliminated by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="648">
                    <text>asparagine residues was eliminated in product kinase domain by a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="649">
                    <text>asparagine residues was eliminated in product kinase domain for a 3 bp deletion in the graph.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                    <arg n="2">product kinase domain</arg>
                </example>
                <example src="REPLACE" no="650">
                    <text>asparagine residues were eliminated by a 3 bp deletion in the graph, such as CD14.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="651">
                    <text>asparagine residues will be eliminated by a 3 bp deletion in the graph at a concentration of 10-fold-higher.</text>
                    <arg n="0">a 3 bp deletion in the graph</arg>
                    <arg n="1">asparagine residues</arg>
                </example>
                <example src="REPLACE" no="652">
                    <text>eliminate exogeneous H(2)O(2) causes the same B-Raf activation level to occur.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="653">
                    <text>eliminate inhibiating phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="654">
                    <text>eliminate inhibiting phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="655">
                    <text>eliminate inhibits phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="656">
                    <text>eliminating exogeneous H(2)O(2) causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="657">
                    <text>eliminating exogeneous H(2)O(2) that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="658">
                    <text>eliminating inhibiating phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="659">
                    <text>eliminating inhibiating phosphorylation causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="660">
                    <text>eliminating inhibiating phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="661">
                    <text>eliminating inhibiting phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="662">
                    <text>eliminating inhibiting phosphorylation causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="663">
                    <text>eliminating inhibiting phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="664">
                    <text>eliminating inhibitory phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="665">
                    <text>eliminating inhibitory phosphorylation causes the same high level of B-Raf activation to occur.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="666">
                    <text>eliminating inhibitory phosphorylation that may be associated with the stable transfer of the HOXB4 gene to human cells, we exploit the ability of HOX proteins to passively transfer through cell membranes.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="667">
                    <text>eliminating inhibits phosphorylation causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="668">
                    <text>exogeneous H(2)O(2) eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="669">
                    <text>exogeneous H(2)O(2) eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">exogeneous H(2)O(2)</arg>
                </example>
                <example src="REPLACE" no="670">
                    <text>inhibiating phosphorylation eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="671">
                    <text>inhibiating phosphorylation eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiating phosphorylation</arg>
                </example>
                <example src="REPLACE" no="672">
                    <text>inhibiting phosphorylation eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="673">
                    <text>inhibiting phosphorylation eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibiting phosphorylation</arg>
                </example>
                <example src="REPLACE" no="674">
                    <text>inhibitory phosphorylation eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="675">
                    <text>inhibitory phosphorylation eliminated causes the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibitory phosphorylation</arg>
                </example>
                <example src="REPLACE" no="676">
                    <text>inhibits phosphorylation eliminated cause the same B-Raf activation level to occur.</text>
                    <arg n="1">inhibits phosphorylation</arg>
                </example>
                <example src="REPLACE" no="677">
                    <text>mutation of a new locus, gals can eliminate the requirement of induction, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="678">
                    <text>mutation of a new locus, gals eliminated the requirement of induction while the S494 mutation had no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="679">
                    <text>mutation of a new locus, gals eliminates the requirement of induction while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="680">
                    <text>mutation of a new locus, gals eliminates the requirement of induction, while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="681">
                    <text>mutation of a new locus, gals has eliminated the requirement of induction while the mutation in S494 had no effect (Figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="682">
                    <text>mutation of a new locus, gals located in O2 or between OT and O1 will eliminate the requirement of induction, while deletion will remain significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="683">
                    <text>mutation of a new locus, gals located inside O2 or between OT and O1 eliminates the requirement of induction, while suppression was significant in the case of an insertion of 10-bp inside O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="684">
                    <text>mutation of a new locus, gals located inside O2 or between OT and O1 will eliminate the requirement of induction, while suppression will be maintained significant in case of insertion of 10-bp into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="685">
                    <text>mutation of a new locus, gals located within O2 or between OT and O1 has eliminated the requirement of induction, while maintaining significant repression in the case of an insertion of 10 bp into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="686">
                    <text>mutation of a new locus, gals may eliminate the requirement of induction while the S494 mutation has no effect (figure 2C).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="687">
                    <text>mutation of a new locus, gals removes the requirement of induction eliminated in constitutive and ultra-induced levels of gal expression.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="688">
                    <text>mutation of a new locus, gals removes the requirement of induction eliminated in constitutive and ultrainduced levels of the gal expression.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="689">
                    <text>mutation of a new locus, gals that eliminated the requirement of induction was within O2 or between OT and O1, while deletion was significant in the case of a 10-bp insertion in O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="690">
                    <text>mutation of a new locus, gals that eliminated the requirement of induction was within O2 or between OT and O1, while maintaining significant repression in the case of a 10 bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="691">
                    <text>mutation of a new locus, gals that eliminates the requirement of induction is within O2 or between OT and O1, while deletion is significant in the case of a 10-bp insertion into O2.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="692">
                    <text>mutation of a new locus, gals), the requirement of induction can be completely eliminated (figure 7).</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="693">
                    <text>mutation of a new locus, gals, as can occur after caspase activation, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="694">
                    <text>mutation of a new locus, gals, as can occur after caspase activation, has eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="695">
                    <text>mutation of a new locus, gals, as can occur after caspase activation, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="696">
                    <text>mutation of a new locus, gals, as may occur after activation of caspase, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="697">
                    <text>mutation of a new locus, gals, as may occur after caspase activation, eliminates the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="698">
                    <text>mutation of a new locus, gals, such as CD14, can eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="699">
                    <text>mutation of a new locus, gals, such as CD14, eliminated the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="700">
                    <text>mutation of a new locus, gals, such as CD14, is able to eliminate the requirement of induction.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="701">
                    <text>the requirement of induction are eliminated by mutation of a new locus, gals, such as CD14.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="702">
                    <text>the requirement of induction has been eliminated by mutation of a new locus, gals at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="703">
                    <text>the requirement of induction has been eliminated by mutation of a new locus, gals, as may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="704">
                    <text>the requirement of induction is eliminated by mutation of a new locus, gals, as it may occur after activation of caspase.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="705">
                    <text>the requirement of induction is eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="706">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="707">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals at a concentration of 10 times higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="708">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals at a concentration of 10-fold-higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="709">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals, such as CD14.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="710">
                    <text>the requirement of induction was eliminated by mutation of a new locus, gals.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="711">
                    <text>the requirement of induction were eliminated by mutation of a new locus, gals, such as CD14.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
                <example src="REPLACE" no="712">
                    <text>the requirement of induction will be eliminated by mutation of a new locus, gals at a concentration 10 times higher.</text>
                    <arg n="0">mutation of a new locus, gals</arg>
                    <arg n="1">the requirement of induction</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
